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 Sumário 
 
Este trabalho pretende contribuir para o conhecimento geral da resposta imunológica 
do mosquito ao parasita da malária, uma vez que a elucidação das interacções entre 
vector e parasita poderão facilitar o desenvolvimento de medidas eficientes para 
bloquear a transmissão. As experiências realizadas neste trabalho incluíram o uso de 
Drosophila melanogaster como modelo de estudo das respostas imunológicas do 
mosquito e a avaliação do impacto da presença de esporozoítos de Plasmodium na 
hemolinfa do mosquito através da determinação de alterações no número de 
hemócitos, activação da reacção de melanização e do padrão de expressão de 
proteínas na hemolinfa do mosquito.  
 
O fármaco antimalárico cloroquina promove a transmissão no mosquito e tem sido 
relacionado com a expressão diferencial de péptidos antimicrobianos no mosquito. 
Para avaliar o efeito da cloroquina na sua produção usámos o modelo Drosophila, uma 
vez que  a expressão e síntese de péptidos antimicrobianos na mosca está bem 
caracterizada, assim como as vias de sinalização da resposta imunológica. Os 
resultados deste trabalho não conseguiram provar algum efeito do fármaco na 
expressão e/ou síntese de péptidos antimicrobianos de Drosophila. O tratamento com 
cloroquina in vivo não afectou as vias de sinalização Toll e Imd, avaliado pela expressão 
de drosomicina e diptericina em moscas infectadas. Experiências in vitro em que se 
utilizaram linhas celulares derivadas de hemócitos de moscas produziram os mesmos 
resultados para a síntese de Drosomicina e Atacina. Experiências de sobrevivência de 
moscas infectadas e tratadas com cloroquina também não evidenciaram qualquer 
efeito do fármaco na resposta imunitária de Drosophila. Como este fármaco 
antimalárico tem um efeito conhecido na resposta imune do mosquito, propomos que 
a cloroquina tenha uma acção sobre moléculas específicas dos mosquito ou sobre 
diferentes vias de activação da sinalização que possam estar presentes apenas no 
mosquito. Por outro lado, a informação conhecida acerca do efeito da cloroquina na 
imunidade foi obtida após tratamento de humanos, ratinhos ou linhas celulares de 
mamíferos, implicando a metabolização do fármaco. Como tal, não é claro se o efeito 
observado resulta da acção do própria fármaco ou de um metabolito específico.  
 
Neste trabalho pretendeu-se também determinar as respostas do mosquito aos 
esporozoítos de Plasmodium na hemolinfa, uma vez que nesta fase da infecção no 
mosquito o parasita sofre uma grande redução no seu número. No hemocélio do 
VI 
  
mosquito podem ser activadas respostas celulares e humorais. Durante o seu 
desenvolvimento no oocysto, os esporozoítos são cobertos por uma camada de 
proteína circumsporozoítica, que constitui o seu maior antigénio de superfície. Quando 
o oocisto rompe e os esporozoítos são libertados, esta proteína pode ser reconhecida 
pelas moléculas de reconhecimento presentes na hemolinfa levando à activação de 
respostas imunes. A activação de respostas imunitárias celulares contra os 
esporozoítos foi testada com base na determinação de variação do número de 
hemócitos quando estimulados com a proteína circumsporozoítica de P. falciparum. 
Apenas uma das doses (5ng) de proteína utilizadas para estimular linhas celulares de 
hemóctios causou uma redução significativa no números de hemócitos. Isto pode ser 
um reflexo de uma cinética de divisão celular mais lenta ou de destruição celular, 
apoptose, que poderia ser despoletada pela fagocitose de parasitas, por exemplo. Não 
foi possível obter uma resposta correlacionada com a dose usada para estimulação. No 
entanto, os hemócitos do mosquito parecem reconhcer a proteína do parasita e 
responder à sua presença. 
   
A activação da reacção de melanização durante a invasão da hemolinfa por 
esporozoítos foi testada, através da determinação da activação da enzima 
profenoloxidase e da actividade da fenoloxidase. Verificou-se que a actividade 
enzimática da fenoloxidase varia com o tempo em mosquitos submetidos a uma 
refeição sanguínea não infectante. A infecção por P. berhgei não pareceu impor 
variações na actividade da fenoloxidase. Diferenças subtis foram observadas aos dias 
9, 12 e 15 pós-infecção, sendo a actividade enzimática mais elevada em mosquitos 
infectados. Os esporozoítos foram detectados na hemolinfa de mosquitos a partir do 
dia 9 pós-infecção, indicando que o parasita pode induzir um aumento subtil na 
activação da melanização. A actividade da fenoloxidase parece ser mantida 
constitutivamente num nível baixo, mesmo em mosquitos não infectados, o que pode 
explicar que apenas pequenas diferenças sejam observadas em mosquitos infectados. 
Injecções da proteína circumsporozoítica de P. falciparum em mosquitos não 
revelaram indução da actividade da enzima fenoloxidase. Apesar de não ter sido 
possível demonstrar conclusivamente a melanização de esporozoítos na hemolinfa, 
experiências de inibição da fenoloxidase mostraram que a actividade desta enzima é 
necessária para controlar o número de esporozoítos na hemolinfa e nas glândulas 
salivares. 
 
A hemolinfa é extremamente rica em proteínas, e conhecida por albergar a maior 
parte das moléculas do sistema imunológico necessárias ao reconhecimento, 
sinalização e à resposta efectora. Como tal, de modo a caracterizar o proteoma da 
hemolinfa durante a infecção por P. berhgei ao dia 13 pós-infecção, usámos uma 
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abordagem que incluiu electroforese bidimensional e espectrometria de massa MALDI-
TOF, visando identificar proteínas diferencialmente reguladas em mosquitos 
infectados. As proteínas com níveis alterados na hemolinfa de mosquitos infectados 
poderão estar envolvidas em processos fisiológicos como metabolismo de ácidos 
gordos, glicólise e transporte de iões. Estes resultados indicam que o parasita impõe 
alterações no metabolismo do mosquito, quer directamente quer levando o mosquito 
a alterar o seu próprio metabolismo como forma de conter a infecção. De facto, não há 
evidência se as alterações observadas são danosas ou necessárias para o 
desenvolvimento do parasita. No entanto, os nossos resultados sugerem que 
mecanismos fisiológicos do mosquito podem ter um papel na resposta imune. Um 
dado interessante obtido neste trabalho foi a inexistência de correlação entre a 
regulação a nível proteico e a nível do RNA na hemolinfa. Isto pode derivar de uma 
janela de tempo diferente entre expressão génica e síntese proteica, uma vez que as 
amostras foram recolhidas ao mesmo tempo, ou pode reflectir um fonte diferente de 
RNA e proteína. O RNA amplificado para avaliar a expressão génica era originário dos 
hemócitos presentes na hemolinfa, enquanto que as proteínas podem ter sido 
produzidas quer pelos hemócitos quer pelo corpo gordo, que sintetiza a maior parte 
das moléculas imunes que são secretadas para a hemolinfa. No entanto, é importante 
tem em atenção que a informação resultante da análise de expressão génica ter de ser 
avaliada cuidadosamente, pois pode não ter uma regulação correspondente ao nível 
da proteína. A biosíntese de eicosanóides teve dois impactos distintos e opostos no 
desenvolvimento do parasita, promovendo e bloqueando a transmissão. Os 
eicosanóides parecem ser importantes para o desenvolvimento do parasita numa fase 
da infecção em que os esporozoítos se desenvolvem nos oocistos, enquanto que numa 
fasemais tardia, estas moléculas parecem ser importantes para controlar o número de 
parasitas na hemolinfa. Os nossos resultados sugerem que o parasita possa 
imunosuprimir o mosquito.            
 
A resposta do mosquito ao Plasmodium parece ser muito complexa, envolvendo 
acções de ambos os organismos. Para responderà invasão da hemolinfa pelos 
esporozoítos, o mosquito parece depender de diferentes mecanismos, como a 
fagocitose e a melanização. Para além destes, moléculas envolvidas em processos 
fisiológicos do mosquito são também afectadas pela infecção. Os nossos resultados 
sugerem que a resposta imunológica do mosquito possa envolver mecanismos para 
além daqueles que são tradicionalmente relacionados com a imunidade, como a 
biosíntese de eicosanóides. Verificámos também que pode não existir correlação entre 
a expressão génica e a síntese de proteínas, e como tal, a resposta imune deveria ser 
analisada em primeiro lugar por uma abordagem proteómica.  
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Abstract 
 
This work aimed at contributing to the general knowledge of the mosquito immune 
responses to the malaria parasite, in hope that the elucidation of vector/parasite 
interactions will facilitate the development of effective transmission blocking 
measures. Experiments performed here include the use of Drosophila melanogaster as 
a model for immunity studies in the mosquito and the evaluation of Plasmodium 
sporozoites presence in mosquito hemolymph impact on hemocyte numbers, 
melanization reaction responses and protein expression pattern. 
 
Chloroquine promotes malaria transmission in mosquito and it has been linked to 
differential AMP gene expression in mosquitoes. As Drosophila AMP expression and 
synthesis is well understood and as we have a good knowledge about immune 
signaling pathways, we chose this model to evaluate chloroquine effect on AMP 
production upon infection. Our results failed to show any drug effect on Drosophila 
AMP expression and/or synthesis. Drug treatment in vivo did not affect either the Toll 
or Imd immune signaling pathways, as shown when accessing drosomycin and 
diptericin expression in infected flies, and in vitro experiments using hemocyte-like cell 
lines produced the same results for Drosomycin and Attacin synthesis. Survival 
experiments were also performed in drug treated flies and failed to indicate any effect. 
For all the mechanisms tested, chloroquine did not seem to have any effect on 
Drosophila immunity. As this antimalarial drug has a known effect on mosquito 
immunity we propose that chloroquine may act on particular mosquito immune 
molecules or on different routes for pathway activation operating in the mosquito. 
Also, data obtained for chloroquine action on immunity were collected from treatment 
of humans, mice or mammalian cell-lines, implying that the drug is metabolized. Thus 
it is not clear if the observed effect results from an action of the drug itself, or from a 
specific metabolite. This would explain why direct drug feeding to flies would fail to 
produce an effect on Drosophila immunity. 
 
Another purpose of this work was to determine the mosquito responses to 
Plasmodium sporozoites in the hemolymph, as parasite development in the mosquito 
suffers a major bottleneck at this stage of infection. Both cellular and humoral 
responses may be triggered in the mosquito hemocel. Upon development inside the 
oocysts, sporozoites are covered with a layer of circumsporozoite protein, its major 
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surface antigen. Recognition molecules present in the hemolymph may recognize 
sporozoites upon oocyst burst, possibly through its surface protein and activate 
immune responses towards it. Cellular responses towards sporozoites were tested, 
based on the evaluation of hemocyte number variation upon stimulation with the 
circumsporozoite protein of P. falciparum. Only one dose (5ng) stimulated hemocyte-
like cell lines and led to a significant reduction in cell numbers. This may reflect a 
slower cell-division kinetics or cell destruction, by apoptosis, following phagocytosis. 
We failed to show any dose-dependent response. Nevertheless, it seems that the CS 
protein is recognized by mosquito hemocytes that respond to its presence only in 
specific conditions.  
 
We also tested for activation of melanization reaction upon sporozoite invasion of the 
hemolymph by accessing PPO activation and PO activity. PO activity was found to vary 
over time in blood fed mosquitoes. P. berghei infection did not seem to impose 
variations in PO activity. Subtle differences were observed at D9, 12 and 15pi, when PO 
activity was higher in infected mosquitoes. Sporozoites were first detected in the 
hemolymph at D9pi indicating that parasite recognition may induce subtle increases in 
melanization activation. PO activity seems to be maintained at a low level even in non-
infected mosquitoes. This may explain the fact that no great variations were observed 
upon infection. Pf-CS protein injections in mosquitoes failed to show PO activity 
induction. Although we could not conclusively determine sporozoite melanization, PO 
inhibition experiments showed that its activity is necessary for control of sporozoite 
load in the hemolymph and salivary glands.  
 
Hemolymph is an extremely protein rich environment, and known to harbor most of 
the immune molecules necessary for recognition, signaling and effector mechanisms. 
As such, we used a two dimensional electrophoresis approach coupled with MALDI-
TOF mass spectrometry to compare the hemolymph proteome of P. berghei infected 
and non-infected An. gambiae mosquitoes at D13pi, aiming at the identification of 
differentially regulated protein in infected mosquitoes. Proteins found to have altered 
levels in the hemolymph of infected mosquitoes are predicted to be involved in 
physiological processes such as fatty acid metabolism, aminoacid synthesis, glycolysis 
and ion transport. This indicated that the parasite imposes alterations in the overall 
mosquito metabolism, either directly, or secondarly to combat infection. Actually we 
have no evidence if the alterations observed are harmful or necessary for parasite 
development. Yet, the results suggest that mechanisms operating in mosquito 
physiology may have a role on immune responses. An interesting fact is that protein 
regulation in the hemolymph did not correlate at any level with gene transcription. 
This may reflect a different time frame between transcription and protein synthesis, as 
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samples were collected at the same time, or a different source for the RNAs and the 
tested proteins. RNA amplified to evaluate transcription was hemolymph, ie, 
hemocyte-derived, while hemolymph proteins may have been produced not only by 
hemocytes, but also by fat body cells, that synthesize the majority of immune-related 
molecules secreted into the hemolymph. Nevertheless, it is important to bear in mind 
that data resulting from gene expression analysis have to be carefully analyzed as it 
may not indicate direct protein synthesis. Eicosanoid biosynthesis was found to have 
two distinctive and opposite impacts in parasite development: both promoting and 
blocking transmission. Eicosanoids seem to be important for parasite biology and 
development, at a time when sporozoites are developing inside oocysts. At a later 
stage, these molecules seem to restrain sporozoite infection in the hemolymph. 
Evidence also point to mosquito immunosuppression by the parasite.  
Mosquito responses to Plasmodium seem to be highly complex, involving actions from 
both organisms. To respond to hemolymph invasion by sporozoites, the mosquito 
seems to rely on different mechanisms, such as phagocytosis and melanization.  
Additionally, molecules involved in physiological processes are affected by hemolymph 
infection. Data obtained by this work suggests that immune responses may include 
mechanisms other than those traditionally related to immunity, as in the case of 
eicosanoid biosynthesis. Also, our results indicate that correlation between 
transcription and protein synthesis is not sure to exist and thus, immune responses 
should be analyzed by proteomics in a first approach. 
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I.1 –  Malaria 
Malaria is one of the most life-threatening diseases affecting the human population. 
Together with HIV/AIDS and tuberculosis, it has become a calamity with worldwide 
proportions, mainly in sub-tropical countries. The WHO reports around 500 million 
cases of malaria each year, resulting in one million deaths, particularly of children 
under 5 years old.   
In old days, malaria was attributed to the fetid marshes around Rome, hence the name 
of “bad-air” (mal-aria, in Italian), or Roman fever. In the late 19
th
 century, scientists 
realized that a single-cell organism is responsible for the illness of malaria.  
  
 I.1.1 – The Parasite  
The single–cell organism is a protozoan parasite from the genus Plasmodium. 
Taxonomically, it belongs to the Alveolata phylum, the Apicomplexa order, the 
Haemosporida family, and the Plasmodium genus, Levine, 1988. Biologically, the 
parasite has an exceedingly complex life cycle in which it alternates between a 
vertebrate host and an anopheline mosquito vector. In the host, the parasite is 
responsible for the illness observed in malaria-infected people, while in the vector it 
multiplies and develops compromising the mosquito’s fitness. Figure I.1.1 shows the 
detailed life cycle of the Plasmodium parasite. 
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I.1.2 – The disease     
Malaria illness occurs during erythrocytic schizogony. Successive cycles of parasite 
invasion result in elevated numbers of red blood cells destroyed, causing acute 
anemia. At the same time, erythrocyte rupture releases pyrogenic substances into the 
blood causing high fevers. Thus, anemia, high fivers chills and renal insufficiency are 
the general symptoms of malaria, and are caused by infection with any of the four 
species of Plasmodium that infect humans:    Plasmodium malariae, Plasmodium ovale, 
Plasmodium vivax and Plasmodium falciparum (Tuteja, 2007). The later has an 
additional property: it induces cytoadherence in the infected red blood cells that easily 
adhere to the blood capillaries wall, hindering oxygen delivery to the major organs. If 
this occurs in the brain, it leads to coma, and inescapably to death. Cerebral malaria is 
the worst form of malaria known, and P. falciparum is the deadliest of the malaria 
parasites.    
Figure I.1.1 – Plasmodium life cycle. (Adapted 
from www.who.int/tdr/diseases/malaria/lifecycle) 
Parasites are passed on to the vertebrate host 
through the mosquito bite (i). The parasite rapidly 
infects the liver (ii) where it multiplies forming new 
invasive forms (merozoites) – hepatic schizogony. 
These are released into the blood stream (iii) and 
invade red blood cells (iv). Merozoites mature into 
schizonts and undergo a series of divisions forming 
new invasive merozoites (v), initiating cycles of 
erythrocyte invasion, maturation and rupture, 
causing the disease – erythrocytic schizogony. 
Some merozoites differentiate into gametocytes 
(vi) that are taken up by the mosquito in a blood 
meal (vii). In the mosquito midgut the parasite 
activates gametocytes maturation into gametes. 
Fertilization occurs (viii) and a motile zygote is 
formed (ookinete). It traverses the midgut epithelia 
and settles down underneath the basal lamina, 
forming a cyst (oocyst) (ix). Inside, thousands of 
new invasive forms develop (sporozoites). Upon 
oocyst burst, these are released into the mosquito 
hemolymph (x) and flow to the salivary glands, 
where they accumulate until the next bite – 
sporogonic development, initiating a new cycle (i). 
 
Mosquito 
Vertebrate host 
i 
ii 
iii 
iv 
v 
vi 
vii 
viii 
ix 
x 
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In the last few decades, the number of malaria-ill people has been rising, and the 
situation is becoming even more serious, since it is estimated that the numbers will (at 
least) double by 2020 (Breman, 2001). Several factors are contributing for this 
increase: i) the increasing development of parasites resistant to antimalarial drugs; ii) 
the existence of different Plasmodium species and their inherent antigenic variation 
that amplifies parasite variability; iii) the geographical and socio-economical conditions 
of endemic countries, and the development of other so called poverty diseases, like 
HIV/AIDS and Tuberculosis; iv) the hot and humid weather, the poor health and 
sanitary system, and insecticide resistance that contribute for the large scale 
development and reproduction of the mosquito vector, and v) the breakdown of 
control programs. 
Therefore, to efficiently combat malaria, an integrated action will have to be created, 
so that all these factors are restrained and controlled. This will include: i) the 
development of new reliable drugs (or a combination of drugs to reduce resistance 
emergence), ii) a new efficient and highly protective vaccine, iii) the improvement of 
sanitary and health conditions, iv) vector control to decrease transmission (removal of 
mosquitoes breeding places, use of insecticide impregnated bed nets and the control 
of parasite development inside the mosquito), and vii) sustainability of malaria control 
programs.   
 
 I.1.3 – The mosquito vector 
The parasite depends on its ability to develop in the mosquito in order to infect a 
human host. Thus, controlling transmission through the mosquito greatly reduces 
malaria outspread.  
Transmission can be impaired by several strategies, as reducing the number of 
mosquitoes (using insecticides and destroying potential breeding sites), avoiding the 
contact between mosquitoes and humans (using insecticide-impregnated bednets) or 
blocking the development of the parasite in its vector. For this, it is vital to understand 
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the biology of parasite and mosquito, their interactions, mosquito permissiveness to 
parasite, and factors in parasite and mosquito necessary for an efficient transmission. 
The mosquito responsible for malaria transmission belongs to the genus Anopheles, 
and is widespread through the major temperate and tropical areas. Even though the 
Anopheles genus is composed by 400 species only about 60 are able to efficiently 
transmit malaria. This reveals a high degree of specificity for the parasite/mosquito 
combination. In fact, each mosquito species has a specific permissiveness to a 
particular species of Plasmodium. Mosquito and parasite factors and interactions that 
may account for this specificity are not yet known. It is clear, however, that both 
organisms engage in a series of interactions in which they are able to recognize and 
respond to each other (Sinden, 2002).  
For instance, the blood meal alone triggers the transcriptional regulation of a set of 
mosquito genes, required for functions such as digestion and immunity against 
bacteria infected blood. A Plasmodium infected blood meal however, triggers a 
different set of genes, suggesting that the mosquito recognizes the parasite and 
mounts a response to its presence through the activation of specific genes. Moreover, 
the parasite itself has to undergo several morphological changes that are also 
regulated at the genomic level and activated with precision both temporally and 
spatially in the mosquito (Dimopoulos et al., 1998, 2002; Richman et al., 1997; Sinden, 
2002).   
Additionally, there are factors external to both organisms able to influence the 
outcome of infection, such as temperature, humidity and blood meal constituents. The 
impact of these factors on parasite development is generally characterized by an 
increase/decrease of parasite load in the midgut.    
 Thus, to be able to control transmission it is essential to fully understand which and 
how factors (from parasite, mosquito or external) are determinant for a successive 
infection.   
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I.2 – The parasite in the mosquito 
There is considerable amount of information regarding the sporogonic development of 
the parasite. Figure I.2.1 summarizes mosquito infection by malaria parasites and the 
successive bottlenecks that the parasite encounters during its development.  
 
All interactions between parasite and mosquito, and the fact that mosquito directed 
antibodies are able to prevent infection by Plasmodium (Dinglasan et al., 2003), come 
as hope for new targets for transmission control.  As malaria infection is able to 
compromise mosquito’s fitness, it is imperative that the mosquito controls parasite 
numbers for survival.  Actually, the mosquito is capable of mounting efficient 
bottlenecks to the development of the parasite, illustrated by the dramatic losses in 
number suffered by the parasite along the sporogonic cycle (Figure I.2.1; Alavi et al., 
2003, Sinden & Billingsley, 2001; Sinden, 2002). What mechanism(s) are responsible 
for the constraint in parasite number, and how they are activated remains to be fully 
elucidated. Nevertheless, it has become clearer that the mosquito immune system 
plays an important role. 
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Figure I.2.1 – The sporogonic cycle of malaria parasites development in the mosquito. Source: 
Sinden & Billingsley, 2001.  
Upon a blood meal the parasite enters the mosquito midgut, where it senses changes in environment, 
as temperature drop, pH increase, and the presence of a mosquito factor, xanturenic acid. These 
cause an increase of cytoplasmic calcium release in Plasmodium gametocytes (Billker et al., 2004), 
triggering the differentiation into gametes. In a few minutes fertilization occurs, and a motile 
ookinete develops. Of the tens of thousands of gametocytes ingested by the mosquito only 50-100 
ookinetes are formed. These have to evade from the midgut, traversing the peritrophic matrix, and 
the midgut epithelium, until settle on the basal lamina. This process involves midgut epithelium 
recognition and some parasite proteins have been implicated, as the secreted ookinete adhesive 
protein (SOAP), and the circumsporozoite- and TRAP-related protein (CTRP). Without these, the 
parasite’s ability to invade the midgut epithelium and progress in infection is reduced (Dessens et al., 
1999, 2003). PbS21 has also been shown to be necessary for its binding to the basal lamina itself, and 
maturation into oocyst (Arrighi & Hurd, 2002). How the parasite recognizes the midgut cells, if it 
actually targets a specific type of cells, and how it reaches the basal lamina is in centre of debate and 
seems to differ with parasite/vector combinations. In some combinations ookinetes take an 
intracellular route of invasion, passing through several cells in the midgut epithelium that undergo 
apoptosis, and are released into the midgut lumen. This calls for a tissue repair system, directed from 
the surrounding cells and involving the actin cytoskeleton and microtubule remodelling that build a 
cover for the ookinete, in the hemocel side of the basal lamina (Han et al., 2000, Vlachou et al., 2004, 
2005). Of the 50-100 ookinetes only 5 successfully develop into an oocyst that matures, producing 
within sporozoites that are released into the hemocel in numbers that reach tens of thousands. It is 
not known if the oocyst burst is a mechanical result of the growth and development of the cells 
within, or a result from a specific action of sporozoites. In the hemocel, sporozoites encounter a new 
environment, with different cells and organs of the mosquito, ultimately reaching the salivary glands. 
Again, only a small proportion of sporozoites (15-80) invade the salivary glands with success. How 
sporozoites recognize salivary glands and differentiate them from the other organs is still unknown. 
But it is sure that there is a specific recognition of the salivary glands, invasion of the distal lateral and 
medial lobes (Ghosh et al., 2001, 2002), and that gliding is essential for cell invasion, parasite 
locomotion in host tissues, and possibly, a target to control transmission (Frischknecht et al., 2004; 
Matuschewski et al., 2002). Some studies also refer to chemotatic attraction that could help to bring 
the parasite closer to the binding site for invasion (Akaki & Dvorak, 2005). Several proteins have been 
identified as essential for sporozoite invasion of the salivary glands, like the parasite proteins CSP and 
TRAP (Myung et al., 2004; Sultan et al., 1997) and the mosquito SGS1. The later is a salivary gland 
specific protein, which localizes at the region that is preferentially invaded by the sporozoites. 
Antibodies anti-SGS1 inhibit sporozoites invasion in Aedes aegypti, making it a good candidate for the 
sporozoites receptor in the salivary gland epithelium (Korochkina et al., 2006).      
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I.3 – The insect immune response 
Numerous studies have shown that insects have the ability to recognize pathogens and 
trigger the activation of effective mechanisms to control or clear an infection. The 
current knowledge about insect response to pathogens is summarized in Figure I.3.1.     
Insects show several lines of defense against pathogens: i) the external cuticle avoids 
massive infections hindering pathogen entry into the hemocel, ii) chitinous 
membranes, acids and enzymes in the digestive tract help restrain infection by 
ingested microorganisms, iii) if pathogens manage to enter the hemocel the insect is 
able to mount a complex immune response to clear the infection.  
Insects do not possess an adaptative immune system as vertebrates, relying solely 
upon an innate immune response. Nevertheless, this can be highly complex, 
presenting outstanding specificity and effectiveness.   
 
Insects have several tissues able to engage in immunity: hemocytes, fat body and epithelium. 
Upon an infection, one or more tissues may be stimulated to participate in the response. How 
they signal to each other is not very clear, but it may require cytokine-like molecules.  
Hemocytes (or blood cells) are the immune-responsive cells by excellence. They move freely 
through the hemolymph and possess the arsenal to combat infections, and are probably the 
first to be activated upon an infection in the hemocel. 
Fat body is the equivalent to the mammalian liver. This organ is responsible for the production 
in large scale of pathogen killing molecules such as antimicrobial peptides, when a systemic 
response is in order. 
Epithelium encloses the local immune responses. Epithelium responses are critical, as localized 
immunity avoids massive spread of infection, facilitating pathogen clearance.     
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As for the way how different effector mechanisms are activated, the response can be 
classified as humoral or cellular. A humoral response is characterized by the use of 
effector and signaling molecules already present in the hemocel, and subsequent 
release (by signal amplification) of the same molecules by either of these tissues into 
the hemocel where they exert their action. This includes the production of small 
peptides with antimicrobial activity (antimicrobial peptides - AMP), generation of 
reactive intermediaries of oxygen and nitrogen (ROI and NOI, respectively), and 
activation of complex cascades that lead to responses such as melanization and 
coagulation. The presence of hemocytes at the infection site is mandatory for cellular 
Figure I.3.1 – Insect immune responses to pathogen infection.  Pathogens are recognized in 
the hemocel by specific receptors that activate proteolytical cascades. These may directly 
trigger pathogen killing mechanisms or activate intracellular signal transduction pathways. 
These result in the transcription of immune related genes whose products are released into the 
hemocel. These molecules can be either effector molecules with antimicrobial activity (AMPs, 
NOIs and ROIs), or secondary signaling molecules that contribute to the activation of other 
effector mechanisms for pathogen killing. As such, insect immune responses can be roughly 
divided into three phases: 1) Recognition of non-self molecules by highly conserved pattern 
recognition receptors (PRR); 2) Signal transduction and amplification through extracellular 
proteolytical cascades (comprised serine proteases and their negative regulators, serpins) 
and/or intracellular immune signaling pathways; and 3) Activation of effective pathogen killing 
mechanisms. AMP: Antimicrobial Peptide; NOI: Nitric Oxide Intermediate; PRR: Pattern 
Recognition Receptor; ROI: Reactive Oxygen Intermediate. 
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immune responses. These are able to engage in responses such as phagocytosis, 
nodulation, aggregation, encapsulation and cytotoxic reactions. As humoral factors 
affect the hemocytes, and these are necessary for the production of the same factors, 
both responses are overlapping and operating when combating an infection.  
 
Pathogen killing mechanisms in insects include phagocytosis, nodulation, 
encapsulation, coagulation, melanization and AMP synthesis. One or more of these 
mechanisms may be activated upon an infection.  
Phagocytosis involves the engulfment and intracellular digestion of non-self particles 
by the hemocytes. It starts with binding of non-self molecules to specific receptors on 
hemocytes, which triggers the target engulfment via an actin polymerization-
dependent mechanism. The target is destroyed within phagosomes by lysosomal 
enzymes. The digestion of pathogens may lead to the production of secondary signals 
sent to the fat body to stimulate other immune responses. Insects are able to 
recognize and phagocyse bacteria, yeast, parasites, virus, and also synthetic particles 
such as negatively charged Sephadex beads (da Silva et al., 2000; Hernandez et al., 
1999; Hillyer et al., 2003; Kocks et al., 2005; Lamprou et al., 2007;  Mizutani et al., 
2003; Moita et al., 2005).   
 
Nodulation and Encapsulation are observed exclusively in invertebrates. They are 
activated in response to microorganisms too large to be phagocised. Nodules refer to 
multicellular aggregates of hemocytes surrounding a high number of bacteria or large 
pathogens in an extracellular material. Encapsulation refers to binding of hemocytes to 
larger targets, or even nodules. Nodules and capsules can be subsequently melanised, 
ie, covered by a melanin layer, that hinders the delivery of oxygen to pathogens. The 
production of cytotoxic quinones and free radicals from ROI and NOI (by-products of 
melanin synthesis), and of AMP’s by hemocytes may also contribute to pathogen killing 
(Jiravanichpaisal et al., 2006).  
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Melanization is a mechanism present in various groups of invertebrates including 
insects. Melanin is produced for several purposes, such as hardening of the egg 
chorion, wound healing, cuticle tanning and immunity. Upon an infection, a melanin 
layer can be deposited extracellularly over the invading microorganism, or 
intracellularly over phagocised microorganisms. The melanin layer keeps the pathogen 
immobilized, avoiding the infection to spread while hindering nutrient and oxygen 
exchanges between the microorganism and the surrounding media. In addition, 
several toxic molecules, such as cytotoxic quinones and ROI and NOI species produced 
in the process of melanin synthesis, may assist in pathogen clearance. Melanization 
can be itself a pathogen killing mechanism or it can be activated as a complement to 
phagocytosis, encapsulation or nodulation. The machinery to produce melanin is 
synthesized in hemocytes and fat body, and delivered to the hemocel. Upon infection 
or wounding melanin is rapidly synthesized to avoid massive infection or loss of 
hemolymph (reviewed by Barillas-Mury, 2007; Soderhall & Cerenius, 1998).       
 
Coagulation, as melanization, is vital for wound healing and immunity. It is essential to 
avoid hemolymph losses when a wound opens in the cuticle and to clear pathogen 
infections. In this process, microorganisms are entrapped inside a clot comprised of 
extracellular protein aggregates and hemocytes (Theopold et al., 2002). It is not known 
whether the clot itself participates in pathogen killing (by the production of toxic side 
products or asphyxiation) or if it functions only to entrap pathogens to be cleared by 
other mechanisms.         
 
Antimicrobial peptides are small cationic molecules with antimicrobial properties. 
These molecules are produced by the fat body and the hemocytes and are released 
into the hemocel (Bulet et al., 1999) and have the ability to kill microorganisms 
generally through the destruction of the cell membrane, by permeabilzation. 
Increasing evidence shows some degree of specificity in the pathogen-AMP relation. 
For instance, in Drosophila melanogaster the antimicrobial peptide Drosomycin was 
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shown to be synthesized upon infection with fungi or Gram-positive bacteria, while 
Diptericin is produced in response to Gram-negative bacteria.  
       
 
 I.3.1 – The Drosophila immune response 
Nowadays, one of the most studied insect immune systems is that of the fruitfly 
Drosophila melanogaster, whose powerful genetic tools allow an accelerated study at 
many molecular levels. Although hematophagous insects such as mosquitoes have a 
higher diversity in pathogen microorganism to which they are exposed (due to the 
nature of the blood meal), the mosquito complexity of breading, the lack of suitable 
genetics and technology of genetic manipulation permit only a limited view of the 
immune responses, making Drosophila a useful model to study immunity even in 
hematophagous insects (Meister et al., 2004).      
The Drosophila’s immune response to infection as been recently reviewed by several 
authors: Hoffmann (2003), Agaisse & Perrimon (2004), Leclerc & Reichhart (2004), 
Naitza & Ligoxygakis (2004), and Lemaitre & Hoffmann (2007).  
 
The best studied pathogen killing mechanism in Drosophila is the synthesis of 
antimicrobial peptides (AMP). AMP synthesis is activated by bacteria and fungi and is 
regulated by two intracellular signal transduction pathways (TOLL and IMD). A third 
pathway (JAK/STAT) is triggered in response to viruses. The recognition of pathogen 
associated molecular patterns in microorganisms (PAMPs) by pattern recognition 
receptors (PRRs) (Medzihtov & Janeway, 2002) activates a specific signal transduction 
pathway that results in the translocation of a cytoplasmatic NF-kB transcription factor 
to the nucleus, where it starts synthesis of AMPs and other immune molecules. These 
pathways are represented in Figure I.3.2. 
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 Apart from AMP production, other effector mechanisms are known to be essential for 
immune responses in Drosophila, as phagocytosis, encapsulation, coagulation and 
melanization of microorganism, which have been observed upon immune challenge. 
However, their activation and regulation was not yet disclosed.  
Additionally, molecules like the iron up-taking molecule transferrin (Yoshiga et al., 
1999) and the inducible nitric oxide synthase NOS (Foley & Farrell, 2003; Nappi et al., 
2004) have been implicated in microorganism killing, although a link to regulation by 
one of the signal transduction pathways is still missing.  
The fly’s immune response is a complex and intricate net of signalling pathways that 
lead to the successive activation of several reactions that work together in order to 
restrain the microbial infection, and to heal the wounded tissues and damaged cells of 
the fly.   
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Figure I.3.2 – Immune signalling transduction pathways in Drosophila immunity. Adapted from Lemaitre & 
Hoffmann, 2007. 
Toll pathway (left) is activated by fungi, yeast and gram-positive bacteria. Recognition involves PRR’s like 
Persephone (Psh), GNBP3 and GNBP1/PGRP-SA/PGRP-SD. Mutants for this pathway have a compromised 
survival for fungal and Gram-positive bacterial infections (Hoffmann & Reichhart, 2002). Recognition 
activates a Spaetzle activating enzyme (SPE) that converts pro-Spaetzle into Spaetzle (SPZ). This binds to the 
receptor Toll (Lemaitre et al., 1996; Imler & Hoffmann, 2001), triggering an intracellular cascade, involving 
Myd88, Tube and Pelle. This results in degradation of the inhibitor Cactus and release of DIF that 
translocates into the nucleus, starting the transcription of AMP’s like Drosomycin. Toll pathway is also 
associated with melanization (Ligoxygakis et al., 2002), along with hemolymph components, like serine 
proteases and their negative regulators, serpins. Loss-of-function mutants for serpin 43Ac have constitutive 
cleavage of Spz and drosomycin expression (Levashina et al., 1999; Ligoxygakis et al., 2002). Serpins seem to 
protect against microbial proteinases, and to regulate endogenous proteinases, preventing over activation 
of hemolymph coagulation, proteolytic cytokine and prophenoloxidase (Kanost, 1999). 
IMD pathway is activated by Gram-negative bacteria. Bacterial peptidoglycan (PGN) is recognized by the 
peptidoglycan recognition protein LE (PGRP-LE). Monomeric PGN’s activate a dimeric receptor composed by 
PGRP-LCx and PGRP-LCa, while polymeric PGN’s activate a dimeric receptor composed by PGRP-LCx. 
Mutants for this pathway have a compromised survival for bacterial infection (Hoffmann & Reichhart, 
2002). Recognition activates the IMD protein that in turn activates dFADD and Dredd, which cleaves the 
inhibitory domain of the Relish, causing it to translocate into the nucleus and start the transcription of 
AMP’s such as diptericin and attacin. IMD may also activate dIAP2, dTAB2 and dTAK1. The later can activate 
IIKγ and IKKβ leading to Relish activation, or trigger the JNK pathway. IMD is also involved in apoptosis, 
through the activation of the caspase-like protein DREDD (Georgel et al., 2001).      
JAK/STAT pathway is triggered by virus, as mutants for this pathway are resistant to bacterial and fungal 
expression, but susceptible to Drosophila Virus C (Dostert et al., 2005). Recognition leads Unpaired-3 
(UPD3) to bind to the receptor Domeless (Dome), activating JAK, and leading STAT to translocate into the 
nucleus and trigger the transcription of genes such as tep2 and turandot. Overexpression of this pathway 
leads to the formation of melanotic pseudotumors (Hanratty & Dearolf, 1993; Harrison et al., 1995; Luo et 
al., 1997). Agaisse et al.(2003) also suggested this pathway to be involved in the response to tissue damage. 
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I.4 – The mosquito immune response to malaria 
The mosquito immune system is believed to be responsible, at least in part for the 
parasite losses occurring along its sporogonic development. Thus, its complete 
understanding will provide a powerful tool to block malaria transmission. 
The completion sequencing of Anopheles gambiae genome (Holt et al., 2002) allowed 
a comparative analysis between the genomes of An. gambiae and D. melanogaster and 
the description of correspondent protein families in the mosquito. This comparison 
revealed that about half of the genes are orthologs 1:1 and identified 242 genes that 
potentially code for components of the immune system (Zdobnov et al., 2002).  
The comparative analysis of 18 gene families from the fly and the mosquito revealed a 
2 fold deficit in 1:1 orthologs in immune-related genes, when compared to the whole 
genome. In contrast these genes present specific gene expansions in the mosquito, 
when compared to the fly. Components of the immune system or gene families that 
include these components have evolved faster than the rest of the genome. Gene 
families coding for recognition, signal modulation and effector mechanisms are poor in 
ortholog genes reflecting species specific expansions and possibly a strong selective 
pressure (Christophides et al., 2002). On the contrary, genes belonging to intracellular 
immune signaling pathways are highly conserved, even more than the genome as a 
whole, probably due to the high range of functions in which they are involved, such as 
development. Although comparative genetics is of vital importance to highlight 
immune-related genes, it is insufficient to point out which of these genes are indeed 
involved in the response to Plasmodium.  
 
Several approaches have been pursued in order to understand parasite-vector 
interactions and to attempt to block malaria transmission in the mosquito. These 
included transcription profile studies of infected and non-infected mosquitoes, and the 
establishment of mosquito strains refractory to malaria infection. 
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I.4.1 – Immune gene expression studies 
Work in mosquito immune responses has focused mainly in differential expression of 
immune-related genes upon infection. Different transcriptional profiling approaches 
included: 
• Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for specific 
immune-related genes. Dimopoulos et al., 1997 found some immune related 
genes to be up-regulated, both locally (midgut) and systemically, upon midgut 
invasion by ookinetes. These genes were also found to be up-regulated in later 
steps of parasite development (Dimopoulos et al., 1998).  
• Subtractive libraries, enriched for genes up-regulated after bacterial challenge 
(Oduol et al., 2000), genes expressed in midguts after ookinete invasion and 
early stages of oocyst development (Abraham et al., 2004), and genes 
expressed in midguts during late stages of oocyst development (Srinivasan et 
al., 2004).  
• EST libraries constructed of immunocompetent cell lines (Dimopoulos et al., 
2000), blood fed and non-blood fed mosquitoes (Ribeiro, 2003).  
• Microarrays (derived from the immunocompetent cell line EST library), used to 
analyze genome responses to injury, bacterial challenge and malaria infection 
(Christophides et al., 2002; Dimopoulos et al., 2002). Microarray studies 
contributed to the identification of several genes with altered expression 
during midgut invasion (Christophides et al., 2002; Dimopoulos et al., 2002; 
Kumar et al., 2003; Vlachou et al., 2005). Vlachou et al. (2005) found that 7% of 
the assessed mosquito genes are differentially regulated at this point in 
infection, including genes belonging to functional classes such as cytoskeleton 
remodelling, apoptosis, immunity, redox metabolism, cell adhesion and 
extracellular matrix maintenance. Microarrays are now a widely used technique 
and a powerful tool to study mosquito responses to the parasite, and have 
been used to target differential expressed genes in the whole genome or in 
specific subsets of genes (immunity, stress, and others). 
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The massive data obtained by transcription profiling has not yet been functionally 
validated by reverse genetics, available through the use of techniques such as RNA 
interference (RNAi) (Blandin & Levashina, 2008). As far as proteomic studies, very few 
have been conducted, thus not much information is available regarding post-
transcriptional protein regulation.   
 
 
I.4.2 – Laboratory models for refractoriness to malaria  
Another approach to attempt to underline the mechanisms used by the mosquito to 
restrain malaria infection was the genetic selection of refractory mosquito strains 
under laboratory conditions. These strains are able to totally (or nearly) eliminate 
Plasmodium ookinetes, either by lysis in the midgut epithelium cells, or melanization in 
the basal lamina of the epithelium (Carton et al., 2005). 
In the lab, strains of Anopheles mosquitoes were selected for refractoriness to malaria:  
• The An. gambiae L3-5 strain restrains infection by melanization of 
ookinetes from P. berghei and allopatric strains of P. falciparum (Collins 
et al., 1986). 
• The An. gambiae SUAF2 strain lysis Plasmodium gallinaceum ookinetes 
while traversing the midgut epithelium (Vernick et al., 1995). 
• A selected line from An. dirus melanizes ookinetes from P. yoelii 
(Somboon et al., 1999).  
 
Malaria infection in these mosquitoes, in particular in An. gambiae L3-5, has been 
exhaustively studied to understand how the mosquito is able to control parasite 
infection. A multidisciplinary approach, comprising morphological, biochemical and 
genetic studies have revealed large physiological differences between refractory and 
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sensitive strains (Blandin et al., 2004; Kumar et al., 2003; Paskewitz et al., 1998; Volz et 
al., 2006; Zheng et al., 2003).  
 
 
I.4.3 – The mosquito response to the parasite 
Even though the mosquito response to Plasmodium is far from disclosed, data 
obtained so far by transcription profiling, genetic selection of refractory mosquitoes, or 
RNAi-based reversed genetics functional studies, have highlighted several molecules 
that might be implicated in this process. These molecules have been grouped here by 
their function in immune responses. 
 
I.4.3.1 – Recognition 
I.4.3.1.1 – Peptidoglycan Recognition Proteins 
PGRPs bind to peptidoglycan with high affinity. These molecules have a domain similar 
to bacterial amidase, which enables PGN cleavage for bacteria clearance.  
Mosquito PGRP’s are grouped in two classes: the long and short forms of PGRP. The 
long form (PGRP-L) may be intracellular or transmembrane, while the short form 
(PGRP-S) is extracellular. PGRPs are processed by alternative splicing that is influenced 
by several immune factors (Michel & Kafatos, 2005). PRGP-LC seems to be involved in 
Gram-negative bacteria (E. coli) phagocytosis and influence Plasmodium development 
in the mosquito (Moita et al., 2005). PGRP-LB is up-regulated after Plasmodium 
infection in adult mosquitoes (Dimopoulos et al., 2002) and sustains a high level of 
expression all through the parasite life cycle (Christophides et al., 2002). 
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I.4.3.1.2 – Gram Negative Binding Proteins 
GNBPs share significant similarities with the catalytic region of bacterial β,1-3 and β,1-
3-1,4 glucanases.  GNBPB1 and GNBPA1 were found to be up-regulated after 
Plasmodium infection. GNBPB1 is also induced in salivary glands and responds to 
bacteria (Christophides et al., 2002; Dimopoulos et al., 2002). GNBP4 weakly co-
localized with Plasmodium berghei ookinetes in the mosquito midgut epithelium (Warr 
et al., 2008). 
 
I.4.3.1.3 – Thioester Proteins 
TEPs are thioester-containing complement-like protein. The Anopheles TEP family 
shares significant similarities with the vertebrate complement factors C3, C4 and C5 
and with the universal protease inhibitors, α2-macroglobulins.  
The protein is activated by cleavage that exposes the thioester bond promoting 
covalent binding to the pathogen that is then marked for phagocytosis or lysis.  
Several TEP proteins (TEP1, 3 and 4) are up-regulated by bacterial and/or Plasmodium 
infection (Blandin et al., 2004; Chistophides et al., 2002; Levashina et al., 2001; Oduol 
et al., 2000), although TEP1 is the most studied. 
The thioester promotes binding of TEP1 to Gram-positive and Gram-negative bacteria 
that are opsonized and targeted for phagocytosis by hemocytes in vitro (Levashina et 
al., 2001).  
TEP1 is secreted by hemocytes into the hemolymph and enters the basal labyrinth of 
the midgut epithelium where it binds to ookinetes promoting lysis (Blandin et al., 
2004).  
In the susceptible An. gambiae mosquito strain (G3), TEP1 binds to ookinetes from 24h 
reaching a maximum of TEP1 marked ookinetes at 48hpi. In the refractory mosquito 
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L3-5 strain TEP1 also binds to ookinetes, but much faster: at 24hpi nearly all ookinetes 
are marked by TEP1 and become later on melanized (Blandin et al., 2004).  
Knock-Down (KD) of TEP1 in adult mosquitoes completely abolishes melanotic 
encapsulation of ookinetes in L3-5 mosquitoes allowing the correct development of P. 
berghei. Additionally, mosquitoes KD for TEP1 are unable to melanize Sephadex beads 
(Warr et al., 2006), revealing an essential role in melanization. In the susceptible strain, 
however, it causes hyperinfection – 5 fold increase in oocyst number and ookinete 
survival (Blandin et al., 2004). TEP1 binds to ookinete surface after crossing the midgut 
epithelium in both sensitive and refractory strains but with different timing leading to 
degeneration. TEP1 associated ookinetes are lysed in midgut cells by a process that 
includes degeneration, represented by parasite blebbing, loss of the vital marker GFP, 
nuclear abnormalities, fragmentation, disturbances in the distribution of PbS28 
(ookinete surface protein). TEP1 is responsible for the death of 100% of P. berghei 
ookinetes in L3-5 and 80% in G3 (Blandin et al., 2004).  
 
I.4.3.1.4 – C-type Lectins 
C-type lectins (CTLs) are either membrane bound or secreted proteins that recognize 
and bind to carbohydrates, in a CA
2+
 binding dependent fashion. In the mosquito CTLs 
have been grouped according to sugar binding specificity: mannose binding (CTLMA), 
galactose binding (CTLGA), selectins (CTLSE) or other CTLs. These molecules mediate 
processes such as cell adhesion, cell-cell interactions, glycoprotein turnover and 
pathogen recognition leading to immune responses, usually activating melanization 
(Christophides et al., 2004). 
CTL4 and CTLMA2 are predominantly expressed in carcasses during midgut invasion 
and protect the parasite. KD of either these molecules leads to massive ookinete 
melanization (97% of ookinetes melanized in CTL4 KD and 48% in CTLMA2 KD) in G3 
susceptible mosquito strain (Osta et al., 2004), reflecting a melanization inhibitory role 
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and transmission permissiveness. However, KD of either CTL4 or CTLMA2 does not 
affect the melanization of negatively charged Sephadex beads (Warr et al., 2006). 
 
I.4.3.1.5 – Leucine rich immune genes 
LRIM (Leucine rich immune genes) proteins can be secreted, membrane-bound or 
cytoplasmic. These PRRs contain numerous leucine-rich repeats (LRR) that are similar 
to motifs found in several immune-related molecules and may mediate protein-protein 
interactions. 
LRIM1 is up-regulated in infections by bacteria and Plasmodium (Dimopoulos et al., 
2002). It is predominantly expressed in carcasses, when compared to midguts and is 
specifically up-regulated in carcasses of infected mosquitoes. The expression in the 
midgut of infected mosquitoes is strong and transient, between 24 and 48hpi. So far 
no homologous genes to LRIM1 have been found in other species (Osta et al., 2004, 
Moita et al., 2005).  
LRIM1 limits parasite development in the mosquito (Osta et al., 2004), as its KD leads 
to a 4 fold increase in oocyst number in the sensitive strain. Also, mosquitoes KD for 
this genes show inability to melanize Sephadex beads (Warr et al., 2006), suggesting a 
role in melanization.  
Double KD of CTL4 and LRIM1 results in an increased number of live oocysts (4 fold) 
without any melanization, suggesting that LRIM1 acts upstream of CTL4 and CTLMA2 
and that parasite death occurs before melanization (Osta et al., 2004).  
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I.4.3.1.6 – Galectins 
Galectins are galactoside binding lectins (GALE) that are thiol dependent. 
GALE8 was found to be up-regulated by bacteria and Plasmodium (Dimopoulos et al., 
1998), while GALE5 is only marginally up-regulated by bacteria infection and midgut 
invasion by the parasite (Christophides et al., 2002). 
 
I.4.3.1.7 – Fibronectins 
FBN have a domain similar to the carboxy-terminus of the fibrinogen γ chain. These 
molecules are involved in microorganism recognition and agglutination. 
Some FBNs are up-regulated upon infection with bacteria, as FBN9, and/or malaria 
infection, like FBN9 and FBN23 (Christopides et al., 2002, Dimopoulos et al., 2002). 
 
I.4.3.2 – Signal modulation by extracellular protease cascades 
I.4.3.2.1 – CLIP domain serine proteases (CLIPs) 
CLIPs are proteases characterized by an N- terminal disulphide-knotted domain (CLIP 
domain), and a C-terminal trypsin-like domain. CLIP proteins modulate the 
extracellular signal that activates several intracellular pathways involved in 
development, AMP synthesis, melanization and hemolymph clotting and are negatively 
regulated by serpins.  
In An. gambiae, the 41 CLIP genes were grouped into 4 classes.  CLIPs belonging to the 
B group are probable candidates for PPO cascade activation (Volz et al., 2005).   
Some CLIPs are regulated by Plasmodium infection: CLIPB1, B4 (Gorman et al., 2000), 
B14 and B15 (Christophides et al., 2004) are up-regulated, while ClipA6 is down-
regulated (Christophides et al., 2004). CLIPB14 and B15 share significant features with 
proteases known to be involved in the PPO cascade activation. These proteins have a 
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role in melanization, affecting the vectorial capacity of An. gambiae to P. berghei (Volz 
et al., 2005).  
  
I.4.3.2.2 – Serpins 
Serpins (SRPNs) are usually inhibitory proteins that act as suicidal substrates for serine 
proteases. SRPN proteolytical activation results in a conformational change of the 
protein that binds irreversibly to the target protease. Other proteins of this group that 
are not inhibitory can have roles in hormone transport, storage and blood pressure 
regulation (Silverman et al., 2001). The mosquito has 14 genes coding for serpins, 10 of 
which are inhibitory. 
SRPN1, 2 and 3 are orthologs of Drosophila SRPN27A, involved in melanization 
activation, and SRPN2 regulates the PPO cascade in the mosquito (Michel et al., 2005). 
SRPN2 is a negative factor for ookinete death and melanization. KD of SRPN2 results in 
the formation of melanotic masses, death and melanization of parasites. It does not 
affect the P. berghei ookinete formation, but strongly reduces the oocyst numbers 
through an increase in ookinete lysis and melanization (Michel et al., 2005). 
Nonetheless, it has no effect on the development of P. falciparum strains (Michel et 
al., 2006). 
SRPN6 is expressed in ookinete invaded midgut cells in both An. gambiae and An. 
stephensi. KD of SRPN6 in An. stephensi increases parasite load, while in An. gambiae it 
does not alter the oocyst number, but the ratio of melanized vs. lysed oocysts. L3-5 
refractory mosquitoes KD for SRPN6 have and increased number of melanized 
ookinetes, while in G3 mosquitoes SRPN6 KD delays parasite lysis progression 
(Abraham et al., 2005). 
SRPN10 has 4 different intracellular isoforms that inhibit different and specific 
proteases. Two of these isoforms (KRAL and RCM) are induced in midgut cells invaded 
by the parasite where they translocated from the nucleus into the cytoplasm (Danielli 
et al., 2003, 2005), causing the cell to detach from the epithelium into the midgut 
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lumen and undergo apoptosis. Hence this protein is a good marker for invasion and 
apoptosis of epithelial cells (Danielli et al., 2005). 
 
I.4.3.3 – Intracellular signal transduction pathways 
I.4.3.3.1 – Toll pathway 
All intracellular components of the Toll pathway are highly conserved between An. 
gambiae and D. melanogaster (Figure I.3.1). As for the extracellular ligand of the Toll 
receptor, the mosquito has at least 6 similar to Drosophila Spaetzle. 
 
 I.4.3.3.2 – IMD pathway 
Like the Toll pathway, all the intracellular components of the IMD pathway are well 
conserved between An. gambiae and D. melanogaster (Figure I.3.1; Christophides et 
al., 2002). 
In An. gambiae, REL2 (ortholog of D. melanogaster Relish) regulates the intensity of 
infection by P. berghei and has a role in melanization. Double KD of REL2/IMD leads to 
a 2 fold increase of oocyst number, as does the single KD of REL2-F. The single KD of 
REL2 results in a limited occurrence of melanized ookinetes (~5%) (Meister et al., 
2005). 
In Drosophila, each pathway seems to be activated by specific microorganisms, while 
in the mosquito the response to Plasmodium seems to require both Toll and IMD 
pathways.  In fact, expression of AMPs such as CEC1, DEF1 and GAM was found to be 
regulated by both Toll and IMD pathways (Luna et al., 2006). Also, in a pre-invasion 
stage of the midgut, the response seems to be regulated by both REL1 (ortholog of D. 
melanogaster Dorsal) and REL2, ie, by both TOLL and IMD pathways. Double KD for 
REL1 and REL2 results in a decreased expression of tep1 and lrim1, compromising 
mosquito resistance to P. berghei. Additionally, KD of cactus (REL1 inhibitor) up-
regulates TEP1 and other immune factors and completely blocks parasite 
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development. In this stage, in non-KD mosquitoes, there is a basal expression of tep1 
and lrim1 that is regulated by REL1 and REL2. However, in a post-invasion stage, there 
is an up-regulation of TEP1, LRIM1 and CTL4 that is independent of REL1/REL2 
regulation. KD of CACTUS at this stage has no effect on oocyst numbers (Frolet et al., 
2006).     
 
I.4.3.4 – Immune effector mechanisms for parasite clearance 
Evidence shows that some immune effector mechanisms are implicated in the 
mosquito response to the parasite, as AMP synthesis, melanization, lysis and 
phagocytosis.  
 
I.4.3.4.1 – AMP synthesis 
The mosquito has genes coding for AMPs, such as defensin, cecropin, attacin and 
gambicin. The efficiency of the antimicrobial activity of the different AMP’s depends on 
the vector-parasite combination (reviewed by Carton et al., 2005). 
 
Defensin1 (DEF1) corresponds to DEFA characterized by Richman et al. (1996). It has 
antimicrobial activity against several Gram-positive bacteria, E. coli, yeasts and 
filamentous fungi (Vizioli et al., 2001b). Administration of exogenous defensin from 
Aeschna cyanea and Phormia terranovae has a profound toxic effect in isolated 
sporozoites and in the development of P. gallinaceum oocysts in Ae. aegypti 
(Shahabuddin & Pimenta, 1998). Defensin lead to a reduction in oocyst number when 
injected (Shahabudin & Pimenta, 1998), and is transcriptionally induced in An. gambiae 
mosquitoes in response to midgut epithelium invasion by Plasmodium ookinetes 
(Richman et al., 1997). Nevertheless, KD of defensin has no impact on P. berghei 
infection rate (Blandin et al., 2002). 
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Cecropin 1 (CEC1 - CECA as described by Richman et al., 1996) is active against several 
strains of Gram-positive and Gram-negative bacteria and fungi (Vizioli et al., 2000). In 
mosquitoes CEC1 is up-regulated upon Plasmodium infection from D2pi (Christophides 
et al., 2002; Dimopoulos et al., 2002, Vizioli et al.2000). Overexpression of this AMP 
results in a significant reduction of oocyst number (Kim et al., 2004).  
 
Gambicin is an AMP unique and exclusive to Anopheles and Aedes mosquitoes. It has 8 
Cys residues that form 4 dissulfide-bridges. Plasmodium parasite induces gambicin 
expression both locally (midgut) and systemically (fat body) in early and late stages of 
infection. Gambicin has a weak inhibitory activity against Plasmodium ookinetes 
(Vizioli et al., 2001a). 
 
I.4.3.4.2 – Melanization 
Melanization was one of the first mechanisms to be proposed as a parasite killing 
mechanism in the mosquito. In 1986, Collins et al. were able to select, under 
laboratory conditions, a strain of An. gambiae mosquitoes (L3-5) that clears P. 
cynomolgi B parasites by melanizing ookinetes, as soon as they emerge from the 
midgut epithelium. The L3-5 strain is refractory by melanization to many but not all 
Plasmodium isolates (Collins et al., 1986; Zheng et al., 2003). Melanin polymerization 
prevents gas diffusion, leading the parasite to suffocate, and its synthesis leads to the 
production of reactive species of oxygen (ROI). The L3-5 strain has higher levels of ROI 
than the susceptible G3 strain, and these levels increased even further with the blood 
meal suggesting that refractoriness may result (at least in part) from a deficient 
detoxification of ROI (Kumar et al., 2003).  
Multiple Quantitative Trait Loci (QTL’s) in the mosquito genome were found to be 
associated with this phenomenon (Gorman et al., 1997; Zheng et al., 1997, 2003). In 
the model An. gambiae – P. cynomolgi B there are 3 QTL’s involved: one major locus 
(Pen1) and two minor (Pen2, 3). In the model An. gambiae – P. cynomolgi Ceylon, a 
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different but closely related parasite species, refractoriness depends on 3 different 
loci: Pen2R, Pen3R, Pen3L. The genomic sequence of Pen1 showed that 38 of the 46 
ORF’s have orthologs in Drosophila (Thomasova et al., 2002). 
Some mosquito molecules have been implicated in P. berghei ookinete melanization. 
They act both for and against the parasite: KD of TEP1 and LRIM1 blocks ookinete 
killing and melanization, while KD of CTL4 and SRPN2 increases the number of 
melanized ookinetes. These molecules are up-regulated upon ookinete invasion of the 
midgut (Whitten et al., 2006). TEP1 however, is not synthesized de novo (as there is 
only a modest up-regulation at 24h and 4d pi) but is already present in the basal 
labyrinth and hemolymph when the ookinete invades the midgut epithelium.  
Melanization is activated by a serine protease cascade that culminates with the 
proteolytical activation of the prophenoloxidase (PPO) enzyme into Phenoloxidase 
(PO). This enzyme is responsible for melanin production, catalyzing the oxidation of 
phenols to quinones that polymerize nonenzymatically into melanin (Soderhall & 
Cerenius, 1998). The An. gambiae genome comprises nine genes coding for PPOs 
(Christophides et al., 2002). PPO1 to PPO4 are expressed in immature stages of the 
mosquito, while PPO6 and PPO9 are expressed in adults. PPO2 and PPO3 are up-
regulated upon blood feeding (Muller et al., 1999). In this work the authors selected a 
mosquito hemocyte-like cell line (4A-3B) that constitutively expressed 6 PPO genes. 
This cell line responds to bacterial infection through the induction of DEF and GNBP, 
but not by inducing any PPO gene. Immune challenge does not induce PPO gene 
expression instead it is believed to activate the enzyme at a post-transcriptional level 
(conversion of PPO into PO), through the conjugated regulation of serine proteases 
and serpins. 
Phenoloxidase enzyme is activated by a cascade of CLIP serine protease. Some CLIPs 
need an inactive CLIP serine protease (serine protease homologue – SPH) as a co-factor 
to activate PPO. In An. gambiae, two classes of CLIP proteases exist: CLIPA proteins are 
SPHs and CLIPB proteins comprise the functional serine proteases (Barillas-Mury, 
2007). 
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Silencing of some CLIPs (CLIPA2, CLIPA5 and CLIPA7) in L3-5 refractory mosquitoes 
leads to an increase of melanization suggesting an inhibitory role. In the same 
mosquitoes, CLIPA8 was found to have the opposite action, ie, to be essential for PPO 
activation cascade. However CLIPA8 KD did not increase the number of live ookinetes, 
suggesting that ookinete death occurs prior to melanization. On the other hand CLIPA8 
KD in the mosquito sensitive strain represses the CTL4 KD melanization phenotype, 
and increases the number of live parasites in contrast to CTL4 KD mosquitoes, 
suggesting that in this strain melanization is a parasite killing mechanism. In the 
sensitive mosquitoes, melanization induced by KD of CTL4 or CLIPA2/A5 is an 
efficiently ookinete killing mechanism (Volz et al., 2006). 
CLIPB14 and CLIPB15 act synergistically promoting ookinete lysis, in both refractory 
and susceptible mosquito strains. KD of CLIPB14 revealed a role in the activation of PO 
in a susceptible strain on An. gambiae.  Double KD of CTL4 and CLIPB14 in a G3 
background lead to a significant decrease in melanized ookinetes reversing the CTL4-
KD phenotype, and a corresponding increase in live developing ookinetes. The KD of 
either CLIPB14 or CLIPB15 independently or jointly, results in a significant increase of 
oocyst number in the G3 strain, while it leads to an increase in the number of 
melanized ookinetes in L3-5. Neither one of these CLIP’s blocks melanization in L3-5 
suggesting that these proteins do not function in the regulation of melanization in the 
refractory strain (Volz et al., 2005). 
In fact, in refractory strains, melanization seems to be a post-mortem event, as 
melanin has never been observed associated with live parasites, only over dead ones. 
Melanization intermediaries may account for some parasite killing, but around 80% of 
the parasites are killed in a sensitive mosquito strain without melanization (Whitten et 
al., 2006). 
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I.4.3.4.3 – Lysis 
Ookinete lysis is characterized by organelle disintegration, cytoplasmic vacuolization 
and membrane blebbing, and has been observed for P. berghei ookinetes.  
As melanization seems now to be a mechanism to clear parasites in L3-5 refractory 
mosquitoes and not a killing mechanism per se, a two step model has been proposed 
for the response of An. gambiae to P. berghei. Firstly, the ookinetes pass through the 
midgut epithelium and reach the basal labyrinth where they come in contact with 
soluble elements from the hemolymph, as TEP1 that binds to live ookinetes targeting 
them to death, both in refractory and sensitive strains. Secondly dead parasites are 
degraded either by melanotic encapsulation or lysis in the refractory strain, or by lysis 
in the sensitive strain (Whitten et al., 2006).  
In mosquitoes KD for TEP1 some ookinetes survive and some die without TEP1 
labeling, suggesting that other products control parasite development (Whitten et al., 
2006). 
 
I.4.3.4.4 – Phagocytosis 
TEP1 was found to be implicated in phagocytosis responses to bacterial infection in 
mosquito (Levashina et al., 2001). However, it does not seem to be a mechanism 
involved in ookinete clearance, as TEP1 marked ookinetes are targeted for lysis and 
not phagocytosis.     
Nonetheless, phagocytosis of sporozoites in An. gambiae mosquitoes has been 
observed in the hemolymph (Hillyer et al., 2007) and in the salivary glands (Korochkina 
et al., 2006). Ae. aegypti were also found to be able to phagocyse P. gallinaceum 
sporozoites in the hemolymph (Hillyer et al., 2003). 
 
 
Introduction 
 
 
31 
  
  I.4.3.4.5 – Other killing Mechanisms 
Some other mechanisms, or in some cases specific molecules, have been linked to the 
mosquito response to the parasite.  
Oxidative stress appears to be a helpful tool in parasite killing, as it is present during 
both melanization and lysis phenomena. In agreement, in vivo inhibition of NOS 
increases parasite survival (Luckhart et al., 1998). Midgut epithelium invasion induces 
NOS in the midgut and in the carcass (Han et al., 2000; Luckhart et al., 1998). NOS 
expression and activity are also induced upon sporozoite egress from the oocyst, which 
is reflected by the increased levels of nitrite and nitrate in the hemolymph of infected 
mosquitoes (Luckhart et al., 1998). NO can rapidly be converted into nitrite that, in the 
presence of hydrogen peroxide (H2O2), mediates tyrosine (Tyr) nitration causing 
extensive degeneration of the invaded cell (Kumar et al., 2004).   
 
Different systemic levels of ROS were proposed to affect melanotic responses to 
Plasmodium (Kumar et al., 2003), as H2O2 levels in the hemolymph of L3-5 refractory 
mosquitoes are twice as high as those of the susceptible G3 strain.  
Although NOS and peroxidase activity and subsequent Tyr nitration are induced in An. 
stephensi mosquitoes upon P. berghei infection, the same is not observed in the Ae. 
aegypti – P. gallinaceum and An. stephensi-P. gallinaceum combinations, suggesting 
that epithelial responses are not universal to every parasite-vector combinations 
(Gupta et al., 2005). 
 
Vlachou et al. (2005) found that midgut epithelium remodeling, involving actin 
cytoskeleton and microtubules, is a major response to ookinete invasion. Other 
responses include innate immunity, extracellular matrix remodeling and apoptosis. 
RNAi studies have shown that among actin dynamics regulators there are agonists and 
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antagonists of parasite development and that actin polymerization is inhibitory to the 
parasite.  
 
Also, there is a dual role in hemolymph lipid transporters for the parasite and egg 
production (Vlachou et al., 2005). RFABG (retinoid and fatty acid binding glycoprotein) 
encodes an apolypophorin precursor that is involved in lipid transport. It is strongly 
induced upon ookinete invasion and has a role in egg development and ookinete 
survival. Silencing this gene leads to a 3.9 fold reduction in oocyst number and to an 
inhibition of egg development in the ovaries (Vlachou et al., 2005).  
 
I.4.3.5 – Immune responses after the midgut stage 
The fact that the major part of parasites is lost during midgut invasion (Vlachou & 
Kafatos, 2005) led to numerous works regarding the midgut epithelium response to 
invading ookinetes.  
Not so much is known about the response to emerging sporozoites and salivary gland 
invasion, as only few studies have paid attention to these stages that also reflect major 
bottlenecks in parasite development in the mosquito. Among others we find the works 
of Dimopoulos et al.(1996, 1998), Hillyer et al.(2003, 2007) and Rosinski-Chupin et 
al.(2007).  
Hillyer et al. (2003) observed both phagocytosis and melanization of P. gallinaceum 
sporozoites in the hemocel of Ae. aegypti, phagocytosis being the major response. 
These authors also found that when sporozoites egress from the midgut the 
hemolymph flux through the dorsal vessel helps parasites to find salivary glands to 
invade. When purified sporozoites (P. berghei/P. gallinaceum) are injected into the 
mosquito hemocel (An. gambiae/Ae. aegypti) only a small proportion (19%) 
successfully invades the salivary glands. The invasion occurs shortly after oocyst burst 
(~8h) and the sporozoites that do not invade the salivary glands are rapidly killed and 
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degraded. The mechanisms behind this parasite clearance are not known, but 2% of 
the mosquito hemocytes contain sporozoites trapped due to phagocytosis (Hillyer et 
al., 2007).      
Rosinski-Chupin et al.(2007) provided the first An. gambiae salivary gland 
transcriptome analysis upon P. berghei infection. Through a Serial Analysis of Gene 
Expression (SAGE) 57 genes were found to be differentially regulated at the transcript 
level in infected mosquitoes. These included genes belonging to different functional 
classes such as transport, lipid and energy metabolism, stress response and immunity. 
Immunity-related gene class alone was represented by 37 genes. Of particular interest 
was the upregulation of Defensin 1 (DEF1), GNBP, Serpin6 (SRPN6) and Cecropin2 
(Cec2). The first two were also shown to respond to P.berghei infection in An. gambiae 
by Dimoupolos et al. (1998), and to be expressed in the salivary gland. SRPN6 is also 
involved in the response to P. berghei upon midgut infection (Abraham et al., 2005).  
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Figure I.4.1 summarizes the knowledge of the mosquito response to the parasite: 
 
 
 
 
 
 
 
 
 
Figure I.4.1 – Interactions between Plasmodium and An. gambiae. Adapted from: Vlachou & 
Kafatos (2005).  
Mosquito molecules putatively involved in positive (+), negative (-) and unclassified reactions to 
the parasite are indicated in boxes. Responses include melanization, lysis and local epithelium 
responses. Following gamete development and fertilization (a) ookinetes (ook) traverse the 
cytoplasm of several midgut cells (1, 2 and 3) before reaching the basal lamina of the epithelium 
emerging basolaterally into the extracellular space (b). During midgut invasion, parasite induces 
local responses such as the induction of directional lamelliopodia protrusions (lam) beneath the 
invaded apoptotic cells, and the formation of cytoplasmatic lamellar protrusions (hood) of the 
invaded cell, which tightly embrace the parasite as it exits from the midgut (c).In the space 
between the epithelium and the basal lamina (BL) the parasite develops into an oocyst (ooc) in 
which thousands of sporozoites (spz) are produced (d). Some days later the oocyst busts and 
releases the sporozoites into the hemolymph where they journey to the salivary glands that are 
then invaded (e). During this journey, parasites are exposed to the immune response of the fat 
body and hemocytes. CP: Capping Protein; IMD: immune deficiency gene; PM: Peritrophic 
Matrix; PO: Phenoloxidase; SOD: Superoxide Dismutase.      
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I.4.4 – Studying rodent vs. human malaria 
The majority of work that has done so far in mosquito immune response to malaria 
relies on the use of rodent (P. berghei, P. yoelii), and in some cases avian (P. 
gallinaceum) malaria parasites. These models are easy to handle and the work can be 
performed in safe conditions, as none of these parasites is infective to humans. P. 
berghei has been the parasite used most often as it is amenable to manipulation, and 
several transgenes now exist including GFP parasites that exhibit green fluorescence. 
However, it is extremely hard to predict if the mosquito responses to P. berghei 
determined under lab conditions correlate to some extent to the ones displayed to P. 
falciparum in the field, but data suggests that the responses to these parasites are in 
fact different. Yet, some molecules and mechanisms seem to be induced by both 
parasites but it is not sure if the similar responses observed are universal for all P. 
falciparum strains.    
For instance, P. berghei and P. falciparum have different optimal temperatures for 
sporogonic development (21ºC and 25ºC, respectively) that may account per se for the 
induction of different molecules and/or effector mechanisms.  
 
SRPN2 is able to bind to and inhibit a heterologous PAE, from Manduca sexta, and its 
subsequent melanization activation in vitro. KD of SRPN2 increases melanin deposition 
in negatively charged Sephadex beads, and affects negatively P. berghei development 
in the mosquito. However, this effect is not seen in the development of field isolates of 
P. falciparum in An. gambiae isolated from the same region (Michel et al., 2006). 
Silencing of SRPN2, LRIM1 or CTL4 markedly affects P. berghei infection but does not 
influence the development of P. falciparum in An. gambiae, suggesting that the PPO 
cascade is under different regulation against the two Plamsodium species (Cohuet et 
al., 2006).   
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A microarray study that aimed at the comparison of the An. gambiae response to P. 
berghei and P. falciparum showed that P. berghei has a more profound effect on the 
mosquito transcriptome, leading to an alteration in expression of several genes, 
belonging to different functional classes, while P. falciparum elicits a broader immune 
response, at the transcription level. Seven out of 12 immune-related genes chosen for 
KD affect mosquito resistance to both parasite species. However, some immune genes 
are involved in species specific resistance: MDL1 and FBN39 are specific for the 
resistance to P. falciparum, while Gambicin and IRSP5 are specific for the resistance to 
P. berghei. Another interesting fact is that all genes affecting Plasmodium 
development also affect bacterial infection. These results show that the mosquito 
response to malaria at the transcription level is diverse, depending on universal and 
species specific factors (Dong et al., 2006).  
Bonnet et al. (2001) found that 16 genes of An. gambiae are regulated by the presence 
of P. falciparum in the blood meal, including a profilin gene. Of these, only 4 are up-
regulated by invasive forms. Profilin, an actin cytoskeleton regulator is also induced in 
midguts infected with P. berghei (Vlachou et al., 2005). These results suggest that 
response to invasion of epithelial cell might be similar for both parasites that cross 
epithelia in a similar way. 
In a study from Tahar et al. (2002) 9 genes were found to be up-regulated in An. 
gambiae infected with P. falciparum gametocyte carriers, including NOS, defensin and 
GNBP. The later is also induced in P. berghei infection, but with a different expression 
pattern (Christophides et al., 2002). As for DEF, GNBP, ICHIT, IGALE20, IMCR14 and 
ISPL5, they are also up-regulated by P. berghei infection in An. gambiae (Dimopoulos 
et al., 1997, 1998; Oduol et al., 2000). 
Although mosquitoes collected in the field are highly efficient in melanizing Sephadex 
beads, it is extremely rare to find melanized P. falciparum ookinetes (Niare et al., 2002; 
Schwartz & Koella, 2002). The L3-5 strain is able to melanized ookinetes from P. 
berghei, P. gallinaceum and P. cynomolgi B, and allopatric but not from sympatric 
strains of P. falciparum. Nevertheless, one African strain of An. gambiae was found to 
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melanize/encapsulate P. falciparum, although at a lower level than L3-5 (Brey, 1999). 
Mosquitoes in the field have a higher frequency of resistant alleles that attenuate 
infection intensity (Niare et al., 2002). 
Mendes et al. (2008) used microarrays and reverse genetics to study 5 genes known to 
regulate P. berghei development and field isolates of P. falciparum in geographically 
related mosquitoes. The transcriptional response seems to be similar in general, but 
not identical. Two genes were found to affect both parasite species in the same 
fashion: WASP and APOII/I. Both act at the midgut invasion level and have opposite 
effects. WASP is an activator of the local actin cytoskeleton dynamics that limits 
parasite development. APOII/I is a lipid transporter that affects the first stages of 
oocyst formation and promotes parasite development. 
Lim et al. (2005) found that An. stephensi infection by P. falciparum leads to the 
induction of NOS in midguts and the production of inflammatory levels of NO, by the 
recognition of parasite glycosylphosphatidylinositol (GPI) anchors. Although GPI 
anchors were not referred in either work of Luckhart et al.(1998) or Han et al.(2000), 
NOS induction and subsequent NO production was also found to occur in P. berghei 
ookinetes invaded cells of the midgut.    
 
These studies indicate that, even tough P. berghei is a useful and necessary model to 
use in laboratory work, the mosquito response so this parasite may not correlate 
entirely to the response to P. falciparum. 
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I.4.5 – Vector control by mosquito manipulation 
Parasite development in the mosquito depends on differences in genetics, ecology and 
behaviour of different mosquito species. The presence of different vector species in 
one area in the field may vary with season and ecology, making transmission control 
difficult. The relative importance of each mosquito species in the field also has a great 
impact on the parasite transmission pattern (Catteruccia, 2007).     
Several attempts have been made in order to restrain transmission in the lab, including 
dietary provision of transmission blocking compounds, and the construction of 
transgenic mosquitoes that express foreign proteins making them resistant to malaria 
infection.   
Examples include Aedes aegypti (Jansinskiene et al., 1998), Anopheles stephensi 
(Catteruccia et al., 2000), An. gambiae (Grossman et al., 2001) and Anopheles 
albimanus mosquitoes (Perera et al., 2002). Since stable germline integration was 
established, a lot of progress has been made in order to construct mosquitoes able to 
restrain parasite development (Riehle et al., 2003). Examples of stable gene expression 
(either by inoculation of virus as gene carriers or by transgenesis) with an impact on 
parasite development in mosquitoes are present in Table I.4.1.  
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Table I.4.1 
Stable gene expression in mosquitoes 
 Model Gene Expression Phenotype Reference 
 Parasite Mosquito     
V
ir
a
l 
e
xp
re
ss
io
n
 
P. 
gallinaceum 
Ae. aegypti Anti-CS MAB Sindbis virus Reduction in 
salivary gland 
invasion 
De Lara 
Capurro 
et al., 
2000 
P. berghei An. stephensi SM1 f88.4 Phage Reduction in 
oocyst number 
and salivary 
gland invasion 
Ghosh et 
al., 2001 
T
ra
n
sg
e
n
e
si
s 
P. berghei An. stephensi SM1 Pcarboxypep Reduction in 
oocyst number 
Ito et al., 
2002 
P. berghei An. stephensi Bee PLA2 Pcarboxypep Reduction in 
oocyst number 
Moreira 
et al., 
2002 
P. berghei An. gambiae CEC Pcarboxypep Reduction in 
oocyst number 
Kim et al., 
2004 
P. 
gallinaceum 
Ae. aegypti DEFA Pvitellog Inhibition of 
parasite 
development 
Kokoza et 
al., 2000 
P. berghei       
P. 
falciparum 
An. stephensi Sea cucumber 
CEL III 
Pcarboxypep Inhibition of 
oocyst 
formation 
Yoshida 
et al., 
2007 
 
 
 
 
Although successful mosquito transformations impairing transmission have been 
achieved, it is atill hard to predict their efficiency in the field (Scott et al., 2002). 
Catteruccia et al. (2003) have observed that in laboratory conditions, transgenes input 
a great burden in An. stephensi fitness. Yet, Moreira et al. (2004) found that transgenic 
In viral expression the correspondent genes were expressed in viruses that were introduced in the 
mosquitoes either by injection or feeding. MAB: Monoclonal antibody. SM1: Salivary gland peptide 1. 
Pvitellog: Vitellogenin promoter. Pcarboxypep: Carboxypeptidase promoter. 
In transgenesis mosquitoes were constructed to express the desired gene under the influence of a 
promoter that is specifically induced in the midgut upon a blood meal (Pcarboxypep or P vitellog).  PLA2: 
Phospholipase A2. CEC: Cecropin. DEFA: Defensin A. CELIII: C-type lectin CEL III. 
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expression of PLA2 in An. stephensi mosquitoes had no impact on mosquito fitness, in 
terms of mortality and egg production.  
 
Another attempt to block transmission has been made by introducing of foreign agents 
into the mosquitoes, either by feeding or injection. Examples follow in Table I.4.2. 
 
Table I.4.2 
Introduction of foreign agents in mosquitoes to block transmission  
 Model Agent Phenotype Reference 
 Parasite Mosquito    
F
e
e
d
in
g
 
P. 
gallinaceum 
P. falciparum 
Ae. aegypti   
An. gambiae 
Snake PLA2 Inhibition of midgut 
invasion 
Zieler et al., 2001 
P. falciparum   
P. berghei 
An. stephensi Gomesin Inhibition of 
exflagellation 
Moreira et al., 2007 
P. berghei          
P. falciparum 
An. stephensi NOS Reduction in oocyst 
numbers 
Luckhart et al., 1998 
P. 
gallinaceum 
Ae. aegypti Anti-CTRP 
AB 
Inhibition of  oocyst 
formation 
Li et al., 2004 
P. 
gallinaceum 
P. falciparum 
Ae. aegypti 
An. stephensi 
An. gambiae 
Anti-WARP 
AB 
Inhibition of oocyst 
formation 
Li et al., 2004 
P. berghei An. stephensi Anti-PbS21 
AB 
Inhibition of oocyst 
formation 
Ranawaka et al., 
1994 
P. 
gallinaceum 
P. falciparum 
Ae. aegypti 
An. freeborni 
Allosamidin Inhibition of oocyst 
development 
Shahabuddin et al., 
1993 
In
je
ct
io
n
 
P. 
gallinaceum  
P. berghei 
Ae. aegypti   
An. gambiae 
Bacteria Reduction in oocyst 
numbers 
Lowenberg et al., 
1999 
 
 
Agents were introduced in mosquitoes either by feeding (blood meal or diet) or injection. PLA2: 
Phospholipase2. NOS: Nitric oxide synthase. Anti-CTRP AB: Anti circumsporozoite and TRAP relate 
protein antibody. Anti-WARP AB: Anti Willebrand factor A protein antibody. Anti-PbS21 AB: Anti P. 
berghei surface protein 21 antibody.  Gomesin: APM from spider. Allosamidin: chitinase inhibitor.  
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I.5 – External factors influence on mosquito malaria infection  
Although much attention has been paid to the mosquito immune responses, other 
factors may affect the sporogonic development of the malaria parasite.  
In the blood meal, along with the red blood cells and the parasites, are introduced a 
series of factors that can affect the outcome of infection. For instance, components of 
the mammalian immune system may have a parasite inhibitory effect: the presence of 
mammalian growth factors in the blood meal seems to be associated with an increased 
expression of NOS and a reduction in the parasite number (Luckhart et al., 2003) and 
the presence of leukocytes seems to be related to a reduction in gamete 
differentiation (Lensen et al., 1997).  
Other blood meal components, like antibodies and drugs also have an influence. An 
immunized blood meal against Plasmodium sporozoites interferes with parasite 
development in the mosquito and affects gene expression of both parasite and 
mosquito (Lopes et al., 2007).  Many studies have been conducted in order to evaluate 
the effect of antimalarial drugs in malaria transmission.  
Several antimalarial drugs were found to have a transmission blocking activity, 
damaging ookinetes and/or reducing oocyst numbers in the mosquito midgut. For 
instance, Atovaquone decreases infectivity of P. berghei to mosquitoes and 
Primaquine has both gametocytocidal    and sporotoncidal effects on P. falciparum. 
Drugs such as Proguanil, Pyrimethamine and the combination 
Sulfadoxine/Pyrimethamine were found to have an inhibitory effect on the parasites 
development in the mosquito without affecting gametocytes. On the other hand, 
Sulfadoxine by itself, Artemisinin and Mefloquine show no effect on P. falciparum 
development in the mosquito. The latter, however, is able to reduce oocyst numbers 
of P. berghei (Butcher, 1997).  
On the contrary to other drugs, Chloroquine has a transmission promoting effect, 
increasing oocyst numbers on P. falciparum, P. berghei and P. yoelii nigeriensis 
infections, even though it has a gametocytocidal action against immature gametocytes 
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(Butcher, 1997, Buckling et al., 1997; Buckling & Read, 1999; Hogh et al., 1998; 
Ichimori et al., 1990 ).  
The mechanisms by which chloroquine may affect increased parasite transmission in 
the mosquito have not been unveiled. One hypothesis is that it affects the mosquito 
immune response, promoting parasite infectivity. This was recently reported for 
another antimalarial drug, Nitorquine that increases the melanotic encapsulation of P. 
yoelii in An. stephensi, which is accompanied by an induction of PPO activity and 
mRNA. Interestingly, it has no effect on PPO expression or activity in non-fed 
mosquitoes or mosquitoes fed on non-infected blood, suggesting that it specifically 
aids response of the mosquito to the parasite (Zhang et al., 2008).  
 
 
I.5.1 – Chloroquine 
Chloroquine was, until a decade ago, the major antimalarial drug used around the 
world. However the constant and widespread development of resistance by the 
parasite has made its use as a safe prophylactic drug nearly impossible. 
Chloroquine is a diprotic weak base that shows a remarkable ability to enter acidic 
compartments in cells and raise its pH (Krogstad et al., 1985), exerting a 
lysosomotrophic action and compromising its function.  The exact mechanism through 
which chloroquine exerts its antimalarial action is still unclear. Yet, it is sure that it 
interferes with the hemoglobin digestion by the parasite, upon blood cell invasion. 
Hemoglobin digestion occurs in an acidic compartment of the parasite, the digestive 
vacuole, resulting in the production of a toxic waste. It is thought that chloroquine 
affects several detoxification mechanisms, leading to parasite killing (Ginsburg et al., 
1999). 
At the same time this drug seems to have a series of effects in the human organism. 
Some of these have special influence in the immune system, and are sometimes 
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controversial. Evidence exists that it promotes nitric oxide synthesis from endothelial 
cells (Ghigo et al., 1998), but also that it strongly inhibits IFN-γ induced NO synthesis in 
macrophages (Hrabák et al., 1998). It inhibits proinflammatory cytokine release (Hong 
et al., 2004; Karres et al., 1998), but induces NF-kB activation and expression of 
proinflammatory cytokines in human astroglial cells (Park et al., 2003a). In addition, it 
inhibits platelet aggregation in vitro (Nosál et al., 2000), and pH dependent steps of 
virus replication (Savarino et al., 2003).    
In the mosquito it was shown to promote Plasmodium infection (Enosse et al., 2000; 
Gautret et al., 2001; Hogh et al., 1998; Ramkaran & Peters, 1969). The exact 
mechanism behind it is still unclear, but accumulating data on chloroquine action on 
mammalian immunity indicate that it might also affect the mosquito immune 
responses to the parasite, thereby increasing its permissiveness to the parasite.      
Abrantes et al. (2005) characterized chloroquine effect in the mosquito immune 
response at the serine protease and AMP synthesis level. After a blood meal, the 
expression of serine protease (Sp14D, Sp24D, ISPL5 and the serine protease 1644280) 
and AMPs (gam, def and cec) are induced. Remarkably, this induction is suppressed in 
mosquitoes fed on mice treated with chloroquine and AMP expression seems to be 
more affected by chloroquine than serine proteases expression. Following a P. berghei 
infected blood meal chloroquine has the same suppressive action at the exception of 
Sp14D, def and 1644280. However, in infected mosquitoes chloroquine action is less 
pronounced, suggesting that the response to the parasite can overcome the drug 
effect. 
A microarray-based study performed to obtain more detailed information on 
chloroquine effect on the mosquito responses, revealed that this drug affects the 
expression of mosquito genes involved in several physiological processes, such as 
immunity, apoptosis, cytoskeleton remodeling and oxidative stress. As all these 
phenomena have been in some way linked to the response to the parasite and it is 
understandable that this drug is able to modulate malaria development in the 
mosquito (Abrantes et al., 2008).         
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Understanding how chloroquine and other external factor can impair the mosquito 
immune response to the parasite and manipulate infection may provide an insight on 
the complex array of interactions between parasite and vector. This is a requisite to 
finally manipulate mosquitoes and block transmission. 
 
To successfully eradicate malaria an integrated action will have to be created, covering 
areas such as vaccination, treatment, prevention, sanitary and health conditions 
improvement and transmission blocking. Each of these areas invokes an enormous 
amount of effort and labor. For transmission blocking alone it is imperative to 
understand the biology of parasite and mosquito, their interactions throughout the 
infection step (including mosquito immune responses and parasite evasion), and the 
factors extrinsic to the parasite and the mosquito that may influence the outcome of 
the infection. Ultimately, this will allow the construction of transgenic mosquitoes 
resistant to malaria infection and fit for field survival and spreading.   
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II.1 – General objectives  
Efficient control of malaria requires integrated actions, covering areas such as sanitary 
and health conditions improvement, sustainable control programs, vaccination, 
reliable drug therapy and transmission control. For this it is vital to understand the 
biology and interactions of both parasite and vector. In this context, the mosquito 
immune responses to the parasite are of critical importance. As such, this work aims at 
contributing to the knowledge about mosquito immunity towards the malaria parasite. 
This will be accomplished by using the insect model for immunity studies Drosophila 
melanogaster and by testing several insect immune responses that the mosquito might 
use to control malaria infection at a specific life cycle stage: the hemolymph invasion 
by Plasmodium sporozoites. This will involve in vivo systems of D. melanogaster and 
An. gambiae infections and in vitro systems of both organisms. Molecular techniques 
will involve gene expression studies, Plasmodium detection PCR techniques and 
proteomics. 
 
 
II.2 – Specific objectives 
 II.2.1 – Objective 1 – Evaluation of Chloroquine effect on mosquito immune 
responses using the Drosophila melanogaster model. 
 
Chloroquine is known to affect malaria transmission in the mosquito vector. When 
present in a blood meal it has a Plasmodium development promoting action, 
enhancing oocyst numbers in the mosquito midgut. Accumulating evidence suggests 
that chloroquine has an impact on mosquito immunity. Knowledge about mosquito 
immunity is still limited and scattered. Oppositely, current understanding about 
Drosophila immune responses is straight forward, particularly in respect to 
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intracellular immune pathway activation and AMP synthesis. Thus, it will be a useful 
model to study the effect of Chloroquine on AMP induction in mosquito immunity.  
Chloroquine effect on fly immunity will be evaluated on AMP (Drosomycin, Attacin and 
Diptericin) gene expression and protein synthesis, using both in vivo and in vitro 
systems, upon infection or immune stimulation, and on survival, upon infection.         
 
 II.2.2 – Objective 2 – Determination of mosquito immune effector mechanisms 
involved in the hemolymph response to Plasmodium sporozoites. 
 
Mosquito vector immune responses to malaria parasites have been widely studied. 
The massive data accumulated so far refers mainly to the responses triggered by 
ookinete invasion of the mosquito midgut. Knowledge about mosquito responses to 
hemolymph invading sporozoites is scarce. We aim at understanding which immune 
effector mechanisms may be triggered on the mosquito hemolymph allowing the 
mosquito to restrain sporozoite numbers and avoid massive salivary gland infection. 
 
a) Determination of hemocyte number variation upon stimulation with a 
Plasmodium sporozoite surface protein. 
Hemocyte numbers in insect hemolymph may vary according to the specific immune 
response triggered: microaggregation reactions reduce the number of circulating 
hemocytes, while other responses may require the induction of hemocyte proliferation 
to amplify the response itself. This will be tested in vitro using hemocyte-like cells that 
will be stimulated with the major surface antigen from P. falciparum sporozoites.    
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b) Evaluation of melanization activation and role upon sporozoite invasion of 
the mosquito hemolymph. 
Massive ookinete melanization has been observed in midguts of malaria refractory 
mosquitoes and on sporozoites in the hemolymph of Ae. aegypti mosquitoes. We aim 
at evaluating melanization induction in mosquito hemolymph in response to the 
presence of Plasmodium sporozoites and determining the potential role of this 
response in the control of sporozoite numbers in the mosquito hemolymph.  
Melanization in the hemolymph will be followed in vivo through P. berghei infection in 
the mosquito and correlated with the presence of sporozoites. It will also be 
determined in vivo upon stimulation with the major surface antigen from P. falciparum 
sporozoites. Its role on parasite control in the hemolymph will be tested by inhibition 
of melanization in infected mosquitoes and evaluation of sporozoite load on salivary 
glands.     
 
c) Proteomic analysis of mosquito hemolymph upon sporozoite invasion. 
The insect hemolymph is a protein rich environment to which several immune proteins 
are secreted. Soluble proteins include PRRs, protease cascades and their regulators for 
signalization and activation of immune effector mechanisms, and AMPs. Some of these 
proteins exist at a basal level in the hemolymph to assure a quick response or are 
produced and secreted upon infection. Thus the hemolymph proteome at a specific 
stage of a particular infection is expected to be unique for the pathogen. We will use a 
proteomic analysis to determine differential regulation of hemolymph proteins upon 
sporozoite invasion of the hemolymph. Gene expression of genes coding for the 
identified proteins will add further knowledge about the response itself. Immune 
effector mechanisms will be evaluated according to the predicted functions of the 
identified proteins.    
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III.1 – Introduction 
Drosophila melanogaster flies represent a powerful model to study physiological 
processes taking place in several organisms, from insects to humans (Alarco et al., 
2004; Bilen & Bonini, 2005; Schneider, 2000). These flies are easy to handle and to 
maintain in the lab. Additionally, their powerful genetic tools allow an accelerated 
study at many molecular levels, also through the establishment of mutant lines, and 
the possibility to knock-down virtually any gene. This is of particular importance in the 
understanding of how the components of a given pathway are ordered. These 
properties allowed identifying components of the intracellular transduction pathways 
(namely TOLL and IMD, Figure I.3.2) and of the extracellular protease cascades acting 
during the immune response. Conversely, mosquitoes are hard to handle and the 
establishment of mutant lines is complex and difficult. Nevertheless, the completion of 
the An. gambiae genome sequencing allowed a comparative analysis of the genomes 
of the fly and the mosquito, including immunity genes. This revealed a great 
conservation of the components of intracellular transduction pathways, as opposed to 
extracellular immune-related molecules. Thus, the fly came as a good model for 
mosquito immunity in particular for the activation of intracellular transduction 
pathways.  
In flies, TOLL and IMD pathway activation is marked mainly by AMP synthesis, the best 
studied effector mechanism in Drosophila. TOLL pathway is known to be responsible 
for the production of AMPs like Drosomycin (Drs) in response to fungi or Gram + 
bacterial infection, while the IMD pathway leads to apoptosis and to the synthesis of 
AMPs such as Diptericin (Dipt) and Attacin (Att) in response to Gram – bacterial 
infection. Experiments in which mutant flies were challenged with fungi or bacteria 
revealed that survival to fungal, but not to bacterial infection, was severely 
compromised in TOLL-deficient mutants, and, by contrast, IMD mutants were 
markedly affected by bacterial infections but resisted fungi with a survival pattern 
similar to that of wild-type flies (Hoffmann & Reichhart, 2002).  
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The antimalarial drug chloroquine was shown to have a transmission boosting action in 
the mosquito of both rodent and human malaria species (Enosse et al., 2000; Gautret 
et al., 2001; Hogh et al., 1998; Ramkaran & Peters, 1969), and it was proposed to 
facilitate transmission through the mosquito by affecting mosquito-parasite 
interactions, especially by interfering with the mosquito immune response.  
Chloroquine can be expected to act at the extra or intracellular level. It has been 
documented to affect proteolytical activity (Staszczak et al., 2000), thus it may 
interfere with extracellular signalling between the microbial recognition and the 
activation of surface receptors and intracellular signalling.  
Chloroquine is a diprotic base with a remarkable ability to enter acidic compartments 
in cells, such as phagosomes, lysosomes and transport vesicles. These are of particular 
importance in immune processes such as phagocytosis, secretion of proteins to the 
extracellular space and the delivery of recognition receptors to the cell wall. The 
accumulation of chloroquine in these compartments results in a pH increase, exerting 
a lysosomotrophic action and affecting processes depending on endo/exocytic 
pathways (Krogstad et al., 1985; Weber et al., 2000). One of the mechanisms that 
could be compromised is the recycling of immune related receptors to the cell surface. 
In this case, no recognition of the extracellular immune signal would occur, no 
intracellular signalling would be produced, and no immune response would be 
observed. It could also happen that the few receptors already present at the cell 
surface by the time of administration of the drug, are enough to receive, transmit and 
amplify the immune signal. But impairment of the exocytic pathway would prevent the 
correct extracellular localization of several immune related molecules, which depends 
on it to be secreted. Additionally, chloroquine was shown to interfere with the 
function of transcription factors (Park et al., 2003a). Thus chloroquine might be 
expected to interfere with processes necessary to fight several types of infections. 
In Drosophila the response to different pathogens is quite well understood, particularly 
at the intracellular level and the AMP synthesis, both in vivo and in vitro, making it a 
good model to study the effect of chloroquine on immunity.     
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III.2 – Methodology 
 III.2.1 – Fly stocks 
Wild type Drosophila melanogaster Oregon R flies were kept at 25ºC, on standard 
medium.  Three to five days old female flies were utilized for toxicity tests, 
antimicrobial peptide expression and survival experiments. 
DD1/DD1; Droplet/TM6c flies were used to qualitatively evaluate the expression of the 
antimicrobial peptides Drosomycin and Diptericin on a gut-localized immune response. 
These flies carry two reporter transgenes, a drosomycin-GFP gene (P[w
+
mC Drom::GFP 
= pDrs-GFP S65T), in which the GFP gene is under control of the drosomycin promoter, 
and a diptericin-β-galactosidase gene  (P[w
+
mC Dipt:: LacZ = pDipt-LacZ]) that has a β-
galactosidase gene under the control of the promoter of diptericin.     
 
 
 III.2.2 – Chloroquine solutions and administration 
Chloroquine diphosphate salt (Sigma) was diluted in water, in order to make a stock 
solution at 10mM , and aliquots were stored at -80ºC.   
For in vivo experiments, dilutions of 2µM and 10µM were prepared in a 1% glucose 
solution, and this was used as a control. All solutions were administered to flies by 
feeding. A filter paper was soaked with a few millilitres of each solution, and placed in 
an empty vial, along with the flies.  Toxicity tests were performed by feeding flies on 
solutions ranging from 0mg/l to 500mg/l of chloroquine for 9 days, and checking 
mortality.   
Solutions for in vitro assays were simply diluted in water (0.1, 0.5, 1, 5, 10μM). Cells 
were checked morphologically for drug toxicity. 
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 III.2.3 – Chloroquine impact on AMP production 
Chloroquine effect on the Drosophila immune response was primarily checked on AMP 
synthesis, using both in vivo and in vitro systems. In adult flies, AMP expression was 
determined at a systemic level, while in vitro AMP de novo synthesis was evaluated on 
hemocyte-like cell lines.    
Figure III.2.1 represents the experimental design for AMP expression and synthesis. 
 
        
 
 
 
 
 
 
 
 
Figure III.2.1 – Experimental design for chloroquine effect on AMP synthesis response of Drosophila 
to infection.  
In vivo assay: wild type flies Oregon R were fed on different amounts of chloroquine (Chl – 0, 10 and 
50 mg/l) and infected with mixed bacteria or B. bassiana. Non-infected flies were collected at 0h post 
infection, mixed bacteria at 6 and 24h post-infection, and B. bassiana infected flies at 48h post-
infection. RNA from collected flies was used for Northern blot and Real-time PCR to determine 
drosomycin and diptericin expression levels. 
In vitro assay: cells from hemocyte-like cell lines were plated on a 24-well plate (1x10
6
cells/well) and 
conditioned to different chloroquine solutions (Chl sol – 0, 0.1, 1 and 10µM) for different times (0, 2, 
6, 12h and ON). Cells were stimulated ON with heat killed (HK) E. coli bacteria (129-69 cell line, 
transfected with a attacin-luciferase (Patt-lucif) gene) or the Spaetzel protein (Spz – 648-IB6 cell line, 
transfected with a drosomycin-luciferase (Pdrosom-lucif) gene). After stimulation, luciferase activity 
was determined for each sample.  
Boxed figure: Toll pathway is activated by Gram + bacteria and fungi. Pathogen recognition leads to 
binding of Spaetzel to the receptor Toll, resulting in the expression and synthesis of AMPs such as 
Drosomycin. Imd pathway is activated by Gram – bacteria (like E. coli) and leads to the expression and 
synthesis of AMPs such as Diptericin and Attacin. 
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III.2.3.1 – In vivo AMP expression 
III.2.3.1.1 – Drosophila infections 
Wild type Oregon R flies were treated by oral feeding with different doses of 
chloroquine: glucose 1%; 10mg/l chloroquine/ 1% glucose; 50mg/l chloroquine/ 1% 
glucose for two days.  
Flies were either pricked with a thin needle dipped into a concentrated mixture of 
overnight grown bacterial cultures of Escherichia coli 1106 and Micrococcus luteus CIP 
A270 or shaken in a Petri dish containing a sporulating culture of the 
entomopathogenic fungus Bauveria bassiana.   
Non-infected flies were collected at time 0 (infection time). Flies infected with mixed 
bacteria were collected at 6h and 24h post-infection (pi). B. bassiana naturally infected 
flies were collected at 48h pi. Twenty flies of each group were frozen for RNA 
collection, for Northern blot and Real Time semi-quantitative PCR. 
Chloroquine treatments were maintained during the course of all infections.  
 
 
III.2.3.1.2 – Northern blot analysis 
RNA was extracted from flies frozen at -80ºC with Trizol Reagent (Invitrogen). Briefly, 
flies were crushed and ressuspended in 1ml of Trizol® reagent and incubated at room 
temperature (rt) for 5min. To this was added 200µl of chloroform (Sigma) and solution 
was vigorously mixed and incubated at rt for 3min. samples were centrifuged at 12 
000xg for 15min at 4ºC. The RNA containing aqueous phase was transferred to a new 
tube and precipitated with 500µl of isopropanol (Sigma) by incubating at rt for 10min. 
Samples were then centrifuged at 12 000xg for 10min at 4ºC. The supernatant was 
discarded and RNA precipitates were washed with 75% ethanol (Sigma), vortexed and 
centrifuged at 7 500xg for 5min at 4ºC. The supernatant was discarded and pellets 
were left to dry until all ethanol had evaporated. RNA was ressuspended in 20µl of 
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diethyl pyrocarbonate (DEPC – Sigma) treated water by incubating at 60ºC for 10min 
and vortexing. RNA samples were kept at -80ºC. 
Twenty μg of RNA was ran on a 1% agarose, 6.7% formaldehyde denaturing gel, and 
transferred ON to a positively charged nylon membrane by capillarity on a 10X saline 
sodium citrate (SSC) buffer solution.  
Radioactive (
32
P-labeled) probes were synthesized using the Rediprime VI Random 
Prime Labeling System (dCTP – GE Hralthcare). Probes were prepared by a reverse 
transcription reaction from rp49, drs and dipt cDNA’s. Primer sets are described in 
table III.2.1. Hybridizations were performed at 42ªC, ON, sequentially for rp49, 
drosomycin and diptericin. 
Signal was visualized in a Bioimager film (Bio-Rad), and on an X-ray film, and quantified 
using the Bioimager software (Bio-Rad). The rp49 signal was used as an internal 
loading control. Five independent experiments were performed, and data was 
analyzed for statistical differences with a Mann-Whitney test, using the GraphPad 
software (Prism). 
 
Table III.2.1 
Primers used for RT-PCR 
Gene Primer sequence 
rp49 Fwd: ATACAGGCCCAAGATCGTGA 
Rev: GTGTATTCCGACCACGTTACA 
drosomycin Fwd: AGCTCCGTGAGAACCTTTTCC 
Rev: CATCCTTCGCACCAGCACTTC 
diptericin Fwd: AGTTCACCATTGCCGTCGCC 
Rev: GTAGGTGTAGGTGCTTCCCA 
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III.2.3.1.3 – Real-Time analysis 
Samples of 5 flies were frozen at -80ºC and crushed with a Mixer Mill 300 (Retch). 
Total RNA was prepared using the Nucleospin 96 kit (Macherey Nagel) with the 
vacuum technique and RNAs eluted in 100 µl of RNase free water. Two µl were used in 
a Reverse Transcription reaction using Superscript II reverse transcriptase (Invitrogen) 
and random primers (Invitrogen) according to the supplier’s instructions.  
Real-Time PCR reactions were set up using the qPCR kit (Eurogentec – SYBRGreen final 
concentration of 1/50000 to 1/75,000) and the synthesized cDNAs. Real-time PCR was 
performed on an i-cycler iQ (Biorad). PCR conditions comprised preincubation at 95°C, 
40 cycles of 15sec at 95 °C and 1min at 60 °C. Reactions were performed in duplicates. 
To check for specificity of the PCR reaction, melting curves were analyzed for each data 
point. The levels of expression of the gene of interest were normalized against the 
level of the RNA coding rp49 determined in each sample. Primers used in Real-Time 
PCR are detailed in Table III.2.2.  
Three independent experiments were performed, and data was analyzed for statistical 
differences with a Mann-Whitney test, using the GraphPad software (Prism). 
 
 
Table III.2.2 
Primers used for Real-Time PCR 
Gene Primer sequence 
rp49 Fwd:GACGCTTCAAGGGACAGTATCTG 
Rev: 5’AAACGCGGTTCTGCATGAG 
drosomycin Fwd:CGTGAGAACCTTTTCCAATATGATG 
Rev: TCCCAGGACCACCAGCAT 
diptericin Fwd: GCTGCGCAATCGCTTCTACT 
Rev: TGGTGGAGTGGGCTTCATG 
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III.2.3.2 – In vitro AMP synthesis 
Two hemocyte-like cell cultures originally derived from Drosophila embryos were used 
to test antimicrobial peptide synthesis. Both cell lines derive from Drosophila S2 from 
transfection: 648-ib6 cells which contain a stable insertion for a drosomycin-luciferase 
gene, and 169-29, with an attacin-luciferase gene insertion. Cells were grown at 25
 
°C 
in Schneider's medium (Biowest) supplemented with 10%
 
fetal calf serum, 10
5
 
units/liter penicillin, 100 mg/liter streptomycin,
 
and 1 µg/ml puromycin. 
Both cell cultures were plated in a 24 well plate (1x10
6
 cell/well), and let to rest 
overnight. The next day cells were treated with 0, 0.1, 1 and 10µM of Chloroquine, for 
0, 2, 6, 12h and ON.   
After treatment, cells were washed and let for 30 minutes with new medium (no 
chloroquine). Cells were then stimulated either with 5nM SPZ protein (648 – IB6 cell 
line) or 4x10
7
 heat killed E. coli bacteria (169-29 cell line).  
After ON stimulation, cells were collected and disrupted using a lysis buffer (Promega). 
Luciferase substrate (luciferin;
 
Promega) was added and luciferase activity was 
immediately read on a luminometer
 
(BCL Book, Promega).
 
 
 
 
 III.2.4 – Chloroquine impact on local immune responses 
For localized immune response study, DD1 flies were fed on different doses of 
chloroquine (0, 10, 50 mg/l in 1% glucose) for 48h. Then, solutions were removed and 
flies were fed with the Gram-negative bacteria Serratia marcescens for 2-3 days.    
Serratia marcescens infected flies were dissected in order to allow the visualization of 
the gut, which was fixed in a glutaraldehyde 1% solution for 10–15 min, and stained in 
a 30 μl/ml X-gal stock solution (5% in DMF). The colorimetric reaction was observed in 
a light microscope. 
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III.2.5 – Chloroquine impact on fly’s survival to infection 
To test chloroquine effect on the survival of flies upon an infection, wild type Oregon R 
flies were treated by oral feeding with different doses of chloroquine: glucose 1%; 
10mg/l chloroquine/ 1% glucose; 50mg/l chloroquine/ 1% glucose for two days. Flies 
were then either challenged with bacteria solutions (mixed bacteria, E. coli, M. luteus, 
Enterococcus fecalis or Staphylococcus aureus) or shaken in a Petri dish containing a 
sporulating culture of B. bassiana. Control groups included non-infected flies.  
Fly mortality was followed for 7 days, by counting the number of dead flies. 
Chloroquine treatments were maintained during the course of experiment. 
 
 
 
III.3 – Results 
 III.3.1 – Chloroquine toxicity to flies 
During 9 days, no lethality occurred with any of the chloroquine treatments, 
suggesting that chloroquine can be used, even at high concentrations, without 
compromising the fly’s survival. 
Solutions of 10 and 50 mg Chl/l were used in all experiments, since they correspond to 
the sub-therapeutical and therapeutical dosages of the drug used to treat mice in the 
mosquito’s experiments.    
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III.3.2 – AMP expression and synthesis 
III.3.2.1 – In vivo AMP expression 
The effect of chloroquine in the activation of specific immune pathways as Toll or Imd, 
was accessed in vivo by determining AMP gene expression in wild type flies Oregon R 
and the DD1 (drosomycin-GFP) flies. The drs (drosomycin) expression was taken as 
readout for the Toll pathway activation. The dipt (diptericin) and att (attacin) 
expressions were used as readout for the Imd pathway activation. The housekeeping 
gene for the ribosomal protein Rp49 was used as an internal control. 
 
 III.3.2.1.1 – Northern blot analysis 
Drosophila drs and dipt gene expression was determined by Northern blot by 
determining signal intensity in the films. Figure III.3.1 shows a representative Northern 
blot signal for rp49, drs and dipt genes of Oregon R flies, as determined in experimentI.   
  
 
Providing a qualitative analysis, Northern blots observation allow to have a rough idea 
of AMP induction.  All groups of flies show similar levels of rp49, indicating that 
approximate amounts of RNA were loaded into the gel. Drs gene expression was 
induced in flies infected with mixed bacteria (M. luteus + E. Coli, in a 1:1 ratio) at 6 and 
24h pi and in flies infected with B. bassiana at 48h pi, in accordance with the expected 
Figure III.3.1 - Northern blot of 
rp49, drs and dipt gene 
expression in Oregon R flies. 
Flies were treated with different 
doses of Chloroquine (0, 10, 50 
mg/l). Non-infected flies were 
collected at 0h, mixed bacteria 
infected at 6h and 24h, and flies 
infected with B. bassiana at 48h. 
Radioactive gene-specific probes 
were incubated with fly RNA.       
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activation of the Toll pathway by Gram-positive bacteria and fungi. Dipt gene 
expression was induced in flies infected with mixed bacteria, at 6 and 24h pi, which 
confirms the IMD pathway activation by Gram-negative bacteria.  
The same pattern of AMP induction was seen in all experiments, indicating that the 
readouts are functional and reproducible.  
Chloroquine treatments did not seem to cause noteworthy alterations in AMP 
expression. Only small alterations were observed in mixed bacterial infection. 
Chloroquine treated flies seemed to have an increased drs expression at 24h after 
mixed bacterial infection, and a reduction in dipt expression at 6h after mixed-bacterial 
infection.  
Nevertheless, the band pattern allows only a rough view of alterations in gene 
expression. It has a low sensitivity, and the relation between the gene of interest and 
the control rp49 can only be accessed qualitatively. To quantify gene expression, the 
intensity of the bands in Northern blots was determined with the bioimager software. 
All values obtained for gene expression of drs and dipt were normalized with the ones 
for rp49.  
Relative expression of drs in flies submitted to different chl treatments and infections 
is shown in Figure III.3.2. 
   
Chloroquine treated flies showed the same pattern of drs induction upon infection as 
control flies (0mg Chl/l). No significant differences in gene expression were observed.  
Nevertheless, a slight reduction (20%) in drs expression was detected in non-infected 
flies treated with the lower dose of Chl (10mg/l) when compared to non-treated flies, 
which was not observed for the higher dose (50mg/l). 
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Influence of Chl on drs expression
 upon infection
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Flies infected with mixed bacteria and treated with the lower dose of chloroquine 
(10mg Chl/l) showed a 1.2fold increase in drs expression at 6hpi and a 1.5fold increase 
in drs expression at 24h when compared with non-treated controls. This trend was 
observed in all experiments performed. The same pattern of induction was not seen 
with the higher dose of Chl. Although flies infected with mixed bacteria treated with 
the higher dose of chloroquine (50mg Chl/l) showed a 1.3fold increase at 24hpi relative 
to controls, this trend was not consistent in all experiments performed.  
AS for dipt, relative gene expression in flies submitted to different chl treatments and 
infections is shown in Figure III.3.3. 
 
Figure III.3.2 – Northern blot evaluation of the influence of Chl on drs expression 
upon infection. Oregon R flies were submitted to different chloroquine (Chl) 
treatments – 0, 10 and 50mg/l – and infections – Non-infected (ni), Mixed bacteria 
(mix bact) and B. bassiana (B. bass). RNA was collected from flies at 0, 6, 24 and 48h, 
respectively to infection. Gene expression of drosomycin (drs) in flies was determined 
by Northern blot and normalized with the expression of rp49 gene.  
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Influence of Chl on dipt expression
 upon infection
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No significant differences were observed in dipt induction pattern for any of the chl 
treatments. However, a slight induction of dipt was observed in non-infected flies 
treated with the higher dose of Chl (50mg/l).  
 
   III.3.2.1.2 – Real-Time analysis 
Expression of drs and dipt was further analyzed by Real-Time PCR.  
Relative expression of drs in flies submitted to different chl treatments and infections 
is shown in Figure III.3.4. 
 
Figure III.3.3 –Northern blot evaluation of the influence of Chl on dipt expression 
upon infection. Oregon R flies were submitted to different chloroquine (Chl) 
treatments – 0, 10 and 50mg/l – and infections – Non-infected (ni), Mixed bacteria 
(mix bact) and B. bassiana (B. bass). RNA was collected from flies at 0, 6, 24 and 48h, 
respectively to infection. Gene expression of diptericin (dipt) in flies was determined 
by Northern blot and normalized with the expression of rp49 gene.  
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Influence of Chl on drs expression
 upon infection
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As for Northern blot results, results obtained by Real-Time PCR show that drs 
expression seems to be induced by mixed bacterial infection, both at 6 and 24hpi, and 
strongly induced by B. bassiana infection at 48hpi, emphasizing the strength of this 
assay.   
Chloroquine did not seem to have any effect on drs induction in any of the treated fly 
groups tested, as no significant differences were observed between Chl treatments for 
any of the infected or the control flies. 
A faint induction of drs expression was seen at 6hpi in flies infected with mixed-
bacteria and treated with the lower dose of Chl (1.2fold) when compared to non-
treated flies, and was in accord with the results from Northern blot. Although small, 
this induction was reproducible between experiments. On the contrary, a minor 
Figure III.3.4 – Real-Time evaluation of the influence of Chl on drs expression upon 
infection. Oregon R flies were submitted to different chloroquine (Chl) treatments – 0, 
10 and 50mg/l – and infections – Non-infected (ni), Mixed bacteria (mix bact) and B. 
bassiana (B. bass). RNA was collected from flies at 0, 6, 24 and 48h, respectively to 
infection. Gene expression of drosomycin (drs) in flies was determined by Real-Time 
PCR and normalized with the expression of rp49 gene.  
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reduction (20%) was observed in the same flies, treated with the higher dose of Chl. 
This reduction pattern was observed in all experiments performed.  
Flies infected with B. bassiana showed a slight drs induction when treated with both 
doses of Chl, contrasting with Northern blot results, where no differences were 
observed. While flies treated with 10mg/l showed increased drs induction (1.5fold) in 
all experiments, flies treated with 50mg/l (1.2fold drs induction) showed inconsistency 
between experiments.  
Additionally, a slight reduction was observed for both chloroquine treatments at 24h in 
flies infected with mixed bacteria, contrasting with the Northern blot results. However, 
this trend was not consistent in all experiments performed and thus is probably due to 
experimental variation.  
 
Real-Time determined dipt relative gene expression in flies submitted to different chl 
treatments and infections is shown in Figure III.3.5. 
Real-Time determined dipt gene expression was strongly induced in flies infected with 
mixed bacteria at 6 and 24hpi, confirming the robustness of the AMP induction 
readouts. 
Yet, no significant differences were observed in dipt expression between Chl 
treatments.  
Only a slight reduction in dipt expression was observed in flies infected with mixed 
bacteria at 6h and treated with the highest dose of Chl (45% reduction relative to non-
treated control flies), contrasting with results obtained by Northern blot, where no 
differences were observed. This trend was seen in all experiments performed.     
Another result that contrasts to Northern blot analysis is the non-observation of dipt 
expression reduction in flies infected with B. Bassiana and treated with Chl. Although a 
slight reduction was observed with the lower dose treatment (30%) it was not 
consistent through experiments.   
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Influence of Chl on dipt expression
 upon infection
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Single experiments performed to evaluate if Chl effect could be masked by the 
timepoints chosen to study the induction of each AMP and the mixture of Gram-
positive and Gram-negative bacteria in one solution to administer. As such, AMP 
expression was evaluated in flies infected with mixed bacteria at 0, 3, 6 and 9hpi. 
Although an overall increasing in both genes expression through the first nine hours of 
infection was seen, no differences between Chl treated and non-treated flies were 
detected. Also, flies were treated with Chl and infected with E. coli and M. luteus  
separately, but once more no differences were observed between Chl treated and 
non-treated flies (data not shown).    
Figure III.3.5 – Real-Time evaluation of the influence of Chl on dipt expression upon 
infection. Oregon R flies were submitted to different chloroquine (Chl) treatments – 0, 
10 and 50mg/l – and infections – Non-infected (ni), Mixed bacteria (mix bact) and B. 
bassiana (B. bass). RNA was collected from flies at 0, 6, 24 and 48h, respectively to 
infection. Gene expression of diptericin (dipt) in flies was determined by Real-Time 
PCR and normalized with the expression of rp49 gene.  
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Table III.3.1 resumes the drs and dipt expression induction and/or repression by Chl 
treatment determined by Northern blot and Real-Time PCR. Note that differences 
expressed are small and not significant, but consistent in all experiments performed. 
 
Table III.3.1 
drs and dipt expression regulation by chloroquine 
  
 
drs 
 
dipt 
infection treatment  NB RT  NB RT 
Ni 0h 
Chl10mg/l   =  = = 
Chl50mg/l  = =  = = 
Mix bact 6h 
Chl10mg/l   
 
 = = 
Chl50mg/l  = 
 
 = 
 
Mix bact 24h 
Chl10mg/l  
 
=  = = 
Chl50mg/l  = =  = = 
B. bass 48h 
Chl10mg/l  = 
 
 = = 
Chl50mg/l  = =  = = 
 
 
 
 
III.3.2.2 – In vitro AMP synthesis 
To directly access the hemocytes immune response and in vitro assay was performed, 
using two stably transformed cell lines, derived from the Drosophila S2 hemocyte-like 
cell line – the 648 – IB6 cell line expresses a recombinant protein, which is codified by 
luciferase under the drosomycin promoter and the 169-29 cell line expresses an 
attacin-luciferase gene. AMP synthesis was evaluated by the induction of luciferase 
activity. 
Ni: non-infected; Mix bact: Mixed bacteria; B. bass: B. bassiana; Chl: Chloroquine; drs: drosomycin; 
dipt: diptericin; NB: Northern Blot; RT: Real-Time PCR; ;  induction; : reduction. 
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Drs synthesis was strongly induced in 648-IB6 cells by SPZ stimulation. In regard to Chl 
treatments, no differences were observed in Chl treated cells without SPZ stimulation, 
and only a modest reduction was observed after 6h incubation with 10μM of Chl and 
SPZ stimulation.  
For Att synthesis, a high induction was observed upon 169-27 cells with heat-killed 
bacteria. Cells treated with Chl showed a slight induction of Att in both stimulated and 
non stimulated cells, after 6h of Chl treatment with the highest doses. These increases 
were very specialized in time, since it was only seen at 6h, and it was not dose 
dependent. Unfortunately, it was not consistent over time or with the different doses 
used.  
Several attempts were performed to check if an altered AMP production could be seen 
after Chl treatment and different times of exposure to Chl. Nevertheless, none showed 
an altered response and thus, in vitro assays were not followed. 
 
 
III.3.3 – Chloroquine impact on local immune responses 
Another attempt to evaluate chloroquine effect in the fly immune response was made 
by using DD1 flies that contain a reporter gene in which the promoter region of drs is 
fused with the gfp gene, and a second reporter gene in which the promoter region of 
dipt is fused with the β-galactosidase gene.  
The evaluation of local immune response may reveal localized differences that would 
be masked by the analysis of a systemic response, as such; flies were infected with a 
natural pathogen of the digestive track, the bacteria Serratia marcescens. No changes 
in coloration were detected between Chl treatments upon infection, reflecting no 
differences in drs and dipt expression pattern, suggesting that chl has no effect on the 
local immune response of the fly.  
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         III.3.4 – Chloroquine impact on fly’s survival to infection 
As the fly’s immune system is complex, other mechanism besides the activation of 
immune pathways and the production of antimicrobial peptides are implicated in the 
response to microorganisms. Nevertheless, no simple readouts are available to test 
these mechanisms. Thus, survival tests are used as a primary approach, to test if Chl 
treatment may compromise the fly ability to survive infection. 
Survival experiments were conducted with pathogenic microorganisms such as E. 
fecalis and E. cloacae, and B. bassiana spores, all able to kill flies. In each infection, a 
mutant fly line was included as a control. For Gram-negative bacterial infection, the 
key (kenny) mutant was included. These flies are deficient for the Imd pathway, are not 
expressing dipt or att, and die faster than wild type flies after Gram-negative bacterial 
infection. For Gram-positive bacterial and fungal infection, the dif mutant was used. 
These flies are deficient for the Toll pathway, do not express drs, and die faster than 
wild type flies after Gram-positive bacterial and fungal infection.  
Although Chl treatment seemed to affect survival of wild type flies to Gram – bacteria, 
as to they start to die somehow faster, at D5pi, they still showed, as non-treated flies, 
a 20% survival, while the mutant key show no survival at D1pi, suggesting that the drug 
does not seriously compromise the ability to survive to Gram-negative infection.  
Survival to Gram + bacterial infection seemed to be slightly affected at the first days pi. 
Flies seem to die faster after treatment, in a dose dependent fashion, although they 
didn’t show the mortality of dif mutants, which die 4 days after infection. 
Unfortunately, an opposite pattern was observed in second experiment, using the 
same microorganism. In this case, non-treated flies and flies treated with 10 mg Chl/l 
showed the same curve, reaching 20% survival at D5pi, but flies treated with 50 mg 
Chl/l had a survival curve comparable to non infected flies (around 80%), suggesting 
that this dose would protect them against infection.  
Survival to fungal infection showed no differences between treatments in wild type 
flies or dif mutants. The few differences observed were modest, and non-reproducible, 
and thus, survival experiments were abandoned. 
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III.4 – Discussion 
This work was conducted in order to understand if chloroquine was acting in the 
mosquito immune response. Drosophila melanogaster was the model used, as it 
provides a set of powerful tools and knowledge, particularly in immunity studies. 
One of the most important and well known features of the fly immune response 
depends on the synthesis of antimicrobial peptides, and two immune pathways that 
lead to their production: the Toll and the Imd pathways. These are activated 
extracellularly, after the recognition of microorganisms, through a serine protease 
cascade or by direct binding of microorganisms to cell surface receptors. This results in 
an intracellular signal transmission that leads to AMP expression (synthesis of drs 
results from Toll pathway activation, and of dit and att upon Imd pathway activation). 
Taking as a premise that the activation of any of the pathways results unconditionally 
in the expression of the respective peptides, we can state that the evaluation of their 
expression reflects the activation of the immune pathway. Thus AMP expression was a 
good candidate to evaluate chl influence on the Drosophila immune system. 
Given that chloroquine seems to reduce this synthesis in the mosquito, and that there 
are evidences of similarities between the immune system backbone of both organisms 
(particularly at the intracellular signalling level), it is probable that the drug is affecting 
in any way either the Toll or the Imd signalling. Hence, it would be expected that after 
feeding chloroquine to the fly and infecting it with different classes of microorganisms, 
a reduction in the expression of either the drs or dipt or att would be observed, as a 
result of an impairment of either the Toll or the Imd pathways.  
In this work, several attempts were made to test AMP gene expression both in vivo 
and in vitro, in the presence of chloroquine and infection. 
 
The in vivo assays performed either by Northern blot or Real-Time PCR proved to be 
robust, as drs induction was detected by both techniques upon infection with mixed 
bacteria and the entomopathogenic fungi B. bassiana, as a result of Toll pathway 
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activation, which is known to happen in response to Gram-positive bacterial and fungal 
infections. As for dipt, it was induced upon mixed bacterial infection, resulting from 
Imd pathway signaling, which is known to be activated upon Gram-negative bacterial 
infection. Thus, AMP expression proved to be a good readout of pathway activation. 
Neither technique used detected significant differences between Chl treated and non-
treated flies, indicating that the antimalarial drug has no important effect on AMP 
expression in flies. Nevertheless, differences were found. These were too small to 
overcome experimental variation and to be considered significant. Nonetheless, they 
were reproducible between experiments, ie, all experiments performed revealed the 
same pattern of induction/repression (Table III.3.1). The only difference detected by 
both Northern blot and Real-Time PCR was found in drs expression at 6hpi in flies 
infected with mixed-bacteria. Flies treated with 10mg/l of Chl showed an induction of 
drs expression when compared with non-treated flies.  The same pattern was not 
observed with the 50mg/l Chl dose, thus, the effect is not dose dependent. In fact, 
Real-Time analysis revealed drs repression with the higher dose of Chl, suggesting the 
opposite role for Chl. The fact that such patterns for drs expression were not detected 
for B. bassiana infection means that in case Chl is acting in the Drosophila immune 
response, it is doing so at an extracellular level, probably over the serine protease 
cascade that leads to Toll pathway activation. This is sustainable, as Chl is known to 
affect the activity of fungal proteases (Staszczak et al., 2000).  
Overall, the antimicrobial peptide expression does not seem to be altered by 
chloroquine treatment in vivo.  
 
In vitro assays also proved to be robust, as hemocyte-like cells efficiently induced the 
synthesis of Drs when stimulated with SPZ and Att when stimulated with heat-killed 
bacteria. The assays, however, did not reveal any alteration in AMP synthesis in 
immune stimulated hemocyte-like cells due to Chl treatment. This suggests that if the 
drug has any effect, even minor in the fly immune response, it is not noticeable in 
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hemocytes, thus it may affect other immune responses, such the one generated by the 
fat body or even local immune responses.   
 
Gut localized immune responses, as assayed in DD1 flies infected with S. marcescens, 
also did not reveal any differences between Chl treated and non-treated flies.  
  
Overall, AMP expression and synthesis induced by immune responses in Drosophila 
does not seem to be affected by Chl treatment. Only subtle variations were observed 
with the drug treatment, and their biological significance remains to be understood. 
However, the differences found do not seem to be enough either to compromise the 
survival neither to protect the fly upon infection with natural pathogens. 
 
Contrary to what happens in the mosquito, Chl does not seem to affect fly immunity. 
The only differences observable relate to an induction of drs expression in flies 
infected with mixed bacteria as a result of Chl treatment, which is contrary to the AMP 
expression patterns observed in the mosquito, upon Chl treatment (Abrantes et al, 
2005). 
 
Several possibilities may account for the differences of chloroquine modulation of the 
immune responses of fly and the mosquito:  
1) It can be acting over a specific molecule, responsible for the regulation of a 
response not tested by the readouts available. Phenomena like 
phagocytosis, encapsulation, melanization, hemocyte aggregation were not 
tested. But if it would seriously affect any of these, it would be observed by 
a decreased survival after infection. 
2) It can be acting over a mosquito regulatory molecule that does not exist in 
the fly, and that is necessary to activate one of the major immune 
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pathways, like a serine protease, or a serpin. Flies and mosquitoes are 
distantly related and, although there are numerous similarities between the 
responses of the two organisms, they also show differences in immunity, 
especially through the presence of specific immune molecules, like 
gambicin in the mosquito.      
3) For the same reason stated above, the response to the parasite can be 
dramatically different from the response to bacteria or fungi. A co-evolution 
of the mosquito and the parasite certainly has led to the appearance of 
highly specialized molecules of recognition and regulation of the immune 
response in the parasite. The antiparasitical response in the fly is still a 
choice of study. 
4) It has to be kept in mind that there are no controls for the quantity of 
chloroquine that the mosquito ingests with the blood meal, meaning that 
the mosquito can take chloroquine, or a metabolite derived from its 
digestion. In mosquitoes experiments, mice were infected and treated with 
chloroquine 48h before the blood meal. As such, there is time for the mice 
to digest the drug and produce a series of metabolites. One of these could 
be the responsible for the raise observed in the number of parasite oocysts 
in the midgut (Hogh et al, 1998). These are conditions that cannot be 
reproduced in the fly model.  
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IV.1 – Introduction 
Hemocytes are crucial players in the immune responses of insects, engaging in both 
humoral and cellular responses in the hemolymph. Contributions to humoral 
responses include AMP synthesis and production and secretion of extracellular 
proteolytic cascade components that activate processes such as melanization and 
coagulation. In cellular responses, hemocytes come in contact with the pathogen, 
either by phagocysing the microorganism or by forming a capsule or a nodule around it 
(Lavine & Strand, 2002).  
Upon infection, if a cellular response is to be activated, hemocytes have to migrate to 
the site of infection, probably by stimulation and/or chemotatic attraction. A particular 
response may require high number of hemocytes (proliferation) and the differentiation 
into a specific cell type, ie, for phagocytosis hemocyte have to be able to phagocyse, 
for nodulation and encapsulation to attach, and for melanotic encapsulation to 
produce the machinery necessary for melanization. For instance Drosophila larvae 
infected with eggs of a parasitic wasp, Leptopilina boulardi, have an increased number 
of hemocytes that differentiate into lamellocytes which can restrain the parasite by 
melanotic encapsulation (Vass & Nappi, 2000; Russo et al., 2001). Hemocyte 
proliferation and differentiation were found to be two independent phenomena. 
Proliferation itself seems to be under the regulation of several molecules/pathways, 
such as the Ras-MAPK pathway, the Toll pathway and PVF2, a growth factor that 
induces an increased hemocyte number when overexpressed (Asha et al., 2003; 
Lemaitre et al., 1995; Luo et al., 1995; Matova & Anderson, 2006; Qiu et al., 1998; 
Zettervall et al., 2004). 
Hemocyte proliferation also occurs in larvae of the fruitfly Anostrepha oblique infected 
with parasitoid wasps, in shrimps stimulated with LPS or Fusarium fungi, Culex 
mosquitoes infected with microfilaria, among others (Brayner et al., 2007; Sequeira et 
al., 1996; Silva et al., 2002).    
Hemocytes are produced and differentiated by a process called Hematopoiesis. When 
required, hemocyte proliferation is followed by differentiation into specialized cells.    
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Several classes of hemocytes have been described for a few insects, based on 
morphology and immune abilities. For instance, during Drosophila hematopoiesis, a 
precursor cell, the prohemocyte is able to differentiate into 3 types of hemocytes: 
plasmatocytes, the major class of hemocytes in the fly, that engage in phagocytosis; 
crystal cells, that represent less than 5% of the hemocytes and secrete enzymes 
necessary for humoral melanization; and lamellocytes that are produced only upon 
infection and engage in encapsulation of microorganisms too large to be phagocysed 
by plasmatocytes (Meister & Lagueux, 2003). As for mosquitoes, Hillyer & Christensen 
(2002) proposed a hemocyte classification for Ae. aegypti that included 4 types of cells, 
based on morphology, binding of selected lectins and enzymatic activity: granulocytes, 
the most abundant type that have attachment ability; oenocytoids that have 
phenoloxidase in the cytoplasm; adipohemocytes, the second most common type that 
have no attachment ability; and thrombocytoids that are rarely seen and are not 
circulating hemocytes, probably existing attached to fixed tissues. Castillo et al. (2006) 
found the same type of hemocytes in An. gambiae mosquitoes, with the exception of 
thrombocytoids. However, which type of hemocyte is induced upon a particular 
infection and engages in a specific mechanism is still unclear for both species.          
Our knowledge on mosquito cellular immune responses to the malaria parasite is 
scarce. During ookinete invasion of the midgut and sporozoite invasion of the salivary 
glands the responses observed so far are humoral and epithelial. Conversely, the 
understanding of the mosquito response to sporozoites upon egress from the oocysts 
is still limited. At this stage, thousands of sporozoites are released into the hemolymph 
but less than 10% efficiently invade the salivary glands. Sporozoites are known to flow 
along with the hemolymph until reaching the salivary glands (Hillyer et al., 2007). At 
this stage, sporozoites come in close contact with circulating hemocytes that are 
bound to recognize and combat the parasite. Sporozoites are known to be destroyed 
in the hemocel, in case they fail to reach the salivary glands (Hillyer et al., 2007). 
Mosquito immune responses to hemolymph sporozoites detected so far include 
phagocytosis and melanization in P. gallinaceum/Ae. agypti and phagocytosis in  P. 
berghei/An. gambiae models (Hillyer et al., 2003, 2007). Other immune responses, 
such as nodulation or encapsulation, have not been disclosed yet.  
Mosquito hemocyte proliferation 
 
 
81 
  
Data available for hemocyte number variation in mosquitoes show that their number is 
reduced in the hemolymph of Ae. aegypti, correlated with aging and contributing to a 
higher mortality caused by E. coli infection (Hillyer et al., 2005). In Armigeres 
subalbatus, hemocyte number decreases at 24h after a blood meal that might be 
associated with encapsulation, lowering levels of circulating hemocytes. Cell number 
returns to control levels at 48-72h post blood meal (Guo et al., 1995). As for sporozoite 
invasion of the hemolymph there is are no data available for induction by the parasite 
of hemocyte proliferation and/or differentiation.  
Data on hemocyte proliferation and differentiation (if possible) upon sporozoite egress 
from the hemolymph would disclose part of the mosquito response to the parasite at 
this stage.       
 
 
IV.2 – Methodology 
IV.2.1 – Cells, bacteria and recombinant Pf-CS 
Sua 5.1* cells are hemocyte-like cells derived from larvae of the An. gambiae Suakoko 
strain. Cells were cultured in Schneider insect medium (Sigma) supplemented with 
penicillin (100 000U – Sigma), streptomycin (100mg – Sigma) and heat inactivated fetal 
calf serum (FCS – 10% - Sigma) and kept at 26ºC.  
Bacteria solutions were prepared by mixing heat killed Escherichia coli and 
Micrococcus luteus in a 1:1 ratio, to a final concentration of 4x10
7
 bacteria/ml. 
Recombinant Pf-Cs (sporozoite surface protein from Plasmodium falciparum) was 
obtained from a sporozoite detection kit (Sclavo Elisa kit – Sclavo Diagnostics). Protein 
was diluted in Schneider medium, aliquoted and kept at -80ºC at a concentration of 
10ng/µl.   
Mosquito hemocyte proliferation 
 
 
82 
  
IV.2.2 – LPS contamination of recombinant Pf-CS  
To evaluate if the Pf-CS solutions were contaminated with LPS (endotoxin), derived 
from cell walls of bacteria used for recombinant protein expression, Pf-CS protein 
solution was submitted to a LPS detection kit (E-Toxate Kit – Sigma), according to the 
manufacture instructions. LPS is detected in a sample by comparison with a standard 
curve of known Endotoxin solutions. Samples are incubated with a substrate that, in 
contact with LPS turns to a gel. Increasing endotoxin concentrations are reflected in a 
higher solidity of the gel formed.   
Samples were prepared according to Table IV.2.1. Samples were gently agitated and 
incubated in a water bath for 1h at 37ºC., then inverted to verify gel formation. 
 
Table IV.2.1 
Sample preparation for LPS detection 
Tube Sample Endotoxin 
4 EU/ml 
E-toxate 
working 
solution 
A Pf-CS 10ng/µl 100µl - 100µl 
A’ Pf-CS 1ng/µl 100µl - 100µl 
B Pf-CS 10ng/µl 100µl 100µl 100µl 
C Negative control 100µl - 100µl 
D Endotoxin 0.015EU/ml  100µl - 100µl 
E Endotoxin 0.03EU/ml 100µl - 100µl 
F Endotoxin 0.06EU/ml 100µl - 100µl 
G Endotoxin 0.125EU/ml 100µl - 100µl 
H Endotoxin 0.25EU/ml 100µl - 100µl 
I Endotoxin 0.5EU/ml 100µl - 100µl 
 
Tube B has the purpose of detect any E-toxate reaction inhibitor present 
in the protein sample. Tubes D to I are the standard endotoxin solutions, 
prepared with endotoxin-free water. 
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IV.2.3 – Hemocyte proliferation assay 
An in vitro approach was used to evaluate if the presence of sporozoites in the 
mosquito hemocel induces hemocyte proliferation. Mosquito hemocyte-like cells were 
stimulated with a recombinant form of the major surface antigen of malaria 
sporozoites, the circumsporozoite protein from P. falciparum (Pf-CS). Hemocyte-like 
cell division was determined by 
3
H-Thymidine incorporation. This radioactive molecule 
is added to culture medium and taken up by cells that use it for DNA synthesis. Hence, 
levels of incorporated 
3
H-thymidine correlate with cell division.     
Sua 5.1* cell concentration was determined on a hematocytometer. Cells were diluted 
in medium to a final concentration of 2x10
5
cells/150µl, plated on a U-shaped 96-well 
plate, and incubated for 24h at 26ºC. 
Cells were stimulated ON with different amounts of Pf-CS (0.5, 5 and 50ng/50µl of 
medium) and a solution of a combination of Gram + and Gram – heat killed bacteria 
(mixed bacteria – 4x10
7
cells/50µl of medium – 10bacteria/cell), as represented in 
Figure IV.2.1. Controls included medium alone and cells plus medium. All samples were 
analyzed in triplicates. 
After ON stimulation, 50µl of a 
3
H-Thymidine (Sigma) solution at 0.02µCi/µl were 
added to each well (1µCi/well). Cells were allowed to incorporate 
3
H-Thymidine for 6h, 
after which cells were harvested from each well onto a piece of 3MM paper. Each 
paper was placed on a scintillation tube and covered with scintillation liquid. 
Incorporated radioactivity was measured on a scintillation β-counter (Beckman LS 
6500, Beckman) and expressed as scintillations per minute (cpm). Three tubes with 
only scintillation liquid were used for blank reading. Five independent experiments 
were performed and data was analyzed for significant differences between controls 
and stimulation with a paired t test, using the GraphPad software (Prism). 
 
 
Mosquito hemocyte proliferation 
 
 
84 
  
 
 
 
 
 
IV.3 - Results  
We used an in vitro assay to test the proliferation of Sua 5.1* hemocyte-like cells from 
A. gambiae upon stimulation with Pf-CS and a mixture of heat killed Gram + and Gram 
– bacteria.  
An endotoxin detection kit was used to detect LPS contamination in Pf-CS samples that 
could induce a response from the mosquito cells. LPS contamination is detected by the 
formation of a gel. Pf-CS samples remained in a liquid form as the negative control. 
Figure IV.2.1 – Experimental design for hemocyte proliferation. Hemocyte-like Sua 
5.1* cells from An. gambiae mosquitoes were plated on a U-shaped 96-well plate 
(2x10
5
cell/well). Cells were stimulated ON with Pf-CS (0.5, 5 and 50ng) and mixed 
bacteria (mix bact) solution of heat killed E. coli and M. luteus. Cells were incubated 
with 1µCi of radioactive 
3
H-Thymide for 6h, harvested and radioactivity was measured 
by counting scintillations per minute in each sample. 
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Endotoxin standards presented a gel-like form whose solidity increased in an 
endotoxin concentration-dependent fashion. No inhibitors were detected on protein 
samples, as Pf-CS plus endotoxin resulted in solid gel formation. This indicated that 
there was no LPS contamination on Pf-CS sample, thus a response of hemocyte-like 
cells to this sample was expected to be directed to Pf-CS protein.      
Results of the proliferation assay are shown in Figure VI.3.1. There was a clear 
difference between scintillation counts in Medium and Medium + Sua 5.1* cells 
samples (P=0.0048), indicating that 
3
H-thymidine was incorporated into the cells, thus 
validating the assay.  Hemocyte number did not significantly differ between stimulated 
and control cells (P >0.05) with the exception of the 5ng Pf-CS treatment (P=0.0433). 
Also, a slight increase in hemocyte numbers was observed for cells stimulated with the 
highest dose of Pf-CS (50ng), which was variable among experiments, and thus, not 
significant.    
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Figure IV.3.1 – Hemocyte 
proliferation. Sua 5.1* cells 
were stimulated ON with 
different amounts of Pf-CS 
(0.5, 5 and 50ng) or a mixture 
of heat killed Gram+ and 
Gram – bacteria (Mix bact – 
10bacteria/cell).  
3
H-Thymidine was allowed to 
incorporate into dividing cells 
for 6h and radioactivity was 
measured by scintillation 
counting in each sample. * 
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IV.4 – Discussion 
This assay intended to demonstrate if exposure of mosquito hemocyte-like cell lines to 
the major antigen of Plasmodium sporozoites (the circumsporozoite protein) induced 
cell proliferation. This would result from a cellular response to sporozoites, triggered in 
the mosquito hemolymph. If the mosquito would rely on cellular responses to restrain 
the vast numbers of sporozoites that invade the hemolymph and given that circulating 
hemocytes in adult mosquito’s hemolymph are in scarce number, it is expected that 
the presence of the parasite would induce the proliferation of hemocytes. 
Our assay failed to significantly show hemocyte proliferation upon contact with Pf-CS 
or heat killed bacteria, excepting for the 5ng Pf-CS dose that showed a significant 
decrease in cell number. Reduction of hemocyte numbers during a mosquito immune 
challenge may reflect microaggregation reactions, where hemocytes cease circulating 
and attach to microorganisms. The occurrence of these reactions was not studied. 
Nevertheless, our in vitro assay counts the total number of hemocytes, whether 
circulating or attached. Another explanation for the reduction observed would be 
hemocyte apoptosis after immune stimulation. The fact that no dose dependent 
response was observed may reflect a drawback of the assay. Even though assay 
optimization included different times of cell stimulation and 
3
H-Thymidine 
incorporation (data not shown), it is possible that our assay did not cover the 
hemocyte proliferation induction window of time and that different doses of Pf-CS 
protein require different times for hemocyte response. Also, this cell line might not 
proliferate upon stimulation, as no major differences were observed after immune 
challenge with bacteria.  
The circumsporozoite (CS) protein is the major antigen of Plasmodium sporozoites, and 
its protein synthesis starts when sporozoites are still developing inside the oocyst, 
covering the surface of the sporozoite. Upon oocyst rupture thousands of sporozoites 
are released into the hemocel, along with massive amounts of the CS protein (Kappe et 
al., 2004). Thus it would be expected that mosquito PRRs would be able to detect and 
recognize this foreign protein. It is possible that other factors from the sporozoite 
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surface or released from the inside of the oocyst, induce hemocyte responses and 
proliferation. It would also be interesting to determine hemocyte numbers in mosquito 
hemolymph in vivo upon sporozoite invasion of the hemolymph. The major drawback 
of in vivo tests on hemolymph stages is that sporozoite egress from oocysts is not 
synchronized and may subsist for a few days. This makes a precise determination of 
hemocyte proliferation induction impossible.   
Additionally, it would be important to evaluate if hemocyte differentiation occurs in 
response to sporozoite invasion, ie, if the response to the parasite requires a specific 
type of cell with particular immune abilities. The Sua 5.1* cell line is kept by selection 
of attached cells. Detached cells are eliminated each time the medium is replaced. As 
different hemocyte types have different attachment abilities, it is possible that our 
model does not include every hemocyte type, namely circulating cells.  
This system was not appropriate to measure hemocyte proliferation, as no hemocyte 
number increase was detected upon bacterial challenge, indicating that this cell line 
may have no proliferation properties upon immune stimulation. Nevertheless, a time 
and dose-specific effect was observed after stimulation with Pf-CS, indicating that 
although not proliferating these cells may respond to the parasite antigen.   
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V.1 – Introduction 
Melanization is an immune effector mechanism, through which insects fight microbial 
infections, and has been described for several insects, such as M. sexta, D. 
melanogaster, and Ae. aegypti, An. gambiae, Ar. Subalbatus mosquitoes (Christensen 
et al., 2005; Jiravanichpaisal et al., 2006 ; Kanost et al., 2004 ; Ligoxygakis et al., 2002). 
Melanization consists in the deposition of a melanin layer over the microorganisms, to 
avoid spreading of infection and to allow a localized killing response, whether by 
melanization side-product (ROI and NOI) cytotoxicity or by another effector 
mechanism. Microbial recognition activates a protease cascade in the hemolymph that 
sequentially activate one another, through proteolysis.  In the end, it leads to the 
cleavage of Prophenoloxidase (PPO), converting it to phenoloxidase (PO). This together 
with other enzymes converts tyrosine into melanin (Figure V.1.1).  An. gambiae 
genome has nine genes that code for PO enzymes. Although six of these have been 
shown to be highly expressed after a blood meal, immune challenge does not lead to 
an increased expression of PPO. Instead, it is believed, that enzyme activation is 
induced at a post-transcriptional level by its cleavage, and is regulated by serpins and 
serine proteases (Muller et al, 1999). 
Malaria vector mosquitoes are able to engage in melanization.  An. gambiae 
mosquitoes were shown to melanize exogenous injected Sephadex beads and 
Plasmodium ookinetes (Collins et al., 1986; Warr et al., 2006). The An. gambiae L3-5 
strain was genetically selected under laboratory conditions to be refractory to malaria. 
Indeed these mosquitoes are able to kill P. berghei and P. falciparum ookinetes, and 
these ookinetes show massive melanization (Collins et al, 1986). Melanization of 
Plasmodium ookinetes in these mosquitoes is known to be regulated by molecules 
such as TEP1, SRPN6 and some CLIP proteases (Abraham et al., 2005; Blandin et al., 
2004; Volz et al., 2006). In susceptible mosquitoes, that do not melanize Plasmodium 
ookinetes, melanization is negatively regulated by CTL4 and CTLMA2 (Osta et al, 2004). 
However these molecules do not seem to be involved in Sephadex bead melanization. 
The latter is however, regulated by TEP1 and LRIM1 
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Albeit anopheline mosquitoes are able to mount melanization responses to 
Plasmodium ookinetes in the lab, it has rarely been observed in field mosquitoes. The 
implication of this mechanism on the control of malaria infection in the mosquito is 
not known. Experiments using P. berghei parasites indicate that melanization observed 
over Plasmodium ookinetes is operating in mosquitoes not as a killing mechanism but 
rather as a post-mortem event (Whiten et al, 2006).  
These studies refer to the midgut stage of malaria infection in the mosquito. In the 
hemolymph stage, melanization was observed in P. gallinaceum sporozoites in Ae. 
aegypti (Hillyer et al., 2003).  It is not known yet if this response is universal for all 
malaria/vector models, nor if melanization may play a role in controlling sporozoite 
numbers in the hemolymph and thus parasite load in salivary glands.  
 
Figure V.1.1 – PPO activation and 
melanin synthesis. Microorganism 
(MO) recognition by pattern 
recognition receptors (PRR) leads to 
activation of a hemolymph serine 
protease cascade, negatively regulated 
by Serpins. Ultimately, serine proteases 
cleave Prophenoloxidases (PPO) into 
Phenoloxidases (PO), activating the 
enzyme. Active POs participate in the 
last steps of Tyrosine conversion into 
melanin. TH: Tyrosine Hydroxylase; 
DCC: Dopa Decarboxylase.  
Mosquito hemolymph melanization 
 
 
93 
  
V.2 – Methodology 
 V.2.1 – Mosquitoes and parasites 
An. gambiae mosquitoes from the strains Suakoko and Yaoundé were maintained in a 
12h light/dark cycle at 26ºC. Mosquitoes were fed on a 10% glucose solution. 
P. berghei ANKA parasites were maintained in Mus musculus CD1 mice by blood 
passage. 
 
 
 V.2.2 – Melanization activation during mosquito infection 
Based on the assumption that PPO activation into PO is the limiting step of melanin 
synthesis, melanization activation was determined by two assays that aimed at 
detecting PO activity: an enzymatic assay using a colorimetric substrate for PO (L-
DOPA) and Western blot to evaluate PPO cleavage into PO. 
 
V.2.2.1 – L-DOPA assay validation in melanizing mosquitoes 
 
V.2.2.1.1 – Mosquito infection and hemolymph collection 
An. gambiae Suakoko female mosquitoes were fed on mice either non-infected or P. 
berghei infected mice with a parasitemia of 10-20% and gametocyte exflagellation. 
Hemolymph was collected at D13 and D15pi by pricking the mosquito through the 
neck membrane with a glass needle inserted in a Nanojet II Auto-nanoliter injector 
(Drummond Scientific). Hemolymph was sucked out of the mosquito and dispensed 
onto a drop (20µl) of phosphate-saline buffer (PBS – Sigma) complemented with a 
cocktail of protease inhibitors (Roche).  
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An. stephensi female mosquitoes massively infected with Microsporidia spores were 
used as a positive control, as extensive spore melanization was microscopically 
observable in the mosquito hemolymph. The collection was performed the same way.  
 
V.2.2.1.2 – L-DOPA assay 
Hemolymph samples were centrifuged at 14 000 rpm for 5min to separate soluble 
proteins from hemocytes and cell debris. Supernatants were reserved as protein 
samples and pellets were discarded.  
Protein quantity in hemolymph samples was determined by incubating 2µl of each 
sample with Bradford reagent (BioRad) for 15min on a flat-bottom 96-well plate. In the 
presence of protein this reagent turns blue and its color intensity is protein load-
dependent. Sample absorbance was read on an Elisa reader (Awareness Technology 
Inc. at 630nm. A BSA standard curve, ranging from 2-14µg, was used for sample 
comparison.  
 
To determine PO activity, 10µg of each sample were diluted in PBS plus protease 
inhibitors to a final volume of 20µl and incubated with 10µl of CaCl2 and 150µl of a 
3mg/ml L-DOPA (3,4-dihydroxy-L-phenylalanine) solution for 1h, on a flat-bottom 96-
well plate. Sample absorbance was read at 492nm at 5, 15, 30, 45 and 60min post 
incubation.  
 
 V.2.2.2 – PPO activation during mosquito infection 
To determine if melanization is activated in response to sporozoite invasion of the 
hemolymph (upon oocyst burst) PO activity in mosquito hemolymph was determined 
at several time-points of infection, starting when sporozoites were still developing in 
the oocyst and terminating when most sporozoites have invaded the salivary glands. 
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V.2.2.2.1 – Mosquito infection and hemolymph collection 
An. gambiae female mosquitoes, from the Yaoundé strain, were fed on mice either 
non-infected or infected with P. berghei in the conditions described above. 
Hemolymph was collected from 20 female mosquitoes as previously described at D7, 
D9 and D11-15pi. 
Hemolymph samples were centrifuged at 14 000 rpm for 5min to separate soluble 
proteins from hemocytes and cell debris. Supernatants were kept for protein samples 
and pellets for DNA extraction. Three independent experiments were performed.  
 
V.2.2.2.2 – PO activity determination 
V.2.2.2.2.1 – L-DOPA assay 
The L-DOPA assay was performed as described above. Data were evaluated for 
statistical significance by the Mann-Whitney test on the GraphPad software (Prism). 
 
V.2.2.2.2.2 – Western blot 
From the same samples, 2µg of hemolymph proteins were separated on a 10% sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), along with 4µl of All 
Blue protein standard (BioRad), and transferred onto a nitrocellulose membrane. 
Proteins were then incubated with a primary antibody directed against AgPO2 (An. 
gambiae Phenoloxidase 2) at a concentration of 1:10 000, followed by a secondary 
anti-rabbit IgG conjugated with horseradish peroxidase (HRP – Sigma) antidoby at a 
concentration of 1:10 000. The signal detection was performed with the ECL system 
(GE HEalthcare) on a Hybond ECL film (GE Health care). 
AgPPO2 has a predicted molecular mass of 78kDa and is cleaved upon activation to 
yirld two peptides of predicted molecular masses of 72 and 6kDa, respectively.  
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V.2.2.2.3 – Sporozoite detection in collected hemolymph 
Hemolymph pellets were submitted to DNA extraction and Plasmodium directed PCR 
to detect the presence of sporozoites.  
DNA was extracted using Chlelx-100. Pellets were dissolved in 10µl of PBS, followed by 
240µl of 100ºC heated 0.5% Chelex-100 (Sigma) and incubated at 100ºC for 10min. A 
tube with no pellet was included as a blank. Samples were centrifuged at 14 000rpm 
for 15min. Supernatants containing DNA were precipitated ON at -20ºC by incubation 
with 45µl of 3M acetic acid (pH5) and 1.0 ml of ice cold absolute ethanol. Samples 
were centrifuged at 14 000rpm for 15min and supernatants were discarded. DNA 
pellets were washed with 80% ice cold ethanol and centrifuged at 10 000 rpm for 
10min. Supernatants were discarded and pellets left to dry ON at rt. DNA was 
dissolved in 10µl of MilliQ water. 
 
Sporozoites in samples were detected by a Nested-PCR technique directed to the 
Plasmodium 18S rRNA, using genus specific primers. This technique is adequate for 
samples with low abundance of the desired DNA, and comprises two sequential PCR 
reactions: the first amplifies a product of ~1Kb of the original material and is hardly 
detected on an agarose gel; the second reaction uses the product generated on the 
first to amplify a product of ~300bp increasing sensitivity and specificity. PCR 
conditions and primer sequences are described in Table V.2.1. 
One µl of each sample was used for the reaction. A positive control, containing DNA 
from P. berghei infected mosquito midguts was included in the reaction. One µl of the 
amplified product of the first reaction was used as a template for the second reaction. 
Amplified products were visualized on a 2% agarose gel, stained with ethidium 
bromide.    
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Table V.2.1 
PCR conditions for Plasmodium detection 
 
 
Primer 
name 
Primer sequence 
Ann. 
Temp. 
Cycle 
rpts. 
Reaction 
1 
rPLU1 5’ – TCAAAGATTAAGCCATGCAAGTGA – 3’ 
62ºC 30 
rPLU2 5’ – ATCTAAGAATTTCACCTCTGACATCTG – 3’ 
Reaction 
2 
rPLU3 5’ – TTTTTATAAGGATAACTACGGAAAAGCTGT – 3’ 
64ºC 35 
rPLU4 5’ – TACCCGTCATAGCCATGTTAGGCCAATACC – 3’ 
 
 
 
V.2.3 – Melanization activation by Pf-CS 
V.2.3.1 – Mosquito injections 
A. gambiae Yaoundé female mosquitoes, 3-5 days-old, were injected intratoraxically 
using a Nanojet II Auto-nanoliter injector (Drummond Scientific). Injected solutions 
included a recombinant form of P. falciparum circumsporozoite protein (Pf-CS – 
10ng/µl – Sclavo Diagnostics) diluted in Schneider medium, BSA (10ng/µl – Sigma) 
diluted in Schneider medium, or with Schneider medium alone as a control. 
Hemolymph was collected as previously described at 6h, 24 and 48h post-injection.  
 
 V.2.3.2 – PO activity determination 
 PO activity was determined by the L-DOPA assay and Western blot, as 
described above. Three independent experiments were performed and data was 
evaluated for statistical significance by applying a Mann-Whitney test on the GraphPad 
software (Prism). 
Ann. Temp.: Annealing Temperature; Cycle rpts.: Cycle repeats 
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 V.2.4 – Effect of PPO inhibition on mosquito infection 
To test if melanization is necessary to control the number of sporozoites that 
effectively invade the salivary glands, infected female mosquitoes were injected with a 
chemical PO inhibitor. Sporozoite load was determined to evaluate differences. 
  
 V.2.4.1 – Mosquito infection 
An. gambiae female mosquitoes, from the Yaoundé strain, were fed on mice infected 
with P. berghei using the conditions described above.  
 
 V.2.4.2 – PTU injections 
At D6pi the infected mosquitoes were injected intratoraxically with 69nl of Schneider 
medium or a 1mM solution of N-Phenylthiourea (PTU), a chemical inhibitor of 
tyrosinases and melanin synthesis, in Schneider medium. Infection load on mosquito 
midgut was accessed at D12pi. 
 
 V.2.4.3 – Sporozoite load determination 
Mosquitoes from both groups were dissected at D21pi and salivary glands were 
collected into a glass homogenizer, crushed to release sporozoites and mixed with 
400µl of PBS. The number of sporozoites in the suspension was counted using a 
hematocytometer. Three independent experiments were performed and data were 
evaluated for statistical significance by applying a ratio t test on the GraphPad 
software (Prism).  
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Experimental design is schematized in Figure V.2.1.  
 
 
 
 
 
 
 
 
 
Figure V.2.1 – Experimental design to determine melanization role in the response to 
hemolymph sporozoites. PPO activation was accessed by L-DOPA assay and Western Blot 
in mosquitoes infected with P. berghei from D7 to D15, and in mosquitoes injected with 
Pf-CS and BSA. Effect of PPO inhibition was determined in P. berghei mosquitoes and 
injected with PTU at D6pi, by determining alterations in salivary gland sporozoite load. Inj: 
Injector; SG: Salivary Gland; SN: Supernatant.   
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V.3 – Results 
 V.3.1 – Melanization activation during mosquito infection 
 V.3.1.1 – L-DOPA assay validation in melanizing mosquitoes 
By the time this work was initiated, L-DOPA assays were commonly used for immunity 
studies in Drosophila, but not in mosquitoes. Thus, it was necessary to validate the 
assay in mosquitoes. For this, we used hemolymph from Microsporidia infected An. 
stephensi mosquitoes, that showed melanized Microsporidia spores (Figure V.3.1 – B). 
      
  
 
 
 
 
As expected, hemolymph of Microsporidia infected mosquitoes showed Absorbance at 
492nm levels (reflecting PO activity) were distinctively higher than those of non-
infected mosquitoes (Figure V.3.1 – A). At D13pi, PO activity levels in the hemolymph 
of P. berghei infected mosquitoes were similar to those of Microsporidia infected 
mosquitoes. At D15pi, however, levels observed were similar to those of non-infected 
mosquitoes, suggesting that PO activity may be regulated by the progression of 
infection (Figure V.3.1 – A).   
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FigureV.3.1 – Melanization activation in the mosquito hemolymph. A: PPO activation by the L-
DOPA assay, at 15 minutes after the addition of substrate in non-infected An. gambiae mosquitoes 
(ni), Pb infected mosquitoes 13 days (Pb - D13) and 15 (Pb - D15) post infection in An. gambiae (Ang) 
and An. stephensi(Ans) mosquitoes , and Microsporidia infected mosquitoes (Mic), measured by the 
absorbance at 492nm (A492nm). B: mosquito midgut infected with Microsporidia, showing 
melanization on the spores, observed by optical microscopy (1000x). 
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  V.3.1.2 – PPO activation during mosquito infection  
PPO activation was followed during P. berghei infection in An. gambiae Yaoundé 
mosquitoes, starting at D7pi (when oocysts are still developing with incipient 
sporozoites inside) up to D15pi (when the majority of sporozoites have been released 
from the oocysts and invaded the salivary glands). 
PO activity seemed to vary in non-infected mosquitoes according to time (Figure V.3.2 
– A, white bars; B, grey line). PPO activity decreased between D7 and D12pi, peaked at 
D13pi, decreased at D14pi after which it remained steady. In P. berghei infected 
mosquitoes, PO activity followed the overall activation pattern observed in non-
infected control mosquitoes (Figure V.3.2 – A, grey bars; B, red line). The only 
differences in PO activity between infected and non-infected mosquitoes were 
observed at D9, D12 and D15pi, when infected mosquitoes showed higher levels of PO 
activation than non-infected control mosquitoes, suggesting that at these time-points 
infection may induce melanization in mosquito hemolymph. Although not significant, 
the increase was observed in infected mosquitoes in all experiments performed. No 
differences were observed for the rest of the infection time-points studied.  
Plasmodium identification by PCR in hemolymph samples (Figure V.3.1 – C) detected 
sporozoites starting at D9pi all through D15, suggesting that from D9 up to D15pi 
sporozoites are continuously being released from the midgut oocysts. However, no 
straight forward correlation was observed between sporozoite appearance in the 
hemolymph samples and PPO activation pattern: sporozoites were detected from D9pi 
in hemolymph samples and PO activation in infected mosquitoes was different from 
the non-infected ones at D9, D12 and D15pi. Although the slight differences in PO 
activation coincide in time with the appearance of sporozoites in the hemolymph, they 
are not maintained during the course of the infection even though sporozoites remain 
present. 
As for Western blot, no differences were observed in hemolymph samples of infected 
and non-infected mosquitoes, correlating with similar pattern of PO activation 
observed in both sets of samples.      
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Figure V.3.2 – PPO activation during mosquito infection. A: Bar graph of PO 
activity in P. berghei infected (Pb) and control non-infected (C) mosquitoes from 
D7 to D15pi, bars represent the measured absorbance at 492nm (A492nm). B: 
Line graph of PO activity in P. berghei infected and control non-infected 
mosquitoes from D7 to D15pi, measured as absorbance at 492nm. C: 
Plasmodium detection in hemolymph samples of P. berghei infected and non-
infected mosquitoes. +: positive control; B: Blank; NT: Non-template control. D: 
Western blot for AgPO2 of hemolymph samples of infected and non-infected 
mosquitoes.    
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V.3.2 – Melanization activation by Pf-CS 
A. gambiae female mosquitoes were injected with Schneider medium, Pf-CS or BSA. 
PO activity was measured at 6, 24 and 48h post-injection.  
PO activity measured in injected mosquitoes is represented in Figure V.3.3 (A and B). 
Overall, PO activity decreased at 24 and 48h, when compared to 6h post-injection, 
possibly reflecting PPO activation upon wounding which results from intrathoraxcial 
injection. PO activity decrease from 6h to 24h was observed in all experiments 
performed in Medium and BSA injected mosquitoes.   
No differences in PO activity were observed between Pf-CS and BSA injected 
mosquitoes and medium injected mosquitoes. Only a slight increase was detected in 
the hemolymph of Pf-CS and BSA injected mosquitoes at 24h pi. However, it was 
neither significant nor consistent in the experiments performed.  
Western blot for AgPO2 (Figure V.3.3 – C) showed no differences in band patterns 
between injections in the hemolymph of An. gambiae mosquitoes. All samples show 
the same band for AgPO2. The fact that both forms of the protein (PPO2: non-
activated protein, 78kDa; PO2:  activated protein72kDa) have similar molecular 
weights makes impossible to determine if the band detected represents AgPPO2 or 
AgPO2.  
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Figure V.3.3 – PPO activation in injected mosquitoes. A: Bar 
graph of PO activity in An. gambiae mosquitoes injected with 
Schneider medium (M), Pf-CS (10ng/µl) and BSA (10ng/µl) at 
6, 24 and 48h post-injection, measured as absorbance at 
492nm (A492nm). B: An. gambiae mosquitoes injected with 
Schneider medium, Pf-CS (10ng/µl) and BSA (10ng/µl) 
measured as absorbance at 492nm C: Western blot for AgPO2 
of hemolymph samples of injected mosquitoes.     
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V.3.3 – Effect of PPO inhibition on mosquito infection 
To evaluate the role of melanization in sporozoite number control in mosquito 
hemolymph, P. berghei infected An. gambiae mosquitoes were injected with PTU, a 
chemical inhibitor of PO. Injections were performed at a time in infection (D6) when 
oocysts were established beneath the basal lamina of the midgut epithelium and 
started to develop sporozoites inside.  
The number of sporozoites per female in the salivary glands of mosquitoes injected 
with PTU was significantly higher (P=0.0099) than in medium alone injected 
mosquitoes. The increase in parasite numbers was consistent in all experiments 
performed (Figure V.3.4).     
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Figure V.3.4 – Effect of PO activity inhibition on parasite 
load. P. berghei infected mosquitoes were injected with 
Schneider medium or PTU (1mM). Sporozoite load on 
salivary glands was determined at D21pi. Each line 
represents an experiment performed. Values on the right 
indicate, for the correspondent experiment, the ratio of 
sporozoite number of PTU vs. Medium injected 
mosquitoes.  
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V.4 – Discussion 
The hemolymph stage of malaria infection in the mosquito is known to represent one 
of the major bottlenecks for the sporogonic development, as only about 2% of the 
sporozoites produced in and released from the midgut oocysts efficiently invade the 
salivary glands. The mosquito is bound to respond to these parasites, as the 
hemolymph contains all the machinery to engage in immune responses, either 
humoral, by soluble proteins or cellular by circulating hemocytes. However, the type of 
response triggered towards sporozoites remains elusive. 
Melanization is a known effector mechanism that insects use to control microbial 
infection. In Ae. aegypti mosquitoes it was shown to be part of the response to 
hemolymph sporozoites, as a small percentage of these were found to be melanized in 
the mosquito hemocel (Hillyer et al., 2003). The work performed aimed at 
understanding if this mechanism represents a general response to malaria sporozoites 
by the mosquito vector.     
Melanization was tested by an assay (L-DOPA assay) measuring PO enzyme activity and 
a Western blot to determine AgPPO2 cleavage and activation into AgPO2. L-DOPA 
assay was validated for mosquito hemolymph, using hemolymph samples from 
mosquitoes massively infected with Microsporidia and exhibiting observable spore 
melanization in the hemocel. As PO values of Microsporidia infected mosquitoes 
samples was distinctively higher than those of non-infected mosquitoes, the assay was 
considered valid to use in mosquito samples, as it is widely used in Drosophila 
immunity studies. The same experiment allowed observing differences in hemolymph 
samples of P. berghei infected mosquitoes collected at different time-points in 
infection. At D13pi P. berghei infected mosquitoes displayed PO activity levels similar 
to those of Microsporidia infected mosquitoes, while at D15pi it decrease close to non-
infected mosquitoes PO activity values. The variation in time of PO activity observed in 
infected-mosquitoes could be an effect of the progression of malaria infection through 
the mosquito. The fact that sporozoites begin to be released into the hemolymph from 
D9-D11pi (depending on the experiment) suggests that at this time sporozoites would 
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be recognized and PO activity induced. At D15pi however, the majority of sporozoites 
have reach the salivary glands and few (if any) oocysts are still bursting would account 
for a decrease in PO activity at this time. 
As such, we followed PO activity in P. berghei-infected and non-infected mosquitoes 
from D7pi, when sporozoites are still developing inside the oocysts, up to D15pi. PO 
activation followed the same pattern previously observed, as activity was lower in until 
D12pi, reached a peak at D13pi and decreased again, showing a low levels in D15pi. 
However, this pattern was observed in both P. berghei infected and non-infected 
mosquitoes. This indicated that PO activity varies in blood-fed mosquitoes, regardless 
of malaria infection. Nonetheless, the values observed are lower than the ones 
observed for Microsporidia infection, suggesting that a low level of PO activity may be 
maintained in blood fed mosquitoes. Melanization may be functioning for some other 
physiological process in mosquitoes. It is necessary to bear in mind that blood fed 
mosquitoes for these experiments were not allowed to lay eggs, and still carry them till 
the conclusion of the experiment. If this would account for some of the observed PO 
activity is not known. No significant differences were observed between infected and 
non-infected mosquitoes. However, a slight induction in PO activity in infected-
mosquitoes was noticed at D9, D12 and D15pi, in all performed experiments. The fact 
that Plasmodium sporozoites are detected by PCR in hemolymph samples of infected-
mosquitoes from D9pi onwards suggests that in fact mosquitoes recognize sporozoites 
and may trigger melanization towards them. The fact that PO remains active in non-
infected mosquitoes may indicate that this activity is sufficient for the mosquito 
response to the parasite.  
We have no indication of sporozoite numbers in the hemolymph samples, or even if 
the DNA detected by PCR belongs to live or dead parasites. Thus, no correlation 
between sporozoite load vs. PO activity was achieved, which might explain the slight 
PO increase in specific time-points of infection. Nevertheless, the fact that every three 
days PO activity seems to be slightly higher in infected mosquitoes, suggests that 
sporozoites may be release from the midgut in waves. Thus, parasite quantification at 
each time-point would be essential to understand PPO activation dynamic through 
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Plasmodium infection. It would also be interesting to analyze hemolymph samples 
from P. berghei infected An. gambiae mosquitoes by electron microscopy to attempt 
to visualize melanized sporozoites.         
 
We also tried to determine PO activity in mosquitoes upon injection of a recombinant 
form of the major surface antigen of P. falciparum sporozoites, the circumsporozoite 
protein (Pf-CS). For all groups tested a higher PO activity was observed at 6hpi, 
possibly reflecting a wound healing procedure due to injection. Again no differences 
were found between controls and Pf-CS or BSA injected mosquitoes. This is consistent 
with the fact that increased melanization does not affect P. falciparum development 
(Michel et al., 2006), even though this work was for midgut stages of the parasite. 
Also, the mosquito may not recognize the protein itself, but the GPI anchor through 
which it attaches to the membrane. Plasmodium GPIs were found to have 
immunogenic properties of in mosquito responses and to be essential for sporogenesis 
(Arrighi et al., 2009; Lim et al., 2005; Wang et al., 2005).      
 
Although no significant differences in PO activity were found to be a result of 
Plasmodium infection in the mosquito, we attempted to determine if melanization has 
a role in the control of sporozoite numbers in the hemolymph. When a PO inhibitor 
was injected in P. berghei infected mosquitoes at a time-point when sporozoites are 
still developing in midgut oocysts and are not detected yet in the hemolymph, parasite 
load increases in the salivary glands. This suggests that PO activity is essential to 
control hemolymph infection by sporozoites. As opposed to midgut stages, where 
accumulating data indicates that melanization may have a post-mortem rather than a 
killing role in infection of malaria and bacteria (Schnitger et al, 2007; Whiten et al, 
2006), in the hemolymph, it appears to be essential to control sporozoite numbers. 
Thus, even though the PO activity activation pattern does not strictly follow the 
presence of sporozoites in the hemolymph, melanization seems to be necessary to 
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help restrain infection. This may not be the only mechanism operating in this 
bottleneck, as the effect observed with PTU injections is not sufficient to account for 
the loss of sporozoites between midgut and salivary glands.   
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VI.1 – Introduction 
Anopheles mosquitoes are known to respond to Plasmodium infection through the 
activation of immune responses. The work done so far in this field has focused mainly 
on the response to the midgut invasion by ookinetes. Only a few studies have been 
performed on salivary gland invasion and even less on the hemolymph response to 
sporozoites released from midgut oocysts. This step is bound to induce an important 
response, as hemolymph sustains systemic immunity. This fluid runs over the hemocel 
carrying immune responsive cells (hemocytes) and immune proteins secreted by 
hemocytes and the fat body. As these include recognition and effector molecules, it is 
likely that the thousands of parasites released into the hemocel are recognized by the 
mosquito immune system and that it mounts a response to clear the invasion. 
Although it is known that only about 2% of the sporozoites released from the midgut 
effectively invade the salivary glands the knowledge about the mechanisms 
responsible for this bottleneck is still scarce. Parasite number reduction in the 
hemolymph may be a result of physical barriers (reducing the success of reaching the 
salivary glands), immunity (parasite clearance), or of mechanisms involved in mosquito 
physiology.  
The massive genomic data obtained to date by microarrays studies, comparing the 
transcriptome of Plasmodium infected and non-infected An. gambiae mosquitoes, has 
revealed that the expression of a large number of genes is altered due to the presence 
of the parasite. Genes affected belong to several functional classes, apart from 
immunity, such as cytoskeleton remodeling, apoptosis, redox metabolism and cell 
adhesion (Christophides et al., 2002; Kumar et al.2003; Vlachou et al., 2005). A lot of 
effort has been made to functionally characterize immune genes whose expression has 
been altered by parasite infection. However, only a few functional studies have 
attempted to evaluate the influence of molecules involved in mosquito physiological 
processes on infection. The gene RFABG (retinoid and fatty-acid binding glycoprotein) 
codes for a precursor of apolipophorin I and II, that account for the two major 
components of the insect lipid transporter. The expression of this gene is highly 
induced upon ookinete invasion and its KD leads to a reduction in oocyst number and 
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to a total inhibition of egg development (Vlachou et al., 2005). This suggests that 
responses to pathogens may include the action of not only molecules previously 
described as immune related but also to physiological and general mechanisms 
operating in the mosquito. 
Eicosanoid biosynthesis in particular, has been repeatedly implicated in the immune 
responses of several insects (reviewed by Stanley & Miller, 2006). Eicosanoids are 
oxygenated metabolites of arachidonic acid (AA) and other polyunsaturated fatty acids 
(PUFAs) that act mainly as signaling molecules, such as ovulatory pheromones and 
modulators of ion transport. Additionally, these molecules were found to modulate 
cellular immune responses in insects. 
Eicosanoid biosynthesis from arachidonic acid is depicted in Figure VI.1.1. Membrane 
phospholipids are hydrolyzed by phospholipase A2 (PLA2) into AA that is subsequently 
metabolized into eicosanoids by three pathways: cyclooxygenases (COX) convert AA 
into prostaglandins, thromboxanes and prostacyclin; lipoxygenases (LOX) convert AA 
into leukotrienes, hydoxy fatty acids, lipoxins and Hepoxillins; and cytocrome P450 
that forms hydroxy fatty acids and epoxy derivatives. Some of these molecules have a 
role in proinflammatory immune responses in mammals. 
In insects, eicosanoid biosynthesis has been implicated in the response to bacteria, 
fungi and parasites, as the treatment with chemical inhibitors of enzymes involved in 
this process results in a compromised immune response. Dexamethasone (DEX), a PLA2 
inhibitor was shown to reduce the hemocyte microaggregation and nodulation 
response of Manduca sexta to the bacterium Serratia marcescens, which was reversed 
by AA treatment (Miller et al., 1994). During bacterial infections, these molecules also 
mediate phagocytosis, cell spreading, prophenoloxidase (PPO) activation, and, in 
Drosophila,  the IMD pathway activation (Downer et al., 1997; Miller et al., 1994; 
Yajima et al., 2003). In M. sexta infected with Metarhizium anisopliae or Beauveria 
bassiana fungi, products of the LOX but not the COX pathway were found to reduce 
the nodulation response (Dean et al., 2002; Lord et al., 2002). As for parasite 
infections, DEX treatment of Drosophila larvae inhibits the encapsulation of Leptopilina 
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boulardi eggs (Carton et al., 2002) and in the model Rhodnius proxilus/Trypanosoma 
rangeli, treatment with DEX, indomethacin (IN, a COX inhibitor) or 
Nordihydroguaiaretic acid (NDGA, a non-specific LOX inhibitor) totally abolishes the 
microaggregation response and greatly reduces PPO activation, while increases 
parasite numbers in the hemolymph. This is reversed by AA treatment, suggesting that 
eicosanoids resulting from both COX and LOX pathways modulate this response (Garcia 
et al., 2004a). 
 
 
 
 
 
An intriguing property of host immunosuppression by pathogens has been observed in 
two models of infection in insects. These include a bacterial and a parasite infections 
and both compromise the respective host’s immunity by interfering with eicosanoids 
biosynthesis. The bacterium Xenorahbdus neatophila is able to inhibit PLA2 activity of 
Spodoptera exigua and the subsequent eicosanoid biosynthesis. To account for this, 
Figure VI.1.1 –Eicosanoid biosynthesis 
pathways from arachidonic acid. 
Phospholipase A2 (PLA2) hydrolyses 
membrane phospholipids into arachidonic 
acid. This is converted to several eicosanoids 
by 3 distinct pathways:  
Cyclooxygenase (COX) pathway, in which AA 
is transformed into prostaglandin H2 (PGH2) 
that is used for the synthesis of 
Thromboxanes (as TXA2, TXB2), 
Prostaglandins (PGD2, PGE2, PGF2) and 
Prostacyclin (PGI2);  
Lipoxygenase (LOX) pathway, that 
metabolizes AA into Leukotrienes, 
Hydro(preo)xy fatty acids, Lipoxins and 
Hepoxillins; 
Cytocrome P450 (Cyt P450) pathway, in 
which AA is converted into Hydroxy fatty 
acids and epoxy derivatives.  
Chemical eicosanoid biosynthesis inhibitors 
are displayed next to the respective enzyme 
inhibited: Dexamethasone (DEX) is a PLA2 
inhibitor; Indomethacin (IN) is a COX 
inhibitor, and Nordihydroguaiaretic acid 
(NDGA) in a non-specific LOX inhibitor. 
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the injection of AA into Spodoptera exigua larvae reduces host mortality to 50%, while 
treatment with inhibitors potentiates bacterial mortality (Park & Kim, 2000; 2003). 
Also in M. sexta, infection with live X. nematophila bacteria produces about one fourth 
of nodules observed upon injection of heat-killed bacteria (Park et al., 2003b). 
Moreover, in a protozoan infection by Trypanosoma rangeli in Rhodnius prolixus, AA 
treatment increases microaggregation reaction and reduces parasite numbers in the 
insect’s hemolymph. T. rangeli was proposed to inhibit the release of AA in its host, 
although it is not known if the parasite has a direct action on PLA2 (Garcia et al., 
2004b). These studies show that the interplay between parasites and hosts is complex 
and dynamic, revealing that physiological mechanisms other than immunity are also 
important in the response to infection. 
In the present work we used a proteomic approach to determine proteins whose levels 
are altered due to sporozoite infection in the mosquito hemolymph. Identified 
proteins were analyzed to understand mechanisms involved in hemolymph response 
to the parasite and to unveil interactions between the host and the parasite.        
 
 
  VI.2 – Methodology 
 VI.2.1 – Mosquitoes and parasites 
 Anopheles gambiae mosquitoes from the Yaoundé strain (isolated from the 
Cameroon) were reared at 25ºC and 75% humidity, with a 12h light/dark cycle and 
maintained on a 10% glucose solution. At day 2-3 post emergence, mosquitoes were 
fed on Mus musculus CD1 mice infected either with:  
i) P. berghei ANKA 2.34 - fully infective and transmissible clone; or 
ii) P. berghei ANKA 2.33 – non-infective clone (carrying defective 
gametocytes). 
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Mosquitoes were allowed to feed for 10-20 minutes. To ensure effective infection only 
mice displaying 10-20% parasitemia and parasite male gametocyte exflagellation were 
used to feed mosquitoes. After blood feeding, mosquitoes were kept on a 10% glucose 
solution and non-infected females were removed. 
The same procedure was followed for injection experiments, with the exception of 
naïve mice being used as controls, instead of P. berghei 2.33 infected mice. Three 
independent experiments were performed.    
 
 
 VI.2.2 – Hemolymph collection 
To control infection in each experiment, 10 female mosquitoes were dissected at 
day13 post infection (D13pi) and the midguts were observed to determine oocyst 
number. Another 10 female mosquitoes were dissected and midguts were crushed 
within a glass homogenizer with 10µl of PBS. The resulting supernatant was then 
placed in a hematocytometer chamber to count the number of sporozoites.      
Hemolymph was collected from female mosquitoes at D12-13pi, when the majority of 
sporozoites leave the midgut and invade the hemolymph. Collection was performed by 
pricking the mosquito through the neck membrane with a glass needle inserted in a 
Nanojet II Auto-nanoliter injector (Drummond Scientific). Hemolymph was sucked out 
of the mosquito and dispensed onto a drop (20µl) of suspension buffer prepared for 
two-dimensional electrophoresis (2DE) – see below. For each group 80-250 female 
mosquitoes were used to retrieve hemolymph. Samples were centrifuged at 10 000 
rpm for 10min to separate proteins suspended in the collection buffer and cell debris 
from hemocytes. Pelleted debris’s were kept at -80ºC for RNA extraction and protein 
suspensions were kept at -20ºC for 2DE.   
The experiments performed to analyze gene expression and proteome of the 
hemolymph collected from P. berghei infected (2.34) vs. non-infected (2.33) 
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mosquitoes at D13pi are summarized in Figure VI.2.1. Hemolymph samples collected 
from mosquitoes in five independent experiments were used for both gene expression 
and proteome analysis.   
 
 
 
 
  
 
  
Figure VI.2.1 – Hemolymph gene expression and proteome analysis of infected vs. non-
infected mosquitoes. Mice infected either with P. berghei ANKA clone 2.33 (non-infective 
to mosquitoes) or P. berghei ANKA clone 2.34 (infective to mosquitoes) were used to feed 
An. gambiae Yaoundé female mosquitoes. Hemolymph was collected at D13pi. Hemolymph 
pellets were used for gene expression analysis by RNA extraction, cDNA synthesis and Real-
Time PCR. Hemolymph supernatants (SN) were used for proteome analysis by 2D 
electrophoresis and MALDI-TOF MS. At D13pi infection was monitored by determine oocyst 
and sporozoite number in the midgut of a few females infected with clone 2.34. 
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VI.2.3 – Hemolymph proteome analysis 
The proteome of the hemolymph collected from non-infected mosquitoes (group 2.33) 
and infected mosquitoes (group 2.34) at D13pi was analyzed by two dimensional 
electrophoresis (2DE) and mass spectrometry (MS) to identify proteins whose levels 
are affected by sporozoite release into the hemolymph.  
2DE allows a high resolution separation of proteins in a sample. This procedure 
includes two steps: firstly proteins are separated according to their isoelectric point 
(pI) – Isoelectric focusing (IEF) – and secondly according to their molecular mass – 
sodium dodecyl sulfate polycarylamide gel electrophoresis (SDS-PAGE). Separated 
proteins from different samples can then be compared to spots of specific proteins 
that exist in altered levels between samples, in this case between the hemolymph of 
non-infected (group 2.33) and infected mosquitoes (group 2.34). Proteins recovered 
from 2D gels are then analyzed and identified by MS.   
 
VI.2.3.1 – Two dimensional electrophoresis  
VI.2.3.1.1 – Sample preparation 
Proteins were solubilized immediately upon hemolymph collection in a suspension 
buffer appropriated for 2DE composed of: 7M urea (Bio-Rad), 2M thiourea 
(Fluka/Sigma), 2% ASB-14 (Fluka/Sigma), 0.2% Bio-Lyte 3/10 Ampholyte (BioRad), 2% 
TritonX-100 (Sigma). Dithiothreitol (DTT) was added to the solution immediately prior 
to IEF to a final concentration of 20mM. Suspension buffer is prepared to assure the 
maximum protein unfolding and denaturation in order to obtain a better resolution in 
proteins spots separated by 2DE.  
Samples were diluted in suspension buffer up to 120µl. Five µl per sample were used 
for total protein quantification using the RC-DC Protein Assay Kit II (Bio-Rad), according 
to manufacturer’s instructions. Briefly, to 5µl of each sample were added 25µl of RC 
Reagent I. Mixture was vortexed and incubated 1min at rt. Next, 25µl of RC Reagent II 
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were added, and mixture was vortexed and centrifuged at 15000xg for 5min. The 
supernatant was replaced by 25.4µl of solution A’ (composed of 250µl RC Reagent A 
plus 5µl of DC Reagent S). Samples were vortexed, sonicated for 4min at rt and 
vortexed again. To each sample 200µl of DC Reagent B were added. Samples were 
vortexed immediately and incubated for 15min and placed on a microplate to read 
their absorbance at 690nm on a spectrophotometer. Protein quantity of each sample 
was obtained by comparison with a standard curve composed of different loads of 
bovine serum albumin (BSA – Sigma) – 2 to 20 µg prepared by the same procedure.       
 
VI.2.3.1.2 – Isoelectric focusing 
IEF allows protein separation according to their isoelectric point (pI), the pH at which 
the protein global electric charge is null. When an electric field is applied on the 
sample, proteins migrate through an immobilized pH range until reach their respective 
pI. Once the charge is null proteins migration stops. IEF was performed using a Protean 
IEF Cell (BioRad) and 7cm immobilized pH gradient (IPG) strip, pH 5-8 or pH 3-10, non 
linear (NL) (BioRad).    
 
Two IEF assays were performed each containing 8 samples:  
Assay A: Experiments II, III, IV and V, groups 2.33 and 2.34;  
Assay B: Experiments I, II, III and IV, groups 2.33 and 2.34. 
 
Thirty µg of protein per sample were diluted in suspension buffer up to 125µl to which 
0.5µl of bromofenol blue 0.5% and DTT was added to a final concentration of 20mM. 
Samples were loaded onto an IPG strip on a focalization tray and allowed to be 
incorporated into the strip by an active rehydration step (16h at 50V). Sample 
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dehydration and oxidation were prevented by covering both sample and strip with 
mineral oil.    
IEF was performed as follows:  
i) 15min at 250V – to eliminate salt excess,  
ii) 2h gradient to 4000V in a slow ΔV, 
iii)  4000V constant to reach a total of 11 000 Vh, 
iv) 500V until program stops to avoid protein diffusion out of the strip. 
 
  VI.2.3.1.3 – Protein reduction/alkylation  
This step is performed to saturate the gel with sodium dodecyl sulfate (SDS) and 
reduce the proteins with DTT. In a second phase, alkylation is achieved by replacing 
DTT by iodoacetamide that acts as a scavenger for the excess of DTT and alkylates 
proteins preventing their reoxidation, increasing spot sharpness and improving protein 
identification by MS.      
Strips were incubated for  
i) 15min in reduction equilibration buffer – 6M urea, 2% SDS, 375mM Tris-
HCl pH 8.8, 20% glycerol, 130mM DTT,  
ii) 15min in alkylation equilibration buffer – 6M urea, 2% SDS, 375mM Tris-
HCl pH 8.8, 20% glycerol, 135mM iodoacetamide. 
 
VI.2.3.1.4 – SDS-PAGE  
SDS-PAGE was performed by placing the equilibrated IPG strips and a small paper 
3MM soaked with 4µl of molecular mass ruler (Fermentas) on top of 12% 
polyacrylamide gels and sealing with 0.5% agarose. Gels were run on a Mini Protean III 
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apparatus (Bio-Rad) at 20V until the samples entered the acrlyamide and at 150V until 
the bromophenol blue left the gel. 
 
 VI.2.3.2 – Gel imaging and analysis   
VI.2.3.2.1 – Gel staining  
Proteins were fixed in the gels by incubating with fixation solution (45% methanol, 1% 
acetic acid) for 20min. Two staining protocols were followed: colloidal brilliant blue 
(CBB) staining and silver nitrate staining. CBB staining is compatible with most protein 
characterization methods such as MS analysis but is not the most sensitive. Silver 
staining is far more sensitive, but less reproducible and not compatible with all protein 
analysis methods. Either staining permits the visualization of the separated proteins 
that appear as spots in gels.    
 
CBB staining was performed by: 
i) incubating the gels with CBB solution – 34 % methanol, 17% ammonium 
sulfate, 0.5% acetic acid, 0.1% brilliant blue G250; 
ii) decolorizing with hot milliQ water (55ºC) until obtaining a satisfying 
equalized relation between spot intensity and background. 
 
Silver staining was performed to increase the number of spots obtained, as follows:  
i) washing with miliQ water after CBB staining to remove all traces of blue; 
ii) sensitizing with 0.05%  (DTT) for 20min;  
iii) staining with 0.1% silver nitrate for 20min;  
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iv) washing twice with milliQ water for 1min each time;  
v) developing with 3% sodium carbonate and 0.02% formaldehyde until 
the desired coloration was obtained;  
vi) incubating with 10% acetic acid for 10min to stop the reaction;  
vii) washing with milliQ water twice for 5min each time. 
 
VI.2.3.2.2 – Image analysis 
Stained gels were scanned using a GS-800
TM
 Calibrated Densitometer (Bio-Rad) and the 
images were used for further analysis with the PDQuest 8.0 software (Bio-Rad) 
according to the manufactures instructions.  
The PDQuest software allows for the comparison of protein spots present in the two 
sets of samples (hemolymph of non-infected mosquitoes (group 2.33) vs. infected 
mosquitoes (group 2.34)) to identify proteins that exist in altered levels in the two sets 
of samples. The software automatically detects proteins spots in gels, which is 
followed by a manual scrutiny to differentiate valid spots from artifacts. 
 
Gels were analyzed simultaneously (both automatically by the program and manually) 
to identify identical spots existing in all gels - matching spots. One gel was then 
considered as the master gel, to which all others were compared for a quantitative 
analysis. 
To avoid variability due to experimental factors, data resulting from the analysis of gels 
were normalized to the total density in gel image. Spots of interest were chosen based 
on quantitative (1.5 fold difference) and statistical (t test, P<0.1) analyses of groups 
2.33 and 2.34, ie, non-infected vs. infected mosquitoes.  
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VI.2.3.3 – Protein identification by MS 
Spots of interest were excised from the gel using a pipette tip cut and placed in a 
microtube. A piece of gel containing no spot was used as a blank control. Tubes were 
kept at -20ºC.  
To perform protein identification, spots were submitted to a digestion with trypsin 
(tryptic digestion) and separated from the gel. The resulting peptides were sequenced 
by MS.  
 
VI.2.3.3.1 – Tryptic digestion 
As silver nitrate coloration is not the most compatible with MS peptide analysis, spots 
excised from gels colored with silver nitrate need a previous washing step to remove 
all traces of dye. Washing was performed by incubating the pieces of gel containing 
the spots of interest with a mixture of potassium ferricyanide and sodium thiosulfate 
(1:1 ratio) until coloration disappeared (1-2min), followed by a minimum of 5 washes 
with milliQ water. 
 
1. Gel pieces were incubated with a buffer containing 50% acetonitrile (ACN - 
Merck) for 15min under agitation, to remove solvents, dyes and other 
contaminants present in the gel. Supernatants were removed and the step 
repeated. 
Gel pieces were dehydrated in 50µl of ACN for 5min under agitation. 
Supernatants were replaced by 50µ of NH4HCO3 buffer (Fluka – Sigma Aldrich) 
25mM, pH 7.8 for 5min under agitation to rehydrate the samples. 
Another 50µl of ACN were added and samples were incubated for 5min under 
agitation. Supernatants were discarded and gel pieces were dried in a Speed-
Vac (Savant) for a few minutes. 
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2. Gel pieces were submitted to reduction and alkylation to ensure protein 
denaturation.  
Samples were incubated with 50µl of NH4HCO3 buffer to which was added DTT 
100mM for 45min at 56ºC. Supernatants were replaced by NH4HCO3 buffer 
with iodoacetamide 25mM for 30min in the dark. Supernatants were discarded. 
3. Gel pieces were washed twice with a mixture of NH4HCO3 buffer and ACN (1:1 
ratio) and once with pure ACN. Supernatants were discarded and gel pieces 
were dried in a Speed-Vac (Savant) for a few minutes. 
4. Digestion was performed in the gel by adding 5µl of trypsin (Promega) - 15ng/µl 
NH4HCO3 buffer. After complete absorption, 2µl of NH4HCO3 buffer were added 
and samples were incubated ON at 37ºC. 
Peptides were excised from gel pieces by incubating with a solution composed 
of 70% ACN and 3% formic acid, sonicated for 10min and desalted and 
concentrated with a Zip Tip C18 microcone (Millipore) and eluting in 4µl of 50% 
ACN.    
 
 VI.2.3.3.2 – Mass Spectrometry analysis 
Peptides resulting from tryptic digestion (tryptic fragments) were analyzed by MALDI-
TOF (Matrix Assisted Laser Desorption Ionization – Time Of Flight) mass spectrometry. 
This technique allows determining the mass of the peptides present in a mixture to a 
subpicomolar concentration.  
Samples were co-crystallized with a matrix (α-cyano hydroxycinnamic acid) and 
bombarded by a laser light. The acid nature of the matrix provides the protons that 
ionize the sample, creating monocharged ions ([M+H
+
]) that are accelerated by a 
uniform electric field (19kV) with a retarded extraction (200ns). Ions traverse a field 
free flight tube in a speed that is inversely proportional to their mass, ie, smaller and 
more charged ions move faster. An internal calibration is used consisting of trypsin 
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autolysis resulting fragments. This analysis results in a list of masses of the different 
digested fragments for each spot.      
To identify the proteins, mass values were compared with calculated values existing in 
proteomic and genomic databases by using informatics tools available in the internet, 
as Protein prospector (http://prospector.ucsf.edu) and Matrix Science 
(www.matrixscience.com). To this comparison a value (score) is attributed based on 
the number of proteolytical fragments obtained whose masses might correspond to 
the masses of the proteolytical fragments in the databases, and on the precision which 
the masses are determined. Known proteins (identified or reported as genes products) 
are then characterized based only on mass determination.     
 
 
 VI.2.4 – Hemolymph gene expression analysis 
Hemolymph pellets, containing hemocyte cell debris, collected from infected (group 
2.34) and non-infected (group 2.33) mosquitoes were used to determined the 
expression of the genes coding for the proteins identified by MS and other immune 
mosquito markers known to respond to malaria infection (AgCTL4, AgCLIPA2, AgPPO5 
and AgSRPN2). To evaluate expression, RNAs extracted from the pellets, were used to 
synthesize cDNAs that were semi quantified by Real-Time PCR.   
 
VI.2.4.1 – cDNA synthesis 
RNA was extracted from pellets using Trizol® reagent (Invitrogen) according to the 
manufacturer’s instructions, as described in section III.23.1.2.  
Total RNA in samples was quantified in GeneQuant (GE Healthcare) using a 1:50 
dilution of the RNA solution in DEPC treated water. In parallel, 2µl of the each RNA 
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solution were loaded into a denaturing 2% agarose gel to verify the integrity of RNA 
and confirm quantification.  
 
Roughly the same amount of RNA was used for cDNA synthesis as follows: 
i) RNA was diluted in 8µ of DEPC treated water to which was added 1µl of DNase 
buffer (Promega) and 1µl of DNase (Promega). Solutions were incubated at 
37ºC for 30min. 
ii) To the solution was added 18µl of the Moloney Murine Leukemia Virus Reverse 
Transcriptase (MMLV-RT – Promega) mix: 8µl of DEPC treated water, 6µl of 
MMLV-RT buffer, 1.5µl of dNTP’s (Sigma) and 5µl of oligo d(T) (Roche). Samples 
were incubated at 65ºC for 5min and then at 37ºC for 10min. One µl of MMLV-
RT enzyme was added to each sample and incubated at 37ºC for 50min 
followed by 75ºC for 5min. Samples were kept at -20ºC.    
 
VI.2.4.2 – DNA standard curve preparation 
DNA was extracted from Anopheles gambiae Yaoundé abdomens using a phenol-
chloroform protocol to generate a standard curve to be used for quantification by 
Real-Time PCR. 
i) Abdomens were incubated with 25µl of lysis buffer (Tris 40mM pH8.0; EDTA 
80mM pH8.0; SDS 2% pH7.2) and 75µl of Pronase E (Sigma – Aldrich) 2mg/ml at 
37ºC ON. 
ii) To the tube was added 300µl of milliQ water and 500µl of phenol. The tube was 
vortexed and centrifuged at 14000rpm for 10min. 
iii) The resulting aqueous phase was transferred into a new tube and mixed with 
500µl of phenol:chloroform:isoamyl alcohol. Samples were centrifuged at 
14000rpm for 10min. 
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iv)  The resulting aqueous phase was transferred into a new tube and mixed with 
45µl of sodium acetate 3M pH5.0 and 1.0ml of ice cold absolute ethanol. For 
DNA precipitation the solution was incubated at -80ºC for 5h. 
v) The solution was centrifuged at 14000rpm for 15min. The supernatant was 
discarded and the pellet was washed with 800µl of ethanol 80%. 
vi) The tube was centrifuged at 14000rpm for 10min and the supernatant 
discarded. The pellets dried ON at rt. 
vii) DNA pellets were dissolved in 20µl of milliQ water. 
viii) DNA was quantified in GeneQuant (GE Healthcare) using a 1:50 dilution.  
ix) Serial dilutions of DNA were performed to generate a DNA standard curve 
composed of the following concentrations: 250, 25, 2.5, 0.25 and 0.025ng/µl.   
  
   VI.2.4.3 – Real-Time PCR 
This technique provides a real-time monitoring of DNA amplification. This is possible 
by the use of a compound (SYBRGreen) that exhibits fluorescence when bound to 
double strand DNA (dsDNA). Thus, in each amplification-cycle the fluorescent signal 
increases proportionally to the number of dsDNA molecules. The more molecules of 
DNA present initially in the sample the lower the cycle to detect the signal. The use of 
a standard curve of known DNA concentrations allows the quantification of the same 
DNA present in each sample. To circumvent sample variation, results for each tested 
gene are normalized with the results obtained for an internal control, in this case, the 
mosquito ribosomal protein S7 (AgS7).   
Primarily reactions were optimized for primer concentration and annealing 
temperature testing different concentrations and temperatures for each primer and 
the standard curve. The primers and the respective optimized conditions are listed in 
the Table VI.2.1. 
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 The reaction was performed using iQ SYBR Green Supermix (Bio-Rad) that includes 
buffer, dNTPs, Taq enzyme, SYBR Green I, fluorescein and stabilizers, concentrated 2x. 
The reaction protocol included a standard PCR amplification protocol followed by a 
melting curve to determine for each sample the temperature at which half the 
molecules are denatured (Tm). As Tm is highly specific for each amplified product it is 
useful to verify contamination and primer dimmer formation. cDNA was used in a 
dilution of 1:10 of the initial solution for better results and placed in triplicate on a 96-
well reaction plate. Reactions were performed on a final volume of 20µl, primer 
concentration varied as descbribed in Table VI.2.1. Cycle conditions included an initial 
step of denaturation at 95ºC for 10min, followed by 40 cycles of denaturation at 95ªC 
for15sec and 1min of annealing and extension at varying temperatures (see table 
VI.2.1). 
Real Time amplification data for each gene was analyzed by the iCycler software 
(BioRad). Statistical data analysis was performed by applying a two-way ANOVA test 
using the GraphPad software (Prism). 
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Table VI.2.1 
Primers used for Real Time PCR 
 
Name 
NCBI gene 
ID 
Primer Sequence 
Stock 
Conc. 
Final 
Conc. 
Ann. 
Temp. 
AgS7 118785342 
Fwd: 5’ – GAGGTGGTCGGCAAGCGTATC – 3’ 
Rev: 5’ – CGGCGCTCGGCAATGAACAC – 3’ 
50µM 0,3µM 62ºC 
AgCTL4 158294013 
Fwd: 5’ – TTGAATTGTTTGATGCCGTGTCCTA – 3’ 
Rev: 5’ – GGCGCTCGTTGGTATCCTTTATTGT – 3’ 
50µM 0,3µM 62ºC 
AgCLIPA2 118793177 
Fwd: 5’ – CTTAACAACATTGCCGTGCTGGAG – 3’ 
Rev: 5’ – AGAACGCACCGACGCAGATAT – 3’ 
50µM 0,3µM 60ºC 
AgPPO5 11877159 
Fwd: 5’ – CTCGGCACGGGGATAGATTTTGT – 3’ 
Rev: 5’ – CATGCTGCCCCCGTTATTGGTC – 3’ 
50µM 0,3µM 62ºC 
AgSRPN2 158286630 
Fwd: 5’ – AGTCTGAGGGCGCGGTCATTACG – 3’ 
Rev: 5’ – GGGCCCGCCGCGAGTGCCATAGA – 3’ 
50µM 0,3µM 60ºC 
AGAP001420 158302077 
Fwd: 5’ – TCCTTCGATTTCCAAACAGG – 3’ 
Rev: 5’ – TTCTGGTTCCACTCCGATTC – 3’ 
50µM 0,3µM 58ºC 
AGAP002401 58383449 
Fwd: 5’ – AGCCGAGGAAGAGTTCAACA – 3’ 
Rev: 5’ – TCCAGTCTTCGAACATGCTG – 3’ 
50µM 0,9µM 60ºC 
AGAP002518 158290877 
Fwd: 5’ – GAGGACCTCCTGCAGAACAG – 3’ 
Rev: 5’ – ATTTTTCACCACCTCGATGC – 3’ 
50µM 0,3µM 62ºC 
AGAP004031 158298313 
Fwd: 5’ – CTGGCTACGTACCGAACGAT – 3’ 
Rev: 5’ – CGATCGTCTTCGAGTCCTTC – 3’ 
50µM 0,3µM 65ºC 
AGAP005645 158294533 
Fwd: 5’ – GGTGCAGTGAAGACGGAAAT – 3’ 
Rev: 5’ – GATGAGCTCGTGCACCTGTA – 3’ 
50µM 0,3µM 62ºC 
AGAP007593-
A 
158285381 
Fwd: 5’ – GTCCCTCGTGGAAATGAAAA – 3’ 
Rev: 5’ – GGCCTTCAACCATTTTGCTA – 3’ 
50µM 0,9µM 58ºC 
AGAP007593-
B 
158285381 
Fwd: 5’ – ATTTACCGCCATCCACAAGA – 3’ 
Rev: 5’ – GGTTGCGTGAGAGGAGAAGT – 3’ 
50µM 0,3µM 62ºC 
AGAP010130 158299169 
Fwd: 5’ – CGAGCAGAGTCCGAATTAGC – 3’ 
Rev: 5’ – ATCATCCCCACTTTCAGTGC – 3’ 
50µM 0,3µM 62ºC 
AGAP011053 158285040 
Fwd: 5’ – GGACGTTTTCGCACAGGTAT – 3’ 
Rev: 5’ – GTGGCGATAACCCTCGTCTA – 3’ 
50µM 0,3µM 62ºC 
AGAP0011833 158300868 
Fwd: 5’ – CTTTCCGGTCGAATTTTTCA – 3’ 
Rev: 5’ – ACGTCCAATGTTTGCCATTT – 3’ 
50µM 0,3µM 62ºC 
Primers are described by Name, NCBI identification, Sequence, stock concentration (conc.), Concentration (conc.) 
to use in reaction and Annealing temperature (Ann. Temp.). Fwd: forward; Rev: reverse. 
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VI.2.5 – Eicosanoid biosynthesis impact on infection  
Some of the proteins identified by 2D with altered levels in infected mosquitoes have a 
role or are involved in fatty-acid metabolism and eicosanoids biosynthesis. As such, 
mosquitoes were injected with either an inhibitor or a substrate for eicosanoids 
biosynthesis to evaluate their influence on P. berghei infection. 
 
VI.2.5.1 – Solution preparation and toxicity 
Indomethacin (IN –Fluka – Sigma) is a COX inhibitor that hinders prostaglandin (PG) 
synthesis and arachidonic acid (AA – Fluka – Sigma) is a COX and LOX substrate that 
promotes the synthesis of PG, leukotrienes and lipoxins (Figure VI.1.1). Both 
compounds were used to prepare solutions of 0.1, 1 and 10mg/ml in Schneider 
medium (Sigma) with 10% ethanol. 
Solutions were injected into Anopheles gambiae Yaoundé female mosquitoes using a 
Nanojet II Auto-nanoliter injector (Drummond Scientific). The glass needle inserted in 
the injector was filled with mineral oil (Sigma). Some of the oil was discarded and 
replaced by a solution of IN, AA or Schneider medium with 10% ethanol that was used 
as a control (C). For each group, 20 female mosquitoes were injected intratoraxically 
with 69nl of the respective solution. Mosquitoes were allowed to recover and survival 
was followed for 7 days. 
 
 VI.2.5.2 – Mosquito infection and injections          
To evaluate the influence of the compounds on infection, 3-5 five days old A. gambiae 
Yaoundé female mosquitoes were allowed to feed on mice infected with P. berghei 
ANKA clone 2.34.  
 At D7pi, when oocysts are still developing, infected mosquitoes (~100♀) were injected 
with either Schneider medium (control group – C7), indomethacin 1mg/ml 
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(indomethacin group – IN7) or AA 1mg/ml (AA group – AA7). To control infection in 
injected mosquitoes, 10 female mosquitoes were dissected at D8pi and midguts used 
to count oocyst numbers. 
Injections of P. berghei infected mosquitoes (non-injected yet) were performed also at 
D12pi, when the majority of oocysts are developed and sporozoites are starting to be 
released in to the hemolymph – groups C12, IN12 and AA12. In this case, infection was 
verified at D14pi.     
   
 VI.2.5.3 – Sporozoite load determination   
The impact of IN and AA injection on malaria infection in mosquitoes was evaluated by 
comparing sporozoite load in salivary glands. For this, mosquitoes were dissected at 
D21pi and salivary glands were collected to a glass homogenizer where they were 
crushed to release sporozoites and mixed with 400µl of PBS. The number of 
sporozoites in the suspension was counted using a hematocytometer.  Data was 
evaluated for statistical significance by applying a ratio t test on the GraphPad 
software (Prism).  
Experiments performed to evaluate the impact of eicosanoids biosynthesis on 
Plasmodium infection in the mosquito are resumed in Figure VI.2.2.  
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Figure VI.2.2 – Mosquito injections to evaluate eicosanoids biosynthesis impact on 
malaria infection. Female An. gambiae Yaoundé mosquitoes were fed on mice infected 
with P. berghei ANKA clone 2.34. One set of mosquitoes were injected with Schneider 
medium (Sch M) or indomethacin (IN)/AA at D7pi. At D9pi infection was monitored by 
determining oocyst number in the midgut of a few injected females. Injections were 
repeated on the other set of mosquitoes at D12pi. Infection was monitored at D14pi. 
Sporozoite load on salivary glands (SG) was determined at D21pi. Inj: injector.   
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VI.3 – Results 
 VI.3.1 – Mosquito infections 
To monitor the infection in each experiment, midguts were dissected at D13pi from 20 
female mosquitoes from group 2.34: 10 were used directly to determine oocyst load 
and 10 were crushed to determine sporozoite load. As P. berghei infection in the 
mosquito is asynchronous it is hard to predict at which exact timepoint and rate 
sporozoite are released from the midgut. A microscopical observation of infected 
midguts allowed a surveillance of matured oocysts and sporozoites while the number 
of sporozoites in the midguts indicated the presence of fully developed invasive forms 
ready to be released into the hemolymph. When both these criteria were fulfilled, it 
was assumed that in the majority of mosquitoes sporozoites had been or were being at 
that time released into the hemolymph. Table VI.3.1 summarizes the information 
about the infection status at D13pi of groups 2.34 in each experiment performed. A 
few mosquitoes belonging to group 2.33 were also dissected to confirm the non-
existence of midgut infection.          
 
Despite the differences in oocyst load, midguts carrying more than one oocyst 
displayed asynchronous infection, as some oocysts were still immature and developing 
while others were fully developed exhibiting thousands of sporozoites ready to release 
into the hemolymph. Also, in all experiments sporozoites were recovered from the 
dissected midguts of groups 2.34. This indicated that oocysts were ready to release 
sporozoites and that they were probably present at the mosquito hemocel at the time 
of hemolymph collection. 
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Table VI.3.1 
Infection parameters at D13pi in P. berghei infected mosquitoes (groups 2.34) 
 
 
 
 
 
Exp Infection D13pi – group 2.34 N mosq
 
 inf mdgt OM Inf 
mdgt 
ooc/ mdgt N  spz
 
2.33 2.34 
 (200x) (400x) (%) Avg
 
SD
 
I -  -  50 ND ND 1,5x10
5 
233 253 
II 
  
100 24,33 19,37 2,9x10
5 
239 246 
III 
  
55 2,11 2,71 6,6x10
4 
241 259 
IV 
  
100 9,1 7,98 1,2x10
5 
252 257 
V 
  
100 40,11 30,49 3,8x10
5 
80 78 
Parameters included: Observation of infected midguts by optical microscopy (inf mdgt OM) using amplifications of 
200 and 400x; percentage of infected midguts (Inf Mdgt); the average (Avg) number of oocysts per midgut 
(ooc/mdgt) and standard deviation (SD); the number of sporozoites in the midgut (N spz) and the number of 
mosquitoes (N mosq) used to collect hemolymph at D13pi in groups of non-infected (2-33) and P. berghei infected 
(2.34) mosquitoes. Exp: experiment.     
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VI.3.2 – Hemolymph proteome analysis 
 VI.3.2.1 – Two-dimensional electrophoresis 
Two proteomic assays (A and B) were performed including the hemolymph protein 
samples of 4 experiments each.  
In assay A, 30µg of hemolymph protein samples from experiments II-V (both groups 
2.33 and 2.34) were loaded onto a 7cm IPG strip with a pH range of 3-10, NL. IEF was 
performed as described in the section VI.2.3.1.2. In figure VI.3.1 are displayed two 2D 
maps representative of this analysis, corresponding to groups 2.33 and 2.34 of 
experiment IV. All 8 maps analyzed (2 groups (2.33 and 2.34) x 4 replicates 
(experiments II-V)) are displayed in Annex 1. 
 
 
 
 
 
 
 
Figure VI.3.1 – 2D maps of CBB stained hemolymph proteins from malaria non-infected (2.33) 
and infected (2.34) mosquitoes. Maps shown in figure are representative of the first analysis 
and correspond to experiment IV. Hemolymph samples were collected at D13pi and submitted 
to 2DE (IEF on 7cm pH3-10NL strips followed by 12% SDS-PAGE). Spots were analyzed by CBB 
staining and by PDQuest software analysis. Around 200 spots were detected in each gel. Spots in 
gels were analyzed qualitatively (fold difference >1.5) and quantitatively (t test, P<0.1). Spots A1 
and A2 show down-regulation (-) in all 2.34 maps. Bands of the protein marker are represented 
in kDa in between maps.    
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The 2D maps obtained show reproducibility and resolution. This indicates that the 
buffer used for protein solubilization was adequate for these samples. However in the 
acidic area of the maps resolution is not as desirable reflecting a property of the 
detergent used (ASB-14) that hinders a correct solubilization of acidic proteins.  
 The 2D maps showed around 200 protein spots each, 69 of which matched all gels 
analyzed. The replicates were analyzed by the PDQuest software (BioRad). Spots were 
considered differentially regulated when the mean spot intensity in 2.34 replicates was 
1.5-fold above or below the mean spot intensity in 2.33, and when applying a t test, 
P<0.1.       
No protein induction or repression was observed, ie the appearance or disappearance 
of protein spots in 2D maps of infected mosquitoes (2.34) when comparing to 2D maps 
of non-infected mosquitoes (2.33). It is important to bear in mind that the 7cm gels 
used do not allow a spot resolution as high as that of a 17cm gel. The latter obliges 
that at least 100µg of protein are analyzed, allowing for the detection of spots 
corresponding to proteins with a low level of expression. As for differential regulation, 
no protein up-regulation was detected in 2.34 maps, corresponding to infected 
mosquitoes. Only two spots were identified as down-regulated in infected mosquitoes: 
spots A1 and A2. 
The low number of spots retrieved from analysis A led us to make some changes in the 
analysis procedure. Alterations were made in pH range, narrowing the area to analyze, 
and by using a silver nitrate staining followed the CBB staining to allow the detection 
of more spots. 
 Two 2D maps representative of this assay are displayed in Figure VI.3.2, corresponding 
to groups 2.33 and 2.34 of experiment III. All 8 maps analyzed (2 groups (2.33 and 
2.34) x 4 replicates (experiments I-IV)) are displayed in Annex 1.     
Around 200 spots were detected in all maps analyzed, of which 130 had a match in all 
maps. Replicate gels were analyzed as previously described for assay A to identify 
differentially regulated spots in 2.34 maps – infected mosquitoes.  
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As for assay A, no induction or repression was detected. Thirteen of the spots found to 
be differentially regulated in 2.34 maps when compared to 2.33 maps (in infected vs. 
non-infected mosquitoes). Three spots were up-regulated in infected mosquitoes (B2, 
B3 and B4) while ten were down-regulated (B1, B5-B13 – Figure VI.3.3 and Figure 
VI.3.4). 
All spots showed the same up/down regulation in all experiments, except for spot B1 
that showed up-regulation in experiment II and down regulation in the others. A 
thorough analysis of highlighted spots revealed a mismatch for spot B7, which was 
retrieved from analysis. 
Differentially regulated spots in analysis B are shown in detail in Figure VI.3.3 that 
corresponds to the yellow box in Figure VI.3.2 and the  differential regulation of each 
spot highlighted in both assays is summarized in Figure VI.3.4 Protein levels for each 
highlighted spot are displayed in Annex2. 
 
Figure VI.3.2 – 2D maps of silver nitrate stained hemolymph proteins from malaria non-
infected (2.33) and infected (2.34) mosquitoes. Maps shown in figure are representative of 
analysis B and correspond to experiment III. Hemolymph samples were collected at D13pi and 
submitted to 2DE (IEF on 7cm pH5-8 strips followed by 12% SDS-PAGE). Spots were analyzed by 
silver nitrate staining and by PDQuest software analysis. Around 200 spots were detected in 
each gel. Spots in gels were analyzed qualitatively (fold difference >1.5) and quantitatively (t 
test, P<0,1). Spots B5 to B13 show down-regulation (-), while spots B2 to 4 show up-regulation 
(+) in all 2.34 maps. Spot B1 analysis was performed in three independent experiments, as 
experiment II was considered an outlier. Bands of the protein marker are represented in kDa in 
between maps. The region defined by the yellow rectangle is detailed in Figure VI.3.4.      
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Spot Regulation 
Ratio  
2.34/2.33 
M SD 
A1 
 
 0,33 0,17 
A2 
 
 0,59 0,20 
B1 
 
 0,15 0,07 
B2 
 
 3,81 2,07 
B3 
 
 2,25 1,83 
B4 
 
 2,01 0,86 
B5 
 
 0,65 0,20 
B6 
 
 0,57 0,22 
B7 
 
 0,38 0,21 
B8 
 
 0,66 0,18 
B9 
 
 0,57 0,09 
B10 
 
 0,52 0,20 
B11 
 
 0,51 0,10 
B12 
 
 0,51 0,09 
B13 
 
 0,57 0,11 
Figure VI.3.3 – Selected area from a 2D map of 
hemolymph proteins of malaria infected mosquitoes. 
Hemolymph was collected at D13pi from P. berghei 
infected female mosquitoes. Thirty micrograms of 
hemolymph protein sample was submitted to 2DE (IEF 
on 7cm pH5-8 IPG strips followed by 12% SDS-PAGE). 
This image illustrates in detail the area limited by the 
yellow box in figure VI.3.3, pH range: 6,69-8. Spots 
indicated were found to be differentially regulated 
regarding non-infected mosquitoes after a qualitative 
and quantitative analysis performed by the PDQuest 
software.    
Figure VI.3.4 – Differential regulation of protein spots 
highlighted in assyas A and B. Protein spots found to be 
differentially regulated in the hemolymph of P. berghei 
infected mosquitoes at D13pi. The differential regulation for 
each spot is expressed graphically for each experiment. In 
graphs, red bars represent spot intensity/protein level in 
hemolymph samples of non-infected mosquitoes (groups 
2.33) while green bars correspond to samples of P. berghei 
infected mosquitoes (groups 2.34). Bars are disposed 
sequentially according to experiment: for spots A1-A2 
experiments II to V (analysis A) and for spots B1-B13 
experiments I-IV (analysis B). Spot regulation is also 
characterized by trend (  - up-regulation;  - down-
regulation) and ratio of spot intensity between groups 2.34 
and 2.33 (Ratio 2.34/2.33), represented by the mean (M) 
and the standard deviation (SD).      
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VI.3.2.2 – Protein identification by MS 
Spots highlighted in analysis A and B as differentially regulated in infected mosquitoes 
(2.34) were removed from the gel and analyzed by MALDI-TOF. Table VI.3.2 shows the 
identification of the highlighted spots as retrieved from MS analysis. Peptides matched 
to the identified proteins by MALDI-TOF MS are displayed in detail in Annex3, along to 
the protein sequence itself. 
 
Table VI.3.2 
Protein spot identification by MALDI-TOF MS. 
 
spot Identification  
Ensemble 
Organism MW 
(kDa) 
pI NCBI  
Accession number 
Score
a 
Mascot 
A1  AGAP010130    An. gambiae str. PEST 30,393 6,64 158299170 46 
A2 AGAP011833 An. gambiae str. PEST 32,705 8,80 58394357 129 
B3 AGAP002518 An. gambiae str. PEST 80,605 6,10 118782666 322 
B4 AGAP002518 An. gambiae str. PEST 80,605 6,10 118782666 520 
B5 AGAP011053 An. gambiae str. PEST 36,262 5,94 158285041 109 
B6 AGAP007593 An. gambiae str. PEST 38,616 6,27 58378155 42 
B8 AGAP004031 An. gambiae str. PEST 34,234 8,37 158298314 191 
B9 AGAP001420 An. gambiae str. PEST 28,749 6,34 58396165 141 
B10 AGAP002401 An. gambiae str. PEST 25,851 6,78 31207169 51 
B11 AGAP005645 An. gambiae str. PEST 26,819 6,78 158294534 243 
 
 
 
Spots retrieved in analysis A and B as differentially regulated in infected mosquitoes at D13pi are identified by: the 
Ensemble ID number, the organism to which the proteins belong to, the molecular weight (MW), given in kDa, the 
protein isoelectric point (pI), the NCBI accession number, and the Mascot scores (
a
) – scores higher than 54 indicate a 
positive identification (p<0,05), scores below indicate a probable identification.  Spots B3 and B4 were identified as 
the same protein. 
Mosquito hemolymph proteome during infection 
 
 
141 
  
For spots B1, B7, B12 and B13, protein amount retrieved from gel was not sufficient to 
produce a result in MS analysis, even though spots were recollected in pools from 
more than one gel. Further analyses should be performed with an increased protein 
load.  
Spots A1, B6 and B10 identification score was lower than desired for statistical 
significance (P<0.05), but provided a probable result.  
Spot B6 reports to a gene that has 2 transcripts (AGAP007593-A and AGAP007593-B). 
The protein identified corresponds to the transcript AGAP007593-B.  
Spot B2 is not represented in table VI.3.2 due to poor identification score. Yet, the best 
result matched a P. chabaudi protein (NCBI accession number – 70939505). 
Spots B3 and B4 were identified as the same protein. These spots appear to have the 
same molecular weight (which corresponds to the one predicted by protein sequence 
analysis – 80kDa) but a different pI. This reflects a post-translational modification in 
the protein that affects its global charge. Also, both spots show a pI in the maps (above 
7.0) higher than that predicted (6.10) from the sequence, indicating that more than 
one modification occurs in the protein. The fact that both spots showed an up-
regulation in infected mosquitoes indicates that the infection does not lead to a 
change of one form into the other, that is, there is no preferential form of this protein 
that is up-regulated. 
Spot B10 shows a molecular mass higher than predicted, also pointing to a post-
translational modification. 
As in assay A, a non linear pH range strip was used making it difficult to predict if the 
observed pIs correspond in fact to the predicted ones. As for analysis B, none of the 
spots identified seems to have the predicted pI – spots B5, B6, B9and B11 seem to 
have a higher pI while B8 seems to have a lower pI. This also points to protein 
modifications. The nature of the modifications was not accessed and requires further 
analysis. 
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To attribute a function to each protein, they were investigated in NCBI, Vectorbase and 
InterPro. As no functional data are available yet for any of the identified proteins, the 
functions provided are predicted based on protein aminoacid sequence and motifs 
present. Predicted protein functions are shown in Table VI.3.3. Proteins identified by 
MS are predicted to be involved in cellular processes such as fatty acid metabolism, 
redox metabolism, aminoacid synthesis, glycolysis and proton transport.  
 
Table VI.3.3 
Protein families of identified spots  
 
          
spot ID Protein family 
Predicted 
Process 
Reg. 
A1 AGAP010130 Enoyl-COA-Hydratase/isomerase 
Fatty acid 
metabolism 
 
A2 AGAP011833 Enoyl-COA-Hydratase/isomerase 
Fatty acid 
metabolism 
 
B3 
B4 
AGAP002518 
Glutamate-5 kinase 
Aldehyde dehydrogenase 
Delta-I-pyrroline-5-carboxylate synthetase 
Aspartate/Glutamate/uridylate kinase 
Gamma-Glutamyl-phosphate reductase 
Aminoacid 
biosynthesis 
 
B5 AGAP011053 Aldo/Keto reductase 
Redox/Fatty acid 
metabolism 
 
B6 AGAP007593 
Glycerol-3-phosphate dehydrogenase 
Glycerol-3-phosphate dehydrogenase, N terminal 
Glycerol-3-phosphate dehydrogenase, C terminal 
Potassium uptake protein TrKA 
Redox 
metabolism 
Cation transport 
 
B8 AGAP004031 
Electron transport flavoprotein, alpha subunit 
Electron transport flavoprotein, alpha subunit C 
terminal 
Electron transport flavoprotein, alpha/beta 
subunit C terminal 
Electron 
transport 
Fatty acid 
metabolism 
 
B9 AGAP001420 
Phosphoglycerate mutase 
Phosphoglycerate mutase 1 
Phosphoglycerate/Bisphosphoglycerate mutase 
Metabolism 
Glycolysis 
 
B10 AGAP002401 ATPase, V1/A1 complex, subnit E 
Proton (H+) 
transport 
Energy 
 
B11 AGAP005645 
Short-chain dehydrogenase/reductase SDR 
Glucose/Ribitol dehydrogenase 
Insect alcohol dehydrogenase 
2,3-dihydro-2,3dihydro benzoate dehydrogenase 
  Polyketide synthase, KR  
Redox 
metabolism 
 
Protein identification/characterization according to MS. Table shows the sequence based prediction of protein 
family/function and the processes in which they may be involved, as described in Vectorbase.  Regulation (Reg) in 
infected (2.34) vs. non-infected (2.33) mosquitoes is also shown.  
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VI.3.3 – Hemolymph gene expression analysis 
The expression of the proteins identified by 2DE and MALDI-TOF MS as differentially 
regulated in P. berghei infected mosquitoes at D13pi was also evaluated at the 
transcriptional level. RNA from the pellets of the hemolymph samples collected was 
converted into cDNA and each gene was amplified by Real-Time PCR, using a DNA 
standard curve for quantification and AgS7 gene amplification for normalization.  
This analysis also included some immune markers known to respond to infection: 
AgCLIPA2, AgCTK4, AgPPO5 and AgSRPN2. 
Figure VI.3.5 shows an example of Real-Time amplification curves retrieved by the 
iCycler software (BioRad), in this case obtained for AgPPO5 gene amplification. The 
curves for all genes are displayed in Annex 4.             
 
 
 
 
 
Figure VI.3.5 – Real-time amplification of AgPPO5, in standard mosquito DNA curve samples, non-
infected and P. berghei infected mosquito hemolymph samples, collected at D13pi. A: DNA standard 
curve: includes points for all samples (blue – DNA standard curve samples; red – tested hemolymph 
samples), curve correlation coefficient and equation, and PCR efficiency. B: Amplification curves of the 
DNA standard curve samples. C: Amplification curves of all samples. D:Melt-curve for all samples. 
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Curves provided by the software included: 
• Real-Time amplification curve for triplicates of each sample. Curves are built 
based on the fluorescence at the end of each cycle. In figure VI.3.4 are 
represented amplification curves for all samples (C) and for standard curve 
samples (B). The latter included DNA amounts of 200ng, 20ng, 2ng and 0.2ng.  
• Standard curve and linear regression analysis (A). In this curve are included 
both DNA standard curve samples (blue dots) and hemolymph samples (red 
dots). Samples shown to have an mRNA amount lower than 0.2ng was 
considered not reliable and removed from analysis. Also in this graph there is 
information about the curve correlation coefficient (in this case 0,995), slope (-
3,368) and PCR efficiency (98,1%).  
• Melting curve (D). As melting temperature (temperature at which half of the 
dsDNA molecule is denatured – the peak of the curve) is highly specific for 
each amplified product this curve allows to determine any contamination or 
primer dimmer in the amplification reaction.    
 
Based on the DNA standard amplification curves and given that a threshold cycle 
number was determined for each reaction, iCycler software provided the mRNA 
amount (triplicate mean and standard deviation) present in each sample. Tables for 
each reaction are displayed on Annex4.  
Relative expression for each gene tested is represented in Figure VI.3.6.    
Significant difference in gene regulation between P. berghei infected (2.34) and non 
infected mosquitoes (2.33) was only observed for 5 of the genes tested. AGAP001420, 
AGAP004031, AGAP010130 and AGAP011053 genes showed up-regulation while 
AGAP007593A showed down-regulation in infected mosquitoes. 
Although not significant, a slight up-regulation in infected mosquitoes was also 
observed for AGAP002518, AGAP011833 and CLIPA2 genes.  
Mosquito hemolymph proteome during infection 
 
 
145 
  
   
   
   
   
  
  
 
* 
* 
* 
* 
* 
FigureVI.3.6 – Relative expression of Real-Time amplified genes in the hemolymph of non-
infected and P. berghei infected An. gambiae mosquitoes, at D13pi. Red bars: Mean values of 
relative expression in non-infected (2.33) mosquitoes. Green bars: Mean values of relative 
expression in P. berghei infected (2.34) mosquitoes. Error bars represent standard deviation 
values. Differences in relative expression of 2.33 and 2.34 mosquitoes were analyzed for 
statistical significance using a two-way ANOVA approach.  At least three independent 
experiments were used for analysis of each gene. Statistical significance (represented by *) was 
considered when P<0.05.   
Mosquito hemolymph proteome during infection 
 
 
146 
  
The infection effect on the levels of the proteins detected in the hemolymph was not 
always similar to that exerted on gene expression. Table VI.3.4 resumes the regulation 
of expression at the genomic and protein level of the tested spots/genes. 
 
 
Table VI.3.4 
Regulation of identified spots at genomic and protein levels in P. berghei infected vs. 
non-infected mosquitoes at D13pi 
  Gene Regulation  Protein levels 
  Ratio 2.34/2.33 Ratio 2.34/2.33 
   Identification Mean SD  Mean SD  
A1 AGAP010130 1.31* 0.11  0.33 0.17  
A2 AGAP011833 1.48 0.38 = 0.59 0.20  
B3 AGAP002518 1.26 0.32 = 2.25 1.83  
B4 AGAP002518 1.26 0.32 = 2.01 0.86  
B5 AGAP011053 2.67* 1.81  0.65 0.20  
B6 AGAP007593- 1.01 0.14 = 0.57 0.22  
B8 AGAP004031 1.51* 0.08  0.66 0.19  
B9 AGAP001420 2.13* 1.21  0.56 0.09  
B10 AGAP002401 1.20 0.71 = 0.52 0.20  
B11 AGAP005645 1.25 0.32 = 0.51 0.10  
 
 
 
 
Spots are identified by number in 2D maps and Ensemble ID. Genomic regulation and protein levels 
are characterized by mean and standard deviation (SD) of ratios of P. berghei infected (2.34) vs. non-
infected mosquitoes (2.33) and by trend:  - up-regulation,  - down-regulation. * indicates 
statistical differences in gene expression between non-infected (2.33) and infected (2.34) groups. 
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 VI.3.4 – Eicosanoid biosynthesis impact on infection 
Some of the proteins identified by 2DE and MS as differentially regulated in P. berghei 
infected mosquitoes at D13pi were found to be involved in fatty acid metabolism 
(Table VI.3.3). This process is intimately related to eicosanoid biosynthesis, as fatty 
acids are used as substrates in this biosynthetic process that is in turn involved in 
processes such as immune responses. Thus, we hypothesised that eicosanoid 
biosynthesis is altered during mosquito infection and that it plays a role in the 
mosquito response to sporozoite invasion of the hemolymph. To test this hypothesis, 
P. berghei infected mosquitoes were injected either with an eicosanoid biosynthesis 
inhibitor (indomethacin - IN) or a substrate (arachidonic acid – AA – Figure VI.1.1).  
 
 VI.3.4.1 – Solutions toxicity 
Before injecting indomethacin (IN) and arachidonic acid (AA) into the mosquitoes it 
was necessary to test for compound toxicity. Survival was determined by counting 
dead mosquitoes for 7 days. Some mosquitoes died in the first day, which was 
attributed to injection itself since there was no more mortality in the IN or AA groups 
than in controls (Figure VI.3.7). Solutions of 1mg/ml were chosen to perform the 
experiements.  
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Figure VI.3.7 – Mosquito 
survival after medium, IN and 
AA injections. Mosquitoes were 
injected either with 
indomethacin (IN), arachidonic 
acid (AA) in Schneider medium 
with 6% ethanol. Control 
mosquitoes were injected with 
Schneider medium with 6% 
ethanol. Dead mosquitoes were 
counted in each group for 7 
days. The graph represents the 
percentage of mosquito survival 
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 VI.3.4.2 – Indomethacin and Arachidonic acid  injections 
To evaluate the impact of eicosanoid biosynthesis on infection, an inhibitor (IN) and a 
substrate (AA) were injected into An. gambiae Yaoundé mosquitoes infected with P. 
berghei at D7pi or D12pi.  
Treatment of infected mosquitoes with the inhibitor resulted in a decreased number of 
sporozoites recovered from salivary glands when inhibition was perfomed at D7pi, 
while an increase was seen when inhibition occurred at D12pi (Figure VI.3.8-A). The 
opposite trend was observed when a eicosanoid biosynthesis substrate was injected 
rather than the inhibitor (Figure Vi.3.8-B). This is probably a result of of sporozoite 
maturation and the timming of their release into the hemolymph (Figure VI.3.8.-C).   
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Figure VI.3.8 – The impact of eicosanoid biosynthesis on the outcome of P. berghei 
infection in An. gambiae mosquitoes. Infected mosquitoes were injected at D7 or D12pi 
with indomethacin (IN) or arachidonic acid (AA). Control mosquitoes were injected with 
69nl of Schneider medium with 6% ethanol. Sporozoite load on salivary glands was 
determined at D21pi and analyzed by a ratio t test. Differences between IN/AA and 
control injected mosquitoes was considered significant when P<0.05. 
A: Eicosanoid biosynthesis Inhibitor (IN) injections. Graphs represent the number of 
sporozoites per female at D21pi in control mosquitoes (C7/12) and in IN injected 
mosquitoes (IN7/12). Left panel: mosquitoes injected at D7pi. Right panel: mosquitoes 
injected at D12pi. Each curve represents an experiment performed. On the right of each 
curve is displayed the ratio of sporozoite number in IN vs. C injected mosquitoes.  
B: Eicosanoid biosynthesis Substrate (AA) injections. Graphs represent the number of 
sporozoites per female at D21pi in control mosquitoes (C7/12) and in AA injected 
mosquitoes (AA7/12). Left panel: mosquitoes injected at D7pi. Right panel: mosquitoes 
injected at D12pi. Each curve represents an experiment performed. On the right of each 
curve is displayed the ratio of sporozoite number in AA vs. C injected mosquitoes.  
C: Schematic representation of parasite infection in the mosquito. At D7 oocysts (ooc) are 
still maturing and sporozoites (spz) developing inside these. At D12 oocysts have matured 
and developed sporozoites start to be released into the hemolymph. BL: Basal Lamina. 
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VI.4 – Discussion 
There is a deficit of data concerning the mosquito response to sporozoite hemolymph 
invasion that contrasts with the increasing amount of information on mosquito 
immune responses to midgut epithelium invasion by ookinetes. This led us to focus our 
attention to the hemolymph stage of parasite infection, as hemolymph is a crucial for 
immune responses. Thousands of parasites invade the hemolymph during sporozoite 
egress from the oocysts. Therefore, the mosquito is bound to respond to Plasmodium 
infection, contributing to the major sporozoite losses observed at this part of the 
parasite life cycle.  
Hemolymph is a protein rich environment, carrying secreted proteins such as immune 
molecules and messengers, and identifying these proteins during infection will clarify 
the processes involved in the mosquito response to sporozoites.  
 
 
 VI.4.1 – Hemolymph proteome analysis 
Protein spots were differentially regulated in the hemolymph of P. berghei infected 
mosquitoes when compared to those in the hemolymph of non-infected mosquitoes. 
Protein identification revealed that the differentially regulated protein spots were 
involved in cellular processes such as fatty acid metabolism, aminoacid synthesis, 
glycolysis and ion transport (Table VI.3.3). No immune-related proteins were detected 
as induced, repressed, up- or down-regulated in this study. This was unexpected, as 
one would expect that the mosquito response to sporozoite invasion of the 
hemolymph would induce the de novo synthesis of immune effector molecules. This 
may reflect the experimental procedure, namely the amount of protein loaded and 
consequent gel size, as a higher protein load on a 17cm gel would provide more 
protein spots to be analyzed and permit to detect spots corresponding to proteins 
existing at low concentrations. Also the detergent used (ASB-14) for protein sample 
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denaturation is not very effective in the acidic area, which also hinders the 
identification of additional protein spots.  
At the same time, the nature of the identified protein spots indicates that mechanisms 
other than those usually related to immunity may be involved in mosquito response to 
the parasite. It is necessary to bear in mind that parasites depend on the mosquito 
biology to survive and that they use many mosquito proteins during their life cycle. A 
variation on the turn-over of proteins that are essential to parasite survival may be 
sufficient to hinder parasite survival and/or development. This strategy would account 
for a lower energy requirement from the mosquito, as exhaustive protein synthesis (as 
in most immune responses) demands a high amount of energy and can be harmful for 
the mosquito (Ahmed et al., 2002; Demas et al., 1997; Moret & Schmid-Hempel, 2000; 
Rivero & Ferguson, 2003; Tripet et al., 2008). These results indicate that the general 
and basic mechanisms operating in mosquito biology may have a role in the control of 
infection, together with more specific immune responses, and that it is important to 
take them into account. 
  
 
 VI.4.2 – Hemolymph gene expression analysis 
To further understand the differential regulation of the proteins identified by 2DE and 
MS, gene expression was studied by Real-Time PCR.  
Although all the 10 protein spots identified were found to be differentially regulated in 
P. berghei infected mosquitoes (2.34) when compared to non-infected mosquitoes 
(2.33), only 4 of these (40%) were found to be differentially regulated at the genomic 
level (Figure VI.3.6). 
Interestingly, no correlation was observed between the RNA transcription and the 
protein expression (Table VI.3.4). For 5 genes (AGAP011833, AGAP002518, 
AGAP007593-B, AGAP002401 and AGAP005645), no differential expression in infected 
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mosquitoes was detected at the mRNA level, even though proteins levels differ from 
infected and non infected mosquitoes. As for the genes that show differential 
regulation (AGAP010130. AGAP011053. AGAP004031 and AGAP001420) they indicate 
an up-regulation in infected mosquitoes at mRNA level while protein levels are down-
regulated in infected mosquitoes.  
At least two processes might explain these discrepancies: a) transcription regulation 
does not coincide in time with protein production and/or b) the origin of proteins that 
circulate in the hemolymph do not coincide with the cells used for profiling. The gene 
expression profiles were described for hemolymph circulating cells, and proteins in the 
hemolymph are probably mainly secreted by the fat body (Meister et al., 1997; 
Meister, 2004; Samakovlis et al., 1990; Shi & Paskewitz, 2006).  
The gene corresponding to one of the proteins identified, AGAP007593-PB, was found 
to have two transcripts (A and B) that result from alternative splicing. Although the 
identified protein is known to correspond to transcript B, we decided to analyze also 
the expression of transcript A. It was interesting to realize that for one transcript there 
is no differential regulation in infected mosquitoes at the RNA level but a 43% down-
regulation occurs at the protein level (transcript B), while for the other (transcript A) 
there is a 60% reduction in gene expression and no variation in protein levels detected 
by 2DE (Figure VI.3.6 and Table VI.3.4).  
Gene AGAP002518 codes for a protein that showed two different spots in 2D maps, 
resulting from a post-translational modification (spots B3 and B4). The gene does not 
seem to be differentially regulated in infected mosquitoes, but both forms of the 
protein show a 2 fold increase in the same mosquitoes. 
These results show that as important as gene expression regulation is, the resulting 
data have to be carefully analyzed, as direct correlation with protein concentration 
may not exist. As proteins are the effectors in biological mechanisms, immunity 
included, gene expression may not be sufficient to indicate a variation in protein levels 
at a specific point during infection.  
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VI.4.3 - Eicosanoid biosynthesis impact on infection 
Fatty acids serve mainly energetic functions, existing in storage compartments in cells, 
but they may be converted into several products that function in numerous processes. 
One process that uses polyunsaturated fatty acids as substrate and is intimately 
related to the immune response is the eicosanoid biosynthesis (Calder, 2006). In 
vertebrates, eicosanoids mediate inflammation and immune responses, having roles in 
platelet aggregation, intensity and duration of pain and fever and blood pressure 
regulation. In insects, eicosanoid biosynthesis has also been linked to immune 
responses. Accumulating data suggests that eicosanoids have an important role in 
mediating responses to bacterial, fungal and parasite infections in six orders of insects 
(reviewed by Stanley & Miller, 2006).  
We showed that eicosanoid biosynthesis inhibitor has an infection promoting action 
when sporozoites are released from oocysts and invade the hemolymph (Figure VI.3.8-
A: right panel), suggesting that eicosanoids are necessary for the mosquito response to 
the parasite, which is in accordance with the eicosanoid effect on immunity described 
for several pathogen/insect models (Stanley & Miller, 2006). Interestingly, inhibition 
occurs when oocysts are still maturing and no sporozoites are observed within the 
oocyst, the number of salivary glands sporozoites decreases to one third of that found 
in control mosquitoes (Figure VI.3.8-A: left panel). This may reflect a role of mosquito 
synthesized eicosanoids in Plasmodium biology and development. The parasite has its 
own eicosanoid biosynthetic pathways that are different from those present in 
mammals, but it is not capable of de novo synthesis of fatty acids requiring arachidonic 
acid from its host (Holz, 1977). The implication of these on oocyst development has 
still to be unveiled.    
 
As would be expected in a robust model, the injection of an eicosanoid biosynthesis 
substrate (arachidonic acid – AA) produced the opposite results obtained with the 
injection of an inhibitor (IN). The injection of AA at D12pi leads to a salivary gland 
sporozoite number reduction to half of that found in control mosquitoes (Figure VI.3.8-
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B: right panel), confirming that eicosanoids are necessary to clear sporozoites from the 
mosquito hemolymph. Also, at D7pi, a 1.7fold increase is observed in parasite number 
in salivary glands of AA injected mosquitoes when compared to controls (Figure VI.3.8-
B: left panel) corroborating that eicosanoids are at some point required for parasite 
development. 
The fact that AA injections boost the mosquito hemolymph response to sporozoites 
suggests that eicosanoid biosynthesis in infected mosquitoes is not operating at a 
maximum level. One possible explanation would be an ability of the parasite to 
immunosuppress its mosquito host. This phenomenon was already observed in some 
pathogen/insect models, like in a bacterial infection of Spodoptera exigua and a 
Trypanosome infection of R. proxilus (Garcia et al., 2004b; Park & Kim, 2003). 
Trypanosome is a parasite closely related to Plasmodium indicating that these 
protozoan parasites, albeit infecting not related hosts, share common ways to 
circumvent the host immune responses.  
The ability of the parasite to evade and/or suppress the host’s immune response has 
been extensively studied in the vertebrate host. In blood stages of its life cycle, 
Plasmodium has been reported to have both immune evasion and suppression 
behaviors. To evade the host’s immunity, the parasite relies on antigen variation, 
differential erythrocyte invasion pathways and, in the case of P. falciparum, 
cytoadherence to blood vessels. As for immunosuppression, it seems to rely mainly on 
the malaria pigment (hemozoin) that results from hemoglobin digestion and 
accumulates in the infected red blood cells. Plasmodium falciparum hemozoin was 
shown to be responsible for the inhibition of human prostaglandin E2 (PGE2) gene 
expression, whose reduced levels would lead to a subsequent increase in TNFα levels 
accounting for the anemia (Keller et al., 2004; 2006). Accordingly, it was reported that 
children with malaria anemia have lower levels of circulating PGE2. At the same time, 
increased TNFα levels impair dentritic cells functions leading to a failure in T cells 
activation (Ocaña-Morgner et al., 2003; Millington et al., 2006, 2007; Wykes et al., 
2007).    
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In its mosquito vector, Plasmodium was also shown to have immune evasion and 
suppression behaviors. In late oocyst stages, parasites are believed to camouflage 
themselves by incorporating mosquito derived proteins into their surface and, in early 
stages, when ookinetes traverse the midgut epithelium it gets wrapped with mosquito 
plasmatic membrane (Vlachou et al., 2004). Some mosquito proteins, as CTL4 and 
CTLMA2, were found to be protective for the parasite, possibly assisting it in immune 
evasion (Warr et al., 2006).  Further, CTL4 KD mosquitoes do not melanize Sephadex 
beads (Warr et al., 2006), suggesting specificity of the protective effect and possible 
parasite manipulation of the immune system.  
At the midgut stage the parasite also has the ability to immunosuppress the mosquito: 
P. gallinaceum infection reduces Ae. aegypti mosquito’s ability to encapsulate 
Sephadex beads (Boete et al., 2004). P. falciparum however, seems to have the 
opposite effect, as its infection increases the melanotic response to Sephadex beads 
(Lambrechts et al., 2007). Nonetheless, P. falciparum infection was found to repress 
NOS gene expression, a gene involved in local epithelial responses (Tahar et al., 2002). 
There is no indication about possible immune evasion and/or suppression mechanisms 
displayed by the parasite while traversing the mosquito hemolymph, a stage at which 
it is most vulnerable to immunity and that represents a significant bottleneck for the 
parasite. The fact that most of the protein spots highlighted in this work by 2DE were 
found to be down-regulated upon sporozoite infection of the hemolymph, may reflect 
an immunosuppression rather than an evasion mechanism by the parasite.     
We therefore propose that the parasite is able to induce a reduction in the levels of 
mosquito proteins (such as those necessary for fatty acid metabolism) and to hinder 
the eicosanoid biosynthesis. An impaired ability to synthesize eicosanoids would 
compromise the mosquito immunity, protecting the parasite while it traverses the 
hemolymph to the salivary glands.              
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 Malaria eradication will integrate several measures, including transmission control. 
For this, it is vital to understand the interplay between parasite and vector. This work 
aimed at contributing to understanding this interaction. In particular, we attempted to 
evaluate the impact of antimalarials on mosquito immune response and the responses 
to sporozoites in the hemolymph.  
We failed to show chloroquine effect on Drosophila immune responses as described 
for mosquitoes, indicating that this is model is not suitable for such a study. 
Antimalarials such as chloroquine are metabolized by cells. If the observed effects are 
due to the drug itself or one of its metabolites is not known, explaining why direct 
feeding of the drug to flies has no effect on Drosophila immune responses. Also, the fly 
and the mosquito have diverged about 250 million years ago, and through evolution 
have specialized their immune responses against natural pathogens, according to their 
life style. It is probable that different molecules and routes to signaling pathways 
activation have emerged to respond to particular pathogens. Even so, several 
molecules, in particular those involved in the intracellular signaling pathways and 
antimicrobial peptide synthesis are well conserved in both organisms, making 
Drosophila a useful model for mosquito immune responses.          
Mosquito response to midgut invasion has been extensively studied and increasing 
amount of data have been produced. However, the response to other parasite stages, 
like sporozoite invasion of the hemolymph, has received little attention. This is 
surprising as it represents a major bottleneck in parasite development, as 90% of 
sporozoites are lost between midgut and salivary gland. In order to understand the 
mechanisms behind this reduction we focused our attention to this stage of parasite 
development in the mosquito. Previously, sporozoites were reported to be phagocysed 
by mosquito hemocytes and pericardial cells, when flowing along in the hemolymph. 
We have added knowledge about mechanisms such as melanization and eicosanoid 
biosynthesis to the mosquito response to the parasite at this stage. Our results point 
to several mechanisms being involved in the control of parasite load in the 
hemolymph. The mosquito seems to use several approaches to combat the infection. 
Cellular immune responses may play an important role, as mosquito hemocytes seem 
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to recognize the circumsporozoite protein of P. falciparum and, in the presence of this 
protein, a hemocyte number reduction is observed, even though it occurs in specific 
conditions (dosage and time of exposure). This points to the occurrence of cellular 
immune responses performed by the hemocytes, which is in accordance with the 
previously described sporozoite phagocytosis observed in both rodent and avian 
malarial infection. The hemocyte-like cells used in this work failed to proliferate upon 
different stimuli. Nevertheless, data from this and previous works suggest that 
hemocytes engage in cellular immune responses to Plasmodium sporozoites. Further 
analysis to determine morphological alterations in hemocytes and to evaluate different 
hemocyte sub-populations should give extra information about action of specific 
hemocyte types during the mosquito immune response to the parasite. Additionally, in 
vivo experiments would help to determine hemocyte proliferation and/or 
differentiation upon spoorozite invasion of the hemolymph. However, the 
asynchronicity of sporozoite release into the hemolymph makes it difficult to 
determine the exact moment of parasite recognition and cellular responses triggering. 
Other cellular immune responses, such as encapsulation and microaggregation should 
also be investigated in order to understand hemocyte dynamics towards sporozoites. 
We also investigated humoral reactions such as melanization. Even though we failed to 
conclusively show induction of melanization upon sporozoite invasion in the 
hemolymph, as previously reported for an avian malaria model, we showed that this 
mechanism is effectively necessary to control parasite numbers in salivary glands, 
indicating that more that one response may me involved in parasite load control. 
Detailed microscopic studies should help to visualize melanized sporozoites, and 
parasite quantification would be helpful to correlate parasite numbers and response 
intensities.  
Additionally, proteomic studies indicate that several molecules, besides the 
traditionally immune-related proteins, are affected by parasite presence. This 
coincides with microarrays studies that show altered expression in genes coding for 
proteins involved in processes such as immunity, apoptosis, detoxification, stress 
response and cytoskeleton remodeling. Our results show that even basic physiological 
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mechanisms like fatty acid metabolism, aminoacid biosynthesis and glycolysis may also 
play a role in immunity. However, we did not find any correlation between RNA 
expression and protein regulation. Even though our proteins are present in the 
hemolymph, their corresponding genes may be expressed in different cells, such as 
hemocytes or fat body. Nevertheless, many proteins known to engage in immune 
responses are processed and modified pos-translationally. Thus, it should be taken into 
account that gene expression may not correlate to protein regulation and, therefore 
immune responses should be analyzed primarily at the protein level. We also 
determined that eicosanoid biosynthesis has two opposite roles in parasite 
development: if, at the midgut stage of parasite development in oocysts eicosanoids 
seem to be necessary for sporozoite production, at the hemolymph stage these 
molecules seem to be necessary for the control of parasite load. At the same time, our 
results indicate that the parasite itself may engage in mechanisms to immunosuppress 
its vector, facilitating the transmission.            
 
The mosquito seems to rely on not one but several mechanisms to control sporozoite 
load in the hemolymph, reducing parasite numbers in the salivary glands. These 
mechanisms involve both cellular and humoral immune responses, as well as 
mechanisms not usually related to immunity but to the mosquito biology and 
physiology. As sporozoites invade the hemolymph in massive quantities it should be 
expected that, depending on only one type of response would be deleterious and 
harmful for the mosquito that would be forced to produce large amounts of proteins 
and/or immune responsive cells. This is evidenced by the fact that each of the 
immune-related mechanisms studied here and elsewhere are not responsible for the 
complete elimination of hemolymph sporozoites. As such we propose that the 
mosquito sustains a basal level of constitutive immunity that can be upleveld to a 
certain extent by a larger number of parasites. At the same time, the parasite seems to 
be able to compromise the mosquito response, by immunosuppression. Overall, the 
interplay between mosquito and parasite seems to be highly complex, involving 
several factors and mechanisms from both organisms, the mosquito fighting for an 
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equilibrium between parasite load and the cost of engaging in several immune 
responses and the parasite attempting to avoid/suppress the mosquito immune 
responses in order to be able to achieve its transmission.       
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Annex 1 
Assay A  
2D maps obtained in analysis A of hemolymph protein samples (30µg) from P. berghei 
infected (2.34) and non-infected An. gambiae mosquitoes (2.33). Samples were 
separated by 2DE on a pH3-10NL IPG strip and on a 12% polyacrylamide SDS-PAGE and 
stained with CBB.  
 
Experiment II – Hemolymph proteins of non-infected mosquitoes (2.33) 
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34) 
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Experiment III – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34)  
 
 
 
 
 
Annexes 
 
 
197 
  
Experiment IV – Hemolymph proteins of non-infected mosquitoes (2.33) 
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34) 
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Experiment V – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34) 
.  
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Assay B –  2D maps pbtained in analysis B of the hemolymph protein samples 
(30µg) of P. berghei infected (2.34) and non-infected An. gambiae 
mosquitoes (2.33). Samples were separated by 2DE on a pH5-8 IPG strip 
and on a 12% polyacrylamide SDS-PAGE and stained with Silver nitrate.  
 
Experiment I – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34) 
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Experiment II – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34)  
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Experiment III – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34)  
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Experiment IV – Hemolymph proteins of non-infected mosquitoes (2.33)   
 
 
Hemolymph proteins of P. berghei infected mosquitoes (2.34) 
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Annex 2 
Protein levels in the protein spots from the hemolymph of P. berghei infected (2.34) 
and non-infected (2.33) An. gambiae mosquitoes, collected at D13pi. Protein spots are 
differentially regulated in infected and non-infected mosquitoes by 2DE. 
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Annex 3 
Mass spectrometry identification of protein spots. Peptides matched to the protein 
sequence are represented in underline. MS parameters include score, sequence 
coverage of the matching peptides, error and the number of matched peptides. 
 
 
AGAP010130 – spot A1 
>gi|158299170|ref|XP_554016.3| AGAP010130-PA [Anopheles 
gambiae str. PEST] 
MLRVLQRSSRMVAPAARNFSSEAGNNKLVITEVDDKTGYATVTLNRPPVNSLSLELLRA
ISQTLDDLQNNKSRGMILTSSSNTVFSAGLDIMEMYKPNQERLRDFWSTLQDVWFKLYG
SPFPTAAAINGHAPAGGCLLSLCCEYRVMCPNYTIGLNETQLGIVAPTWFQASLRNTIS
RRESELALTLGKMYTTDEALKVGMIDEIAENKEKALEQAVAFLNRFRKISPMARAMTKQ
ALRSKDIVELEDNRSQDIDLFVYAVNQPAVQKGLEVYLESLKKKAQK 
 
Socre: 46 
Sequence coverage: 7%  
Error: 183ppm 
Peptides matched: 2 
 
AGAP011833 – spot A2 
>gi|58394357|ref|XP_320683.2| AGAP011833-PA [Anopheles 
gambiae str. PEST] 
MANIGRLLASRVAGQLVRNVATNQQQQQANLLRFYSSAPKAYEFIKAELAGEKKNVAVI
TLNRPKALNALCNGLVAEISDALDRYEADDSIGAIVITGSEKAFAAGADIKEMQPNTYA
KCINTDFLANWTRVAKAQKPVIAAVNGYALGGGCELAMMCDIIYAGDKARFGQPEIALG
TIPGAGGSQRTTRAMGKSKAMEMCLTGNMITAEEAERSGLVSKVFPAEKLVEEAVKLGE
KISTFSPLIVRLCKEAVNASYEMSLNEGLRFERRHFHATFSTKDRLEGMTAFVEKRAPK
FSNE 
 
Socre: 129 
Sequence coverage: 28%  
Error: 401ppm 
Peptides matched: 3 
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AGAP011053 – Spot B5 
>gi|158285041|ref|XP_308082.4| AGAP011053-PA [Anopheles 
gambiae str. PEST] 
MAPKVPSVRLNNGLEMPVLGLGTYLATEEEGIAAVKMAIDEGYRHIDTAYFYQNENQVG
QAVRAKIAEGLIKREDVFIVTKVWNTYHAPEHVAEACQRSLDNLGLGYIDLFLIHWPMG
WKFCGWTGDDLLPMNANGKSIDSDVDYLDTWKAMERLVKEGKVKSIGVSNFNSEQLTRL
LANCEIKPVTNQVECNPGINQRKLIEFCRQHDIVITAYSPLGRPNMADPVVGTAGIPKH
ALDDPRVIAIGQKYGKSAGQVVLRYLVELGTLPIPKSSKLERIRQNIDIFDFSLTEEEI
KLMDGFNTGGRTVPFHFSSEHKYFPFKLEY 
 
Socre: 109 
Sequence coverage: 23%  
Error: 432ppm 
Peptides matched: 5 
 
AGAP002518 – spot B3/B4 
>gi|118782666|ref|XP_312421.3| AGAP002518-PA [Anopheles 
gambiae str. PEST] 
ERKQATFSERNQLKYARRLVVKLGSAVITREDEHGLALGRLASIVEQVAEYHVEGRECI
MVTSGAVAFGKQRLTQELIMSLSMRETLSPTDHTRQDAGTLVEPRAAAAVGQSGLMSLY
DAMFAQYGIKIAQVLVTEPDFYNEETRKNLFSTLSELIHLNIVPIINTNDAVVPPMFIV
DQEVSATGKKRGIRIKDNDSLAALLAAEIHADLLILMSDVDGIYNKPPWEDGARLMHTY
TAGDKNLIKFGEKSKVGTGGMNSKVMAATWALDRGVSVVICNGMQDKAIKSILTGRKVG
TFFTESTAEKATPVEQIAENARNGSRVLQNLTAAERAQAVNTLADLLISRQSQILEANA
KDLDEAKKSGLAKPLLSRLSLTPSKLESLAKGLKQIADDSHRNVGRVVKRTKLADGLEL
KQVTVPIGVLLVIFESRPDSLPQVAALAMASGNGLLLKGGKEAAHSNRALMELVKESLA
ATGASNAISLVSTREEISDLLSMDEHIDLIIPRGSSELVRSIQEKAQHIPVMGHAEGIC
HVYVDREADLDKALKIIRDSKCDYPAACNAMETLLIHEDLLQNSSFFTDVCNMLKREGV
KINSGPKLNQMLTFGPPQAKSLKFEYGALECSIEVVKNLEEAIDHVHTYGSGHTDVIVT
ENPTSATYFQSNVDSACVFHNASSRFADGFRFGLGAEVGISTARIHARGPVGVEGLLTT
KWILSGVDHTASEFTDGSRAWLHQSLPTDQ 
 
Socre: 322/520 
Sequence coverage: 20%/29%  
Error: 94ppm/134ppm 
Peptides matched: 12/18 
 
Note: two protein spots were identified as the same protein. Peptides derived from 
both spots are represented in underline in the protein sequence; one is also 
represented in bold to allow for differentiation.  
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AGAP007593-B – spot B6 
>gi|58378155|ref|XP_308279.2| AGAP007593-PB [Anopheles 
gambiae str. PEST] 
MSDKVRVCIVGSGNWGSAIAKIVGANAKRLATFEDRVTMYVYEEMIDGKKLTEIINTTH
ENVKYLPGHKLPENVVAVPDVVEAAKDADILIFVVPHQFIRGLGTQLLGKIKPTAVGLS
LIKGFDVAEGGGMELISHLITKHLKIPCSVLMGANLAGEVAEEKFCETTIGCRDMKIAQ
TLRDLFLTPNFRVVVVDDVDAVEICGALKNIVACGAGFVDGMGLGDNTKAAVIRLGLME
MIKFVDVFYPGSKLSTFFESCGVADLITTCYGGRNRKVSEAFVKTGKTIVELENEMLNG
QKLQGPITAEEVNFMLKSKGMEDKFPLFTAIHKICTGTVKPQGFLDCLRNHPEHM 
 
Socre: 42 
Sequence coverage: 37%  
Error: 57ppm 
Peptides matched: 9 
 
AGAP004031 – spot B8 
>gi|158298314|ref|XP_318487.3| AGAP004031-PA [Anopheles 
gambiae str. PEST] 
ILRASAKFVNGINCFRQGFRRFQSTLVLAEHNNETLNPITANAVTAAKKLGGDVTVLVA
GTKVGPVSEAAAKLDGVKKVLVAEGDAYKGLLAESLTPLILATQEQLKFTHIVAGATAF
GKAVLPRIAAKLDVSPVSDIIGVQSADTFVRTIYAGNAIQTVKSKDPVKVITVRGTNFE
PTGAAGSAAAIEKAPEGDFASKTTEFVSQELTKSDRPSLTAAKIIVSGGRGMKSGDNFK
MLYDLADKWGAAVGASRAAVDAGYVPNDLQIGQTGKIVAPEVYVAIGISGAIQHLAGMK
DSKTIVAINKDPEAPIFQVADYGLVADLFKVVPEINEKC 
 
Socre: 191 
Sequence coverage: 34%  
Error: 67ppm 
Peptides matched: 8 
 
AGAP001420 – spot B9 
>gi|58396165|ref|XP_321710.2| AGAP001420-PA [Anopheles 
gambiae str. PEST] 
MAAKYRIVMVRHGESEWNQKNLFCGWFDANLSDKGKEEALAAGKAVKEAGLKFDIAHTS
LLTRAQVTLDSILKESGQTSIPIQKTWRLNERHYGGLTGLNKSETAAKYGEEQVLIWRR
SFDVPPPNMEPDHAYYDAIVKDERYKDDPKPNEFPMAESLKLTIARTLPYWNDVIIPQL
KEGKNIIIAAHGNSLRGIVKHLDQMTDEAIMGLNLPTGIPFVYELDENLKPVVSMKFLG
DEETVRKAIESVANQGKAK 
 
Socre: 141 
Sequence coverage: 28%  
Error: 316ppm 
Peptides matched: 7 
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AGAP002401 – spot B10 
>gi|31207169|ref|XP_312551.1| AGAP002401-PA [Anopheles 
gambiae str. PEST] 
MALSDADVQKQIKHMMAFIEQEANEKAEEIDAKAEEEFNIEKGRLVQQQRLKIMEYYEK
KEKQVELQKKIQSSNMLNQARLKVLKVREDHVSNVLDECRRRLGEVTKDPARYGEILTA
LITQGLLQLMEAKVLIRGRQADAQVIQNVLPAAVELYKSKCGRDVVVTLDTENFLPADT
TGGVDLLAQSGRIKVANTLESRLELIAQQLVPEIRNALFGRNMNRKFND 
 
Socre: 51 
Sequence coverage: 12%  
Error: 627ppm 
Peptides matched: 3 
 
AGAP005645 – spot B11 
>gi|158294534|ref|XP_315663.4| AGAP005645-PA [Anopheles 
gambiae str. PEST] 
MDRWNGKVAVVTGASSGIGAEIAKDLAKAGMITIGLARRVERVEQLKQQLPKEAANRLH
AMKCDVSIETDIERTFQRIADTYGGVDVLVNNAGIVRQNNLLDLGTAADLRAVLDTNVT
GLVLCSQWAYKSMVDRKVDGHIVHISSIAGHSVPNFPKLNIYPGTKHAVRAITETMRHE
MRDAGTKIKVTSVSPGAVKTEILDGVPIPEEMPLLEAEDISAAVLYAIGTPPHVQVHEL
IIKPVGEVM 
 
Socre: 243 
Sequence coverage: 39%  
Error: 39ppm 
Peptides matched: 7 
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Annex 4 
Real-Time amplification of mosquito genes.  
A - standard curve and linear regression analysis - DNA standard curve samples 
represented as blue dots, hemolymp samples represented by red dots. 
B – amplification curves of DNA standard samples. 
C – amplification curves of hemolymph samples. 
D – melting curve.    
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AgCTL4 
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AGAP011053 
 
 
Annex 5 
Composition of gels used to separate DNA, RNA and proteins, for Plasmodium 
detection, Northern blot and Western blot, respectively.  
 
 
Standard agarose gel  
for DNA separation 
  
1% agarose gel DNA sample 
TBE buffer (10X) 25ml 
1µl 
Agarose  2,5g 
dH2O 225ml 
Total volume 250ml 
 
 
 
Denaturing agarose gel  
for RNA separation 
  
1% agarose gel RNA sample prepration 
MOPS buffer (10X) 30ml RNA sample 20µg 
Agarose 3g Loading Buffer 8µl 
MiliQ H2O 216ml Heat at 70ºC for 10min 
Heat to dissolve Keep on ice 
Formaldeheyde 54ml   
Total volume 300ml   
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SDS-PAGE for 
protein separation 
Stacking gel Resolving gel 
Sample preparation  (4%)  (10%) (12%) 
Stacking buffer (4x) 2,000ml - -  Protein sample 2µg 
Resolving buffer (4x) -  2,500ml 2,500ml MiliQ H2O Up to 8µl 
Acryl/Bisacrylamide 
37:1 (40%) 
0,800ml 2,500ml 3,000ml Laemmli  buffer 
(5x) 
2µl 
MiliQ H2O 5,140ml 4,895ml 4,395ml Heat at 95ºC for 3min 
APS (10%) 50µl 100µl 100µl Short spin 
TEMED 10µl 5µl 5µl Keep on ice 
Total volume 8ml 10ml 10ml   
 
